{"doc_id": 0, "doc": {"person_id": 115967924, "visit_occurrence_id": 85358796, "death_date": null, "visit_concept_name": "Hospital", "visit_start_datetime": "2016-04-24 00:00:00", "visit_end_datetime": "2016-04-24 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Hospital, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-04-24, presumably until 2016-04-24\n\n", "approximate_token_count": 99, "patient_first_visit_date": "2014-10-03 14:30:00", "patient_last_visit_date": "2018-07-08 11:13:00", "end_obs_date": "2017-04-24", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 1, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 17, "cumulated_visit_num": 17, "cumulated_approximate_token_count": 4295, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-03 14:30:00, ended at 2014-10-03 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Primary malignant neoplasm of rectosigmoid junction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 12:12:00, ended at 2014-10-13 14:02:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n- Pure hypercholesterolemia\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- ranitidine 150 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 150 mg by mouth 2 times a day.\n- sucralfate 1000 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 1 g by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 14:03:00, ended at 2014-10-13 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-02 13:32:00, ended at 2014-11-02 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-03 00:00:00, ended at 2014-11-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-17 00:00:00, ended at 2015-01-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 12:36:00, ended at 2015-02-02 14:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Neoplasm defined only by topography: Rectum, NOS\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-02-02, presumably until 2015-02-03, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 14:30:00, ended at 2015-02-02 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Digestive symptom\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-07 10:30:00, ended at 2015-03-07 13:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- atorvastatin 10 MG Oral Tablet, through Oral route, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2015-03-30, with intended 0 refill(s). Instructions: take 40 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-13 00:00:00, ended at 2015-03-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-03-13, presumably until 2015-03-15, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- ertapenem 1000 MG Injection, started on 2015-03-15, presumably until 2015-03-15\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- midazolam 1 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 07:36:00, ended at 2015-03-17 13:47:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.49 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Glucose [Mass/volume] in Blood: 131 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- Other anterior resection of rectum\n- Anastomosis of large intestine to large intestine\n\n### Condition\n- Pure hypercholesterolemia\n- Primary malignant neoplasm of rectum\n- Gastroesophageal reflux disease\n- Intestinal disaccharidase deficiency\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-16\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2015-03-16, presumably until 2015-03-16\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-03-16, presumably until 2015-03-17\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-03-16, presumably until 2015-03-16\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-16\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2015-03-15, presumably until 2015-03-15\n- alvimopan 12 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-03-16, presumably until 2015-09-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-30 13:08:00, ended at 2015-03-30 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-21 11:06:42, ended at 2015-09-21 11:41:05\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-09-21, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n- prochlorperazine 10 MG Oral Tablet, started on 2015-06-14, presumably until 2015-06-14, with intended 0 refill(s)\n- psyllium 6000 MG Powder for Oral Suspension, through Oral route, started on 2015-09-21, presumably until 2015-09-21. Instructions: take 1 Packet by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2016-03-11, presumably until 2016-03-11, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-04-24, presumably until 2016-04-24\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-03 14:30:00, ended at 2014-10-03 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Primary malignant neoplasm of rectosigmoid junction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 12:12:00, ended at 2014-10-13 14:02:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n- Pure hypercholesterolemia\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- ranitidine 150 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 150 mg by mouth 2 times a day.\n- sucralfate 1000 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 1 g by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 14:03:00, ended at 2014-10-13 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-02 13:32:00, ended at 2014-11-02 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-03 00:00:00, ended at 2014-11-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-17 00:00:00, ended at 2015-01-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 12:36:00, ended at 2015-02-02 14:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Neoplasm defined only by topography: Rectum, NOS\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-02-02, presumably until 2015-02-03, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 14:30:00, ended at 2015-02-02 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Digestive symptom\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-07 10:30:00, ended at 2015-03-07 13:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- atorvastatin 10 MG Oral Tablet, through Oral route, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2015-03-30, with intended 0 refill(s). Instructions: take 40 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-13 00:00:00, ended at 2015-03-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-03-13, presumably until 2015-03-15, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- ertapenem 1000 MG Injection, started on 2015-03-15, presumably until 2015-03-15\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- midazolam 1 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 07:36:00, ended at 2015-03-17 13:47:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.49 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Glucose [Mass/volume] in Blood: 131 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- Other anterior resection of rectum\n- Anastomosis of large intestine to large intestine\n\n### Condition\n- Pure hypercholesterolemia\n- Primary malignant neoplasm of rectum\n- Gastroesophageal reflux disease\n- Intestinal disaccharidase deficiency\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-16\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2015-03-16, presumably until 2015-03-16\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-03-16, presumably until 2015-03-17\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-03-16, presumably until 2015-03-16\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-16\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2015-03-15, presumably until 2015-03-15\n- alvimopan 12 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-03-16, presumably until 2015-09-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-30 13:08:00, ended at 2015-03-30 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-21 11:06:42, ended at 2015-09-21 11:41:05\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-09-21, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n- prochlorperazine 10 MG Oral Tablet, started on 2015-06-14, presumably until 2015-06-14, with intended 0 refill(s)\n- psyllium 6000 MG Powder for Oral Suspension, through Oral route, started on 2015-09-21, presumably until 2015-09-21. Instructions: take 1 Packet by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2016-03-11, presumably until 2016-03-11, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-04-24, presumably until 2016-04-24\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of intestinal_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "2f8946aab9035e9ecc732786397cf833bf4a5cccd6d30e12f3f10b40affe0d8c", "prompt_hash": "91a56e9c51bde5bf7c36be066fe1bfa358c1fa65d767ff2dce6ceb7ed9d4cdfc", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 1, "doc": {"person_id": 115968162, "visit_occurrence_id": 49258395, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2012-08-05 00:00:00", "visit_end_datetime": "2012-08-05 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-05 00:00:00, ended at 2012-08-05 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valproic acid 50 MG/ML Oral Solution, started on 2012-08-05, presumably until 2012-08-05, with intended 11 refill(s). Instructions: GIVE VIA G J-TUBE 15ML (750MG) TWICE DAILY AT 8AM & 4PM BEFORE MEALS  THEN 20ML (1000MG) AT 10PM.\n\n", "approximate_token_count": 134, "patient_first_visit_date": "2009-02-16 00:00:00", "patient_last_visit_date": "2015-11-10 00:00:00", "end_obs_date": "2013-08-05", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 17, "cumulated_visit_num": 17, "cumulated_approximate_token_count": 18061, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2009-02-16 00:00:00, ended at 2009-02-16 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 156 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.30 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 110.1 (microgram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-02 23:01:00, ended at 2011-11-08 16:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 30 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 481 (unit per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 13.8 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 21.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Erythrocyte sedimentation rate: 134 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 159 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 149 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.08 (milli-international unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: >1000 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 946 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.1 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 19 (percent)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.0 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: Result checked (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 33.1 (microgram per milliliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 330 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 19 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 16.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- Prophylactic administration of vaccine against other diseases\n- Echocardiography\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences\n- Molecular diagnostics; reverse transcription\n- Molecular diagnostics; interpretation and report\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; subsequent\n- Radiologic examination, chest; single view, frontal\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Molecular diagnostics; amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (List separately in addition to code for primary procedure)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Radiologic examination, chest, special views (eg, lateral decubitus, Bucky studies)\n- Collection of venous blood by venipuncture\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Essential hypertension\n- Seizure disorder\n- Disorder of pericardium\n- Cardiomegaly\n- Fever\n- Acute renal failure syndrome\n- Leukocytosis\n- Physiological development failure\n- Pleural effusion\n- Atelectasis\n- Acquired hypothyroidism\n- Disorder of magnesium metabolism\n- Iron deficiency anemia\n- Cerebral palsy\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2011-11-05, presumably until 2011-11-08\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- atenolol 50 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-07\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-05, presumably until 2011-11-08\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-07\n- miconazole nitrate 0.02 MG/MG Topical Ointment, through Topical route, started on 2011-11-06, presumably until 2011-11-08\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-03, presumably until 2011-11-05\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2011-11-03, presumably until 2011-11-08\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-12 13:34:00, ended at 2011-11-12 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-11-15 00:00:00, ended at 2011-11-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-11-16 07:24:00, ended at 2011-12-08 10:30:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Globulin [Mass/volume] in Serum: 6.2 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 299 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.27 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 678 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Valproate [Mass/volume] in Serum or Plasma: 50.6 (microgram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.99 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 3.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 22.6 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 3.13 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 21 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 308 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.6 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 17.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 67 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Prothrombin time (PT): 15.4 (second)\n- Reticulocytes [#/volume] in Blood by Automated count: 47.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 134 (millimeter per hour)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: <1 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 95.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.02 (thousand per microliter)\n\n### Procedure\n- Counseling\n- Pericardiocentesis\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Other incision of pleura\n- Molecular diagnostics; enzymatic digestion, each enzyme treatment\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Echocardiography\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure)\n- Pericardiocentesis; initial\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Replacement of gastrostomy or cecostomy (or other colonic) tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study\n- Motion fluoroscopic evaluation of swallowing function by cine or video recording\n- Molecular diagnostics; mutation identification by sequencing, single segment, each segment\n- Biopsy of blood vessel\n- Collection of venous blood by venipuncture\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Occupational therapy evaluation\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Evaluation of oral and pharyngeal swallowing function\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, abdomen; single anteroposterior view\n- Arterial puncture, withdrawal of blood for diagnosis\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiological guidance (ie, fluoroscopy, ultrasound, or computed tomography), for percutaneous drainage (eg, abscess, specimen collection), with placement of catheter, radiological supervision and interpretation\n- Radiologic examination, chest; single view, frontal\n- Packed blood cell transfusion\n\n### Condition\n- Cerebral palsy\n- Disorder of magnesium metabolism\n- Primary malignant neoplasm of colon\n- Disorder of lung\n- Familial Mediterranean fever\n- Temporal arteritis\n- Lung field abnormal\n- Physiological development failure\n- Cardiac arrhythmia\n- Disorder of pericardium\n- Osteoporosis\n- Anemia\n- Leukocytosis\n- Acute renal failure syndrome\n- Hypoxemia\n- Pleural effusion\n- Acquired hypothyroidism\n- Atelectasis\n- Atherosclerosis of aorta\n- Dysphagia\n- Dyspnea\n- Fever\n- Pneumonitis due to inhaled substance\n- Prostatitis\n- Second degree atrioventricular block\n- Acute idiopathic pericarditis\n- Epilepsy\n\n### Drug\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2011-11-19, presumably until 2011-12-06\n- atenolol 50 MG Oral Tablet, through Oral route, started on 2011-12-07, presumably until 2012-01-08, with intended 0 refill(s). Instructions: take 50 mg by mouth daily. Hold for systolic BP below 100, and if heartrate is below 60 BPM \n- methylprednisolone 40 MG Injection, started on 2011-11-27, presumably until 2011-11-30\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-12-07. Instructions: 10 mg by Other route every bedtime. Given Via G-J Tube.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-11-25, presumably until 2011-12-08\n- potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- tribasic potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-11-21, presumably until 2011-12-01\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2011-11-19, presumably until 2011-11-29\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2012-04-01. Instructions: 200 mg by Other route 2 times a day. Given via G-J tube\n- alendronic acid 70 MG Oral Tablet, presumably until 2012-06-05. Instructions: 70 mg by Other route once a week. Every Friday Given via G-J tube\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-11-25, presumably until 2011-12-08\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-12-08. Instructions: take by mouth 2 times a day.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-17, presumably until 2011-11-17\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2011-12-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ibuprofen 400 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-11-30\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-17, presumably until 2011-12-08\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2011-11-19, presumably until 2011-11-19\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-11-19, presumably until 2011-11-30\n- tribasic sodium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-22, presumably until 2011-11-22\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-26. Instructions: take by mouth daily.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2012-04-01. Instructions: 250 mg by Other route daily. Given via G-J tube.\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2012-04-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day.\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08. Instructions: take by mouth daily.\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08. Instructions: take by mouth daily.\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-30\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2011-11-29, presumably until 2012-01-08, with intended 5 refill(s). Instructions: take 1 Tab by mouth daily.\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2011-12-08, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily.\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2011-11-20, presumably until 2011-11-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-29\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-17\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-11-30, presumably until 2012-01-08, with intended 5 refill(s). Instructions: take 15 mL by mouth every morning.\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-11-16, presumably until 2011-11-16\n- sodium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- sodium phosphate, monobasic, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-11-17, presumably until 2011-11-19\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-11-16, presumably until 2011-11-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-21\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2011-11-30, presumably until 2011-11-30\n- sodium phosphate, dibasic, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- lamotrigine 25 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-22. Instructions: take 25 mg by mouth every other day.\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08\n- 2 ML diazepam 5 MG/ML Auto-Injector, started on 2011-11-24, presumably until 2011-12-01\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-17. Instructions: take 500 mg by mouth 2 times a day.\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2011-12-05, presumably until 2011-12-05\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-23, presumably until 2011-11-29\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2011-12-01, presumably until 2011-12-02\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2012-02-25. Instructions: take 1 Tab by mouth daily. 500 mg 3 times a day \n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2012-01-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q12H.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-11-21, presumably until 2011-12-02\n- dibasic potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-29, presumably until 2011-12-04\n- 1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-16, presumably until 2011-11-16\n- 300 ML linezolid 2 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-16 08:39:08, ended at 2011-11-16 12:45:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-20 10:20:21, ended at 2011-11-20 16:50:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-30 08:06:54, ended at 2011-11-30 14:56:55\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-12-06 15:05:29, ended at 2011-12-06 15:35:19\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-12-14 00:00:00, ended at 2011-12-14 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Prostatitis\n- Epilepsy\n- Anemia\n- Leukocytosis\n- Cerebral palsy\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2011-12-14, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 420 g by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-12-16 19:06:00, ended at 2012-01-08 13:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 55 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 161 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 42 (percent)\n- Thrombin time: 16.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.9 (microgram per milliliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 21 (percent)\n- MCHC [Mass/volume] by Automated count: 36.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Body height: 5' 4.016\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 128 (milliunit per milliliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1430 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.86 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Erythrocyte sedimentation rate: 99 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 5.7 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 44 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 28.4 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.06 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 29.5 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Osmolality of Serum or Plasma: 327 (milliosmole per kilogram)\n- Prothrombin time (PT): N/A (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.42 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 125 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 15.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.5 (percent)\n- Osmolality of Urine: 360 (milliosmole per kilogram)\n- Sodium [Moles/volume] in Serum or Plasma: 155 (millimole per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: N/A (nanogram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 69.6 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.7 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 3.60 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 490 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.94 (milli-international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 661 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n\n### Procedure\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Insertion of endotracheal tube\n- Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Echocardiography\n- Radiologic examination, abdomen; single anteroposterior view\n- Physical therapy evaluation\n- Conversion of gastrostomy tube to gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Packed blood cell transfusion\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Controlled ventilation procedure and therapy, initiation and management\n- Occupational therapy evaluation\n- Central venous catheter placement with guidance\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Percutaneous [endoscopic] gastrojejunostomy\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Counseling\n- Other incision of pleura\n- Continuous invasive mechanical ventilation for less than 96 consecutive hours\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Insertion of gastrostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Evaluation of oral and pharyngeal swallowing function\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Endoscopic polypectomy of large intestine\n- Motion fluoroscopic evaluation of swallowing function by cine or video recording\n\n### Condition\n- Atelectasis\n- Disorder of pericardium\n- Neoplasm of uncertain behavior of digestive organ\n- Acquired hypothyroidism\n- Hyperosmolality and or hypernatremia\n- Lymphadenopathy\n- Pleural effusion\n- Severe sepsis\n- Sepsis\n- Septic shock\n- Pain in limb\n- Acute renal failure syndrome\n- Anemia\n- Dysphagia\n- Fever\n- Pneumonitis due to inhaled substance\n- Thoracic spondylosis without myelopathy\n- Acute posthemorrhagic anemia\n- Benign neoplasm of colon\n- Cerebral palsy\n- Diarrhea\n- Epilepsy\n- Hypoxemia\n- Leukocytosis\n- Physiological development failure\n- Disorder of magnesium metabolism\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-12-24, presumably until 2012-01-04\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2011-12-26, presumably until 2011-12-28\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2011-12-24, presumably until 2011-12-25\n- clonazepam 0.25 MG Disintegrating Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 50 ML famotidine 0.4 MG/ML Injection, through Intravenous route, started on 2011-12-19, presumably until 2011-12-21\n- acetaminophen 650 MG Rectal Suppository, through Rectal route, started on 2011-12-29, presumably until 2013-01-07, with intended 1 refill(s). Instructions: insert 1 Suppository into the rectum every 4 hours as needed for Fever.\n- methylprednisolone 40 MG Injection, started on 2011-12-24, presumably until 2012-01-04\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 10 mg by mouth every bedtime.\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-12-17, presumably until 2011-12-21\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-17. Instructions: take 200 mg by mouth 2 times a day.\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-12-19, presumably until 2011-12-21\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-12-27, presumably until 2011-12-28\n- divalproex sodium 125 MG Delayed Release Oral Capsule, through Oral route, started on 2011-12-24, presumably until 2011-12-28\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-12-22, presumably until 2011-12-28\n- nystatin 100000 UNT/ML Topical Cream, through Topical route, started on 2011-12-18, presumably until 2012-01-08\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-04\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2011-12-25, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 3 Tabs by mouth daily. Take 3 tabs per day until 12/20.  On 01/16/2012, start taking 2 tabs per day.  On 01/29/2012, start taking 1 tab per day and continue at this dosage until your appointment with rheumatology.\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-12-24, presumably until 2012-01-02\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2011-12-20, presumably until 2011-12-20\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-12-17, presumably until 2012-01-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-12-29, presumably until 2011-12-29\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-01-06, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take for another 4 days.\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-12-19, presumably until 2011-12-27\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-27. Instructions: take by mouth daily.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-12-19, presumably until 2011-12-19. Instructions: take 250 mg by mouth daily.\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-12-17, presumably until 2012-01-08. Instructions: take 400 mg by mouth 3 times a day.\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2011-12-28. Instructions: take by mouth daily.\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2011-12-28. Instructions: take by mouth daily.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2011-12-17, presumably until 2011-12-24\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2011-12-17, presumably until 2011-12-29\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 1 Tab by mouth daily.\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2011-12-29, presumably until 2012-01-05\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2011-12-22, presumably until 2012-01-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2011-12-16, presumably until 2011-12-21\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2012-01-08. Instructions: take 200 mg by mouth 2 times a day.\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2011-12-18, presumably until 2011-12-26\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-12-17, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 20 mL by mouth daily in the evening. Administer via G-tube at 10PM every day.\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-12-16, presumably until 2012-01-04\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2012-01-06, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. Take for 4 days.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2011-12-30, presumably until 2011-12-30\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-12-26, presumably until 2011-12-30\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-12-16, presumably until 2012-01-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-12-29, presumably until 2012-01-03\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2011-12-25, presumably until 2011-12-26\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2012-01-08, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2011-12-20, presumably until 2011-12-20\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2012-01-08\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 1 Tab by mouth daily. 500 mg 3 times a day \n- midazolam 1 MG/ML Injectable Solution, started on 2011-12-20, presumably until 2011-12-20\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-01-03, presumably until 2012-01-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-02-25 15:55:00, ended at 2012-02-26 19:17:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Valproate [Mass/volume] in Serum or Plasma: 54.1 (microgram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordinat\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Replacement of gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n\n### Condition\n- Seizure\n- Stoma malfunction\n- Physiological development failure\n- Cerebral palsy\n- Epilepsy\n- Mechanical complication of gastrostomy\n- Clinical finding\n\n### Drug\n- polysaccharide iron complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous gluconate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous fumarate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous ascorbate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron,peptonized, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous succinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous bisglycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous cysteine glycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous aspartate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ammonium ferrous sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2012-02-26, presumably until 2012-02-26\n- soy protein-iron complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous carbonate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous glycine sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron succinyl milk protein complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron-dextran complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- teferrol, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous asparto glycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous cacodylate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2012-02-26, presumably until 2012-02-26\n- iron, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous oxalate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-02-25, presumably until 2012-02-25\n- iron sucrose, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron carbonyl, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous lactate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous chloride, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- levothyroxine sodium 0.075 MG Oral Tablet. Instructions: 75 mcg by Other route daily. Given via G-J tube. \n- iron sorbitex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous phosphate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-03-30 15:33:00, ended at 2012-04-01 17:13:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.75 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 2.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 20.5 (milliequivalent per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 38.0 (picogram)\n- MCV [Entitic volume] by Automated count: 104.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 7.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 27 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Globulin [Mass/volume] in Serum: 5.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 27.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 17.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 51 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Oxygen [Partial pressure] in Blood: 36 (millimeter mercury column)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide [Partial pressure] in Blood: 34.2 (millimeter mercury column)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Change of gastrostomy tube\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n- Radiologic examination, chest; single view, frontal\n- Radiologic examination, abdomen; single anteroposterior view\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Replacement of gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Fever\n- Cerebral palsy\n- Vomiting\n- Epilepsy\n- Infective pneumonia\n- Pneumonitis due to inhaled substance\n- Tachycardia\n- Acquired hypothyroidism\n- Pleural effusion\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2012-03-30, presumably until 2012-03-30\n- polysaccharide iron complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous gluconate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous fumarate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous ascorbate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron,peptonized, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous succinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous bisglycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous cysteine glycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 3 refill(s). Instructions: take 8 mL by mouth 3 times a day.\n- clonazepam 0.25 MG Disintegrating Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-01\n- ferrous aspartate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-03-31\n- ammonium ferrous sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-01\n- soy protein-iron complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2012-04-01, presumably until 2013-04-01, with intended 5 refill(s). Instructions: take 25 mL by mouth 2 times a day. Hold for more than 3 bowel movements per day.\n- ferrous carbonate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous glycine sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- diatrizoate, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- lacosamide 10 MG/ML Oral Solution, through Oral route, started on 2012-04-01, presumably until 2012-04-01, with intended 3 refill(s). Instructions: take 200 mg by mouth 2 times a day.\n- iron succinyl milk protein complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron-dextran complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- prednisone 1 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- teferrol, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous asparto glycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous cacodylate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- diatrizoic acid, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-01\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 3 refill(s). Instructions: take 20 mL by mouth every bedtime.\n- iron, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous oxalate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-01\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-04-01, presumably until 2012-04-01\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2012-03-30, presumably until 2012-03-30\n- iron sucrose, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron carbonyl, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous lactate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous chloride, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- calcium carbonate 250 MG/ML Oral Suspension, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 5 refill(s). Instructions: 5 mL by Azul Swain route 2 times a day with meals.\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-03-30\n- iron sorbitex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous phosphate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-06-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-05-31 09:32:00, ended at 2012-05-31 12:53:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Attention to gastrostomy\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Acquired hypothyroidism\n- Stoma malfunction\n- Developmental delay\n- Cerebral palsy\n- Constipation\n- Disorder of vertebral column\n- Mechanical complication of gastrostomy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-05 10:24:00, ended at 2012-06-05 15:09:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 1.5\" (inch (US))\n\n### Procedure\n- Replacement of gastrostomy or cecostomy (or other colonic) tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Change of gastrostomy tube\n\n### Condition\n- Cerebral palsy\n- Developmental delay\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-06-05, presumably until 2012-06-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-06 00:00:00, ended at 2012-06-06 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n\n### Drug\n- polysaccharide iron complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous gluconate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous fumarate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous ascorbate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron,peptonized, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous succinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous bisglycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous cysteine glycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous aspartate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ammonium ferrous sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- soy protein-iron complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous carbonate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous glycine sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron succinyl milk protein complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron-dextran complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- teferrol, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous asparto glycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous cacodylate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous oxalate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron sucrose, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron carbonyl, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous lactate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous chloride, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron sorbitex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous phosphate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-05 00:00:00, ended at 2012-08-05 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valproic acid 50 MG/ML Oral Solution, started on 2012-08-05, presumably until 2012-08-05, with intended 11 refill(s). Instructions: GIVE VIA G J-TUBE 15ML (750MG) TWICE DAILY AT 8AM & 4PM BEFORE MEALS  THEN 20ML (1000MG) AT 10PM.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-02-16 00:00:00, ended at 2009-02-16 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 156 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.30 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 110.1 (microgram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-02 23:01:00, ended at 2011-11-08 16:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 30 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 481 (unit per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 13.8 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 21.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Erythrocyte sedimentation rate: 134 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 159 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 149 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.08 (milli-international unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: >1000 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 946 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.1 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 19 (percent)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.0 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: Result checked (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 33.1 (microgram per milliliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 330 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 19 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 16.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- Prophylactic administration of vaccine against other diseases\n- Echocardiography\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences\n- Molecular diagnostics; reverse transcription\n- Molecular diagnostics; interpretation and report\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; subsequent\n- Radiologic examination, chest; single view, frontal\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Molecular diagnostics; amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (List separately in addition to code for primary procedure)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Radiologic examination, chest, special views (eg, lateral decubitus, Bucky studies)\n- Collection of venous blood by venipuncture\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Essential hypertension\n- Seizure disorder\n- Disorder of pericardium\n- Cardiomegaly\n- Fever\n- Acute renal failure syndrome\n- Leukocytosis\n- Physiological development failure\n- Pleural effusion\n- Atelectasis\n- Acquired hypothyroidism\n- Disorder of magnesium metabolism\n- Iron deficiency anemia\n- Cerebral palsy\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2011-11-05, presumably until 2011-11-08\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- atenolol 50 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-07\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-05, presumably until 2011-11-08\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-07\n- miconazole nitrate 0.02 MG/MG Topical Ointment, through Topical route, started on 2011-11-06, presumably until 2011-11-08\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-03, presumably until 2011-11-05\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2011-11-03, presumably until 2011-11-08\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-12 13:34:00, ended at 2011-11-12 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-11-15 00:00:00, ended at 2011-11-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-11-16 07:24:00, ended at 2011-12-08 10:30:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Globulin [Mass/volume] in Serum: 6.2 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 299 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.27 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 678 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Valproate [Mass/volume] in Serum or Plasma: 50.6 (microgram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.99 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 3.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 22.6 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 3.13 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 21 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 308 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.6 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 17.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 67 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Prothrombin time (PT): 15.4 (second)\n- Reticulocytes [#/volume] in Blood by Automated count: 47.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 134 (millimeter per hour)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: <1 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 95.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.02 (thousand per microliter)\n\n### Procedure\n- Counseling\n- Pericardiocentesis\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Other incision of pleura\n- Molecular diagnostics; enzymatic digestion, each enzyme treatment\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Echocardiography\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure)\n- Pericardiocentesis; initial\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Replacement of gastrostomy or cecostomy (or other colonic) tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study\n- Motion fluoroscopic evaluation of swallowing function by cine or video recording\n- Molecular diagnostics; mutation identification by sequencing, single segment, each segment\n- Biopsy of blood vessel\n- Collection of venous blood by venipuncture\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Occupational therapy evaluation\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Evaluation of oral and pharyngeal swallowing function\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, abdomen; single anteroposterior view\n- Arterial puncture, withdrawal of blood for diagnosis\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiological guidance (ie, fluoroscopy, ultrasound, or computed tomography), for percutaneous drainage (eg, abscess, specimen collection), with placement of catheter, radiological supervision and interpretation\n- Radiologic examination, chest; single view, frontal\n- Packed blood cell transfusion\n\n### Condition\n- Cerebral palsy\n- Disorder of magnesium metabolism\n- Primary malignant neoplasm of colon\n- Disorder of lung\n- Familial Mediterranean fever\n- Temporal arteritis\n- Lung field abnormal\n- Physiological development failure\n- Cardiac arrhythmia\n- Disorder of pericardium\n- Osteoporosis\n- Anemia\n- Leukocytosis\n- Acute renal failure syndrome\n- Hypoxemia\n- Pleural effusion\n- Acquired hypothyroidism\n- Atelectasis\n- Atherosclerosis of aorta\n- Dysphagia\n- Dyspnea\n- Fever\n- Pneumonitis due to inhaled substance\n- Prostatitis\n- Second degree atrioventricular block\n- Acute idiopathic pericarditis\n- Epilepsy\n\n### Drug\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2011-11-19, presumably until 2011-12-06\n- atenolol 50 MG Oral Tablet, through Oral route, started on 2011-12-07, presumably until 2012-01-08, with intended 0 refill(s). Instructions: take 50 mg by mouth daily. Hold for systolic BP below 100, and if heartrate is below 60 BPM \n- methylprednisolone 40 MG Injection, started on 2011-11-27, presumably until 2011-11-30\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-12-07. Instructions: 10 mg by Other route every bedtime. Given Via G-J Tube.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-11-25, presumably until 2011-12-08\n- potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- tribasic potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-11-21, presumably until 2011-12-01\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2011-11-19, presumably until 2011-11-29\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2012-04-01. Instructions: 200 mg by Other route 2 times a day. Given via G-J tube\n- alendronic acid 70 MG Oral Tablet, presumably until 2012-06-05. Instructions: 70 mg by Other route once a week. Every Friday Given via G-J tube\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-11-25, presumably until 2011-12-08\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-12-08. Instructions: take by mouth 2 times a day.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-17, presumably until 2011-11-17\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2011-12-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ibuprofen 400 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-11-30\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-17, presumably until 2011-12-08\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2011-11-19, presumably until 2011-11-19\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-11-19, presumably until 2011-11-30\n- tribasic sodium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-22, presumably until 2011-11-22\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-26. Instructions: take by mouth daily.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2012-04-01. Instructions: 250 mg by Other route daily. Given via G-J tube.\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2012-04-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day.\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08. Instructions: take by mouth daily.\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08. Instructions: take by mouth daily.\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-30\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2011-11-29, presumably until 2012-01-08, with intended 5 refill(s). Instructions: take 1 Tab by mouth daily.\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2011-12-08, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily.\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2011-11-20, presumably until 2011-11-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-29\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-17\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-11-30, presumably until 2012-01-08, with intended 5 refill(s). Instructions: take 15 mL by mouth every morning.\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-11-16, presumably until 2011-11-16\n- sodium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- sodium phosphate, monobasic, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-11-17, presumably until 2011-11-19\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-11-16, presumably until 2011-11-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-21\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2011-11-30, presumably until 2011-11-30\n- sodium phosphate, dibasic, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- lamotrigine 25 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-22. Instructions: take 25 mg by mouth every other day.\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08\n- 2 ML diazepam 5 MG/ML Auto-Injector, started on 2011-11-24, presumably until 2011-12-01\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-17. Instructions: take 500 mg by mouth 2 times a day.\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2011-12-05, presumably until 2011-12-05\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-23, presumably until 2011-11-29\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2011-12-01, presumably until 2011-12-02\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2012-02-25. Instructions: take 1 Tab by mouth daily. 500 mg 3 times a day \n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2012-01-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q12H.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-11-21, presumably until 2011-12-02\n- dibasic potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-29, presumably until 2011-12-04\n- 1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-16, presumably until 2011-11-16\n- 300 ML linezolid 2 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-16 08:39:08, ended at 2011-11-16 12:45:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-20 10:20:21, ended at 2011-11-20 16:50:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-30 08:06:54, ended at 2011-11-30 14:56:55\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-12-06 15:05:29, ended at 2011-12-06 15:35:19\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-12-14 00:00:00, ended at 2011-12-14 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Prostatitis\n- Epilepsy\n- Anemia\n- Leukocytosis\n- Cerebral palsy\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2011-12-14, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 420 g by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-12-16 19:06:00, ended at 2012-01-08 13:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 55 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 161 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 42 (percent)\n- Thrombin time: 16.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.9 (microgram per milliliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 21 (percent)\n- MCHC [Mass/volume] by Automated count: 36.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Body height: 5' 4.016\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 128 (milliunit per milliliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1430 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.86 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Erythrocyte sedimentation rate: 99 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 5.7 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 44 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 28.4 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.06 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 29.5 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Osmolality of Serum or Plasma: 327 (milliosmole per kilogram)\n- Prothrombin time (PT): N/A (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.42 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 125 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 15.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.5 (percent)\n- Osmolality of Urine: 360 (milliosmole per kilogram)\n- Sodium [Moles/volume] in Serum or Plasma: 155 (millimole per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: N/A (nanogram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 69.6 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.7 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 3.60 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 490 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.94 (milli-international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 661 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n\n### Procedure\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Insertion of endotracheal tube\n- Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Echocardiography\n- Radiologic examination, abdomen; single anteroposterior view\n- Physical therapy evaluation\n- Conversion of gastrostomy tube to gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Packed blood cell transfusion\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Controlled ventilation procedure and therapy, initiation and management\n- Occupational therapy evaluation\n- Central venous catheter placement with guidance\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Percutaneous [endoscopic] gastrojejunostomy\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Counseling\n- Other incision of pleura\n- Continuous invasive mechanical ventilation for less than 96 consecutive hours\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Insertion of gastrostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Evaluation of oral and pharyngeal swallowing function\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Endoscopic polypectomy of large intestine\n- Motion fluoroscopic evaluation of swallowing function by cine or video recording\n\n### Condition\n- Atelectasis\n- Disorder of pericardium\n- Neoplasm of uncertain behavior of digestive organ\n- Acquired hypothyroidism\n- Hyperosmolality and or hypernatremia\n- Lymphadenopathy\n- Pleural effusion\n- Severe sepsis\n- Sepsis\n- Septic shock\n- Pain in limb\n- Acute renal failure syndrome\n- Anemia\n- Dysphagia\n- Fever\n- Pneumonitis due to inhaled substance\n- Thoracic spondylosis without myelopathy\n- Acute posthemorrhagic anemia\n- Benign neoplasm of colon\n- Cerebral palsy\n- Diarrhea\n- Epilepsy\n- Hypoxemia\n- Leukocytosis\n- Physiological development failure\n- Disorder of magnesium metabolism\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-12-24, presumably until 2012-01-04\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2011-12-26, presumably until 2011-12-28\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2011-12-24, presumably until 2011-12-25\n- clonazepam 0.25 MG Disintegrating Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 50 ML famotidine 0.4 MG/ML Injection, through Intravenous route, started on 2011-12-19, presumably until 2011-12-21\n- acetaminophen 650 MG Rectal Suppository, through Rectal route, started on 2011-12-29, presumably until 2013-01-07, with intended 1 refill(s). Instructions: insert 1 Suppository into the rectum every 4 hours as needed for Fever.\n- methylprednisolone 40 MG Injection, started on 2011-12-24, presumably until 2012-01-04\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 10 mg by mouth every bedtime.\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-12-17, presumably until 2011-12-21\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-17. Instructions: take 200 mg by mouth 2 times a day.\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-12-19, presumably until 2011-12-21\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-12-27, presumably until 2011-12-28\n- divalproex sodium 125 MG Delayed Release Oral Capsule, through Oral route, started on 2011-12-24, presumably until 2011-12-28\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-12-22, presumably until 2011-12-28\n- nystatin 100000 UNT/ML Topical Cream, through Topical route, started on 2011-12-18, presumably until 2012-01-08\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-04\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2011-12-25, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 3 Tabs by mouth daily. Take 3 tabs per day until 12/20.  On 01/16/2012, start taking 2 tabs per day.  On 01/29/2012, start taking 1 tab per day and continue at this dosage until your appointment with rheumatology.\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-12-24, presumably until 2012-01-02\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2011-12-20, presumably until 2011-12-20\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-12-17, presumably until 2012-01-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-12-29, presumably until 2011-12-29\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-01-06, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take for another 4 days.\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-12-19, presumably until 2011-12-27\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-27. Instructions: take by mouth daily.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-12-19, presumably until 2011-12-19. Instructions: take 250 mg by mouth daily.\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-12-17, presumably until 2012-01-08. Instructions: take 400 mg by mouth 3 times a day.\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2011-12-28. Instructions: take by mouth daily.\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2011-12-28. Instructions: take by mouth daily.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2011-12-17, presumably until 2011-12-24\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2011-12-17, presumably until 2011-12-29\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 1 Tab by mouth daily.\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2011-12-29, presumably until 2012-01-05\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2011-12-22, presumably until 2012-01-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2011-12-16, presumably until 2011-12-21\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2012-01-08. Instructions: take 200 mg by mouth 2 times a day.\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2011-12-18, presumably until 2011-12-26\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-12-17, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 20 mL by mouth daily in the evening. Administer via G-tube at 10PM every day.\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-12-16, presumably until 2012-01-04\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2012-01-06, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. Take for 4 days.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2011-12-30, presumably until 2011-12-30\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-12-26, presumably until 2011-12-30\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-12-16, presumably until 2012-01-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-12-29, presumably until 2012-01-03\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2011-12-25, presumably until 2011-12-26\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2012-01-08, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2011-12-20, presumably until 2011-12-20\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2012-01-08\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 1 Tab by mouth daily. 500 mg 3 times a day \n- midazolam 1 MG/ML Injectable Solution, started on 2011-12-20, presumably until 2011-12-20\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-01-03, presumably until 2012-01-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-02-25 15:55:00, ended at 2012-02-26 19:17:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Valproate [Mass/volume] in Serum or Plasma: 54.1 (microgram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordinat\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Replacement of gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n\n### Condition\n- Seizure\n- Stoma malfunction\n- Physiological development failure\n- Cerebral palsy\n- Epilepsy\n- Mechanical complication of gastrostomy\n- Clinical finding\n\n### Drug\n- polysaccharide iron complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous gluconate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous fumarate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous ascorbate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron,peptonized, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous succinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous bisglycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous cysteine glycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous aspartate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ammonium ferrous sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2012-02-26, presumably until 2012-02-26\n- soy protein-iron complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous carbonate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous glycine sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron succinyl milk protein complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron-dextran complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- teferrol, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous asparto glycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous cacodylate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2012-02-26, presumably until 2012-02-26\n- iron, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous oxalate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-02-25, presumably until 2012-02-25\n- iron sucrose, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron carbonyl, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous lactate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous chloride, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- levothyroxine sodium 0.075 MG Oral Tablet. Instructions: 75 mcg by Other route daily. Given via G-J tube. \n- iron sorbitex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous phosphate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-03-30 15:33:00, ended at 2012-04-01 17:13:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.75 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 2.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 20.5 (milliequivalent per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 38.0 (picogram)\n- MCV [Entitic volume] by Automated count: 104.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 7.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 27 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Globulin [Mass/volume] in Serum: 5.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 27.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 17.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 51 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Oxygen [Partial pressure] in Blood: 36 (millimeter mercury column)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide [Partial pressure] in Blood: 34.2 (millimeter mercury column)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Change of gastrostomy tube\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n- Radiologic examination, chest; single view, frontal\n- Radiologic examination, abdomen; single anteroposterior view\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Replacement of gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Fever\n- Cerebral palsy\n- Vomiting\n- Epilepsy\n- Infective pneumonia\n- Pneumonitis due to inhaled substance\n- Tachycardia\n- Acquired hypothyroidism\n- Pleural effusion\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2012-03-30, presumably until 2012-03-30\n- polysaccharide iron complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous gluconate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous fumarate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous ascorbate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron,peptonized, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous succinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous bisglycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous cysteine glycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 3 refill(s). Instructions: take 8 mL by mouth 3 times a day.\n- clonazepam 0.25 MG Disintegrating Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-01\n- ferrous aspartate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-03-31\n- ammonium ferrous sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-01\n- soy protein-iron complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2012-04-01, presumably until 2013-04-01, with intended 5 refill(s). Instructions: take 25 mL by mouth 2 times a day. Hold for more than 3 bowel movements per day.\n- ferrous carbonate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous glycine sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- diatrizoate, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- lacosamide 10 MG/ML Oral Solution, through Oral route, started on 2012-04-01, presumably until 2012-04-01, with intended 3 refill(s). Instructions: take 200 mg by mouth 2 times a day.\n- iron succinyl milk protein complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron-dextran complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- prednisone 1 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- teferrol, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous asparto glycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous cacodylate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- diatrizoic acid, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-01\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 3 refill(s). Instructions: take 20 mL by mouth every bedtime.\n- iron, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous oxalate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-01\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-04-01, presumably until 2012-04-01\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2012-03-30, presumably until 2012-03-30\n- iron sucrose, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron carbonyl, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous lactate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous chloride, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- calcium carbonate 250 MG/ML Oral Suspension, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 5 refill(s). Instructions: 5 mL by Azul Swain route 2 times a day with meals.\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-03-30\n- iron sorbitex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous phosphate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-06-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-05-31 09:32:00, ended at 2012-05-31 12:53:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Attention to gastrostomy\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Acquired hypothyroidism\n- Stoma malfunction\n- Developmental delay\n- Cerebral palsy\n- Constipation\n- Disorder of vertebral column\n- Mechanical complication of gastrostomy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-05 10:24:00, ended at 2012-06-05 15:09:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 1.5\" (inch (US))\n\n### Procedure\n- Replacement of gastrostomy or cecostomy (or other colonic) tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Change of gastrostomy tube\n\n### Condition\n- Cerebral palsy\n- Developmental delay\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-06-05, presumably until 2012-06-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-06 00:00:00, ended at 2012-06-06 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n\n### Drug\n- polysaccharide iron complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous gluconate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous fumarate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous ascorbate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron,peptonized, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous succinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous bisglycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous cysteine glycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous aspartate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ammonium ferrous sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- soy protein-iron complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous carbonate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous glycine sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron succinyl milk protein complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron-dextran complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- teferrol, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous asparto glycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous cacodylate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous oxalate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron sucrose, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron carbonyl, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous lactate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous chloride, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron sorbitex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous phosphate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-05 00:00:00, ended at 2012-08-05 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valproic acid 50 MG/ML Oral Solution, started on 2012-08-05, presumably until 2012-08-05, with intended 11 refill(s). Instructions: GIVE VIA G J-TUBE 15ML (750MG) TWICE DAILY AT 8AM & 4PM BEFORE MEALS  THEN 20ML (1000MG) AT 10PM.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of intestinal_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "835aee01e92312e16f29194f3405735d2930ce89d234c70037c4634aff84fec5", "prompt_hash": "e61ef10590bfe09a209de911aa8d7aba35ce0f14af6f0e3d3255091b28129630", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115968494, "visit_occurrence_id": 132854128, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2019-03-30 10:25:00", "visit_end_datetime": "2019-03-30 23:59:00", "visit_length_in_hours": 13.566666666666666, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-30 10:25:00, ended at 2019-03-30 23:59:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 113 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 134, "patient_first_visit_date": "2017-09-03 00:00:00", "patient_last_visit_date": "2022-10-26 09:59:00", "end_obs_date": "2020-03-29", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 118, "cumulated_visit_num": 118, "cumulated_approximate_token_count": 48683, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-03 00:00:00, ended at 2017-09-03 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Mature T-cell AND/OR NK cell neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-10 00:00:00, ended at 2017-09-10 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-09-10, presumably until 2017-09-10, with intended 3 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-09-10 17:36:00, ended at 2017-09-17 16:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 39 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 4 (per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 413 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.25 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.8 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Prothrombin time (PT): 13.0 (second)\n- Thrombin time: 15.0 (second)\n- Urate [Mass/volume] in Serum or Plasma: <2.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 453 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Body height: 5' 4.764\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.67 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 1049 (microgram of fibrinogen equivalent unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: 1 (per microliter)\n\n### Procedure\n- Diagnostic bone marrow; biopsy(ies)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Extraction of Iliac Bone Marrow, Percutaneous Approach, Diagnostic\n- Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach\n- Hospital discharge day management; more than 30 minutes\n- Ultrasound, scrotum and contents\n- Collection of venous blood by venipuncture\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Chemotherapy administration, into CNS (eg, intrathecal), requiring and including spinal puncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n\n### Condition\n- Non-Hodgkin's lymphoma of extranodal site\n- Atrial fibrillation\n- Pleural effusion\n- Abnormal findings on diagnostic imaging of lung\n- Anemia in neoplastic disease\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Disorder of male genital organ\n- Abnormal cytological findings in CSF\n- Electrocardiogram abnormal\n- Anemia\n\n### Drug\n- benzocaine 15 MG / menthol 3.6 MG Oral Lozenge, through Submucosal route, started on 2017-09-15, presumably until 2017-09-15\n- sodium bicarbonate 650 MG Oral Tablet, started on 2017-09-16, presumably until 2017-09-19, with intended 0 refill(s). Instructions: Take 2 tabs the night before chemotherapy and the morning of chemotherapy.\n- metoclopramide 1 MG/ML Oral Solution, through Oral route, started on 2017-09-15, presumably until 2017-10-05, with intended 0 refill(s). Instructions: take 10 mL by mouth 3 times a day as needed (hiccups)\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-09-12, presumably until 2018-05-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2017-09-11, presumably until 2017-09-16\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-09-14, presumably until 2017-10-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed (Mild to moderate nausea/vomiting.)\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-09-12, presumably until 2017-10-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-09-11, presumably until 2017-09-17\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-09-12, presumably until 2017-09-14\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-09-11, presumably until 2017-09-15\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-09-11, presumably until 2017-09-11\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2017-09-17, presumably until 2017-10-04, with intended 3 refill(s). Instructions: take 1 Lozenge by mouth 5 times a day\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-09-13, presumably until 2017-09-16\n- sodium chloride 9 MG/ML Injection, started on 2017-09-16, presumably until 2017-09-16\n- gadobenate, through Intravenous route, started on 2017-09-11, presumably until 2017-09-11\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-09-10, presumably until 2017-09-17\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-09-10, presumably until 2017-09-16\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-09-11, presumably until 2017-10-05, with intended 4 refill(s). Instructions: inject 0.8 mL subcutaneous (under the skin) daily\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2017-09-14, presumably until 2017-10-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed (Mild to moderate nausea/vomiting)\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-09-15, presumably until 2017-09-15\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2017-09-16, presumably until 2018-02-07, with intended 1 refill(s). Instructions: take 1 Tab by mouth every day Do not take 24 hours prior to chemotherapy\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-09-13, presumably until 2017-09-13\n- mesna 400 MG Oral Tablet, through Oral route, started on 2017-09-15, presumably until 2017-09-15\n- leucovorin 25 MG Oral Tablet, through Oral route, started on 2017-09-15, presumably until 2017-09-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-09-13, presumably until 2017-09-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-19 00:00:00, ended at 2017-09-19 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2017-09-19, presumably until 2018-02-07, with intended 2 refill(s). Instructions: take 4 Tabs by mouth every 4 hours Starting at 6 am on the day of hospital admission\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-04 12:00:00, ended at 2017-10-04 15:36:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 187 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.68 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 163 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 147 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 91 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.0 (second)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.98 (thousand per microliter)\n- Prothrombin time (PT): 15.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 418 (unit per liter)\n- Thrombin time: 21.0 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 475 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- MCV [Entitic volume] by Automated count: 86.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 821 (microgram of fibrinogen equivalent unit per milliliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 240 (unit per liter)\n- MCH [Entitic mass] by Automated count: 29.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-04 12:43:33, ended at 2017-10-04 14:51:18\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.8 (milligram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 334 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-04 15:37:00, ended at 2017-10-05 17:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Thrombin time: 20.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.38 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 158 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Prothrombin time (PT): 16.0 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.7 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 439 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Body height: 5' 5.551\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 565 (microgram of fibrinogen equivalent unit per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 86 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 136 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n\n### Procedure\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination \n- Transfusion, blood or blood components\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; complete study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of bilirubin metabolism\n- Disease of liver\n- Fatigue\n- Headache\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Anemia of chronic disease\n- Atrial fibrillation\n- Nausea\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-10-04, presumably until 2017-10-05\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-10-04, presumably until 2017-10-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-10-04, presumably until 2017-10-05\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-10-04, presumably until 2017-10-05\n- gadobenate, through Intravenous route, started on 2017-10-04, presumably until 2017-10-04\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-10-04, presumably until 2017-10-05\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-10-04, presumably until 2018-04-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain (headache)\n- docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-10-05, presumably until 2018-04-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day as needed For constipation\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-07 07:40:00, ended at 2017-10-07 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.76 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 321 (unit per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.1 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Thrombin time: 18.6 (second)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.6 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 168 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 290 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.36 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.24 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 991 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 734 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Prothrombin time (PT): 13.1 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-11 12:12:00, ended at 2017-10-11 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 701 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 233 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.45 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 238 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.6 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.61 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 553 (microgram of fibrinogen equivalent unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- Thrombin time: 16.5 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 195 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.90 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 322 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-17 10:00:00, ended at 2017-10-17 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.51 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Thrombin time: 14.9 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 311 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 489 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.2 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 383 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.02 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Prothrombin time (PT): 12.2 (second)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 205 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 231 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 35.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 261 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-17 10:56:58, ended at 2017-10-17 13:31:27\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-18 00:00:00, ended at 2017-10-18 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-10-19 12:16:00, ended at 2017-10-23 15:30:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 1 (per microliter)\n- Thrombin time: 15.2 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Body height: 5' 5.157\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 469 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.62 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 193 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 357 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 227 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: <1 (per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Prothrombin time (PT): 12.5 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 271 (unit per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 368 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.55 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n\n### Procedure\n- Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach\n- Collection of blood specimen from a completely implantable venous access device\n- Hospital discharge day management; more than 30 minutes\n- Radiologic examination, chest; single view, frontal\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Chemotherapy administration, into CNS (eg, intrathecal), requiring and including spinal puncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n\n### Condition\n- Pleural effusion\n- Disease of liver\n- Essential hypertension\n- Disorder of the central nervous system\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Anemia due to and following chemotherapy\n- Chronic atrial fibrillation\n- Headache\n- Elevated level of transaminase and lactic acid dehydrogenase\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-10-19, presumably until 2017-10-23\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-10-21, presumably until 2018-04-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed (Mild to moderate nausea/vomiting.)\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-10-19, presumably until 2017-11-29, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-10-19, presumably until 2017-10-21\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2017-10-21, presumably until 2017-10-21\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-10-19, presumably until 2017-10-22\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-10-19, presumably until 2017-10-23\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2017-10-21, presumably until 2017-10-22\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2017-10-21, presumably until 2017-11-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-10-19, presumably until 2017-10-23\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-10-24, presumably until 2017-11-15, with intended 0 refill(s). Instructions: inject 0.8 mL subcutaneous (under the skin) daily For 10 days starting in the evening on 9/28\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-10-20, presumably until 2017-10-21\n- mesna 400 MG Oral Tablet, through Oral route, started on 2017-10-22, presumably until 2017-10-22\n- leucovorin 25 MG Oral Tablet, through Oral route, started on 2017-10-22, presumably until 2017-10-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-23 14:40:00, ended at 2017-10-23 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplastic disease of uncertain behavior\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-25 09:08:22, ended at 2017-10-25 10:28:31\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.118\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-01 00:00:00, ended at 2017-11-01 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-04 00:00:00, ended at 2017-11-04 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2017-11-04, presumably until 2017-11-14, with intended 1 refill(s). Instructions: take 30 mL by mouth 3 times a day as needed Titrate to 2 soft stools daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-04 07:46:00, ended at 2017-11-04 13:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 97 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-04 07:46:00, ended at 2017-11-04 13:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-04 13:01:06, ended at 2017-11-04 15:19:46\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.12\" (inch (US))\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm\n- Extranodal NK/T-cell lymphoma, nasal type\n- Primary diagnosis: Malignant tumor of lymphoid hemopoietic and related tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-04 14:00:00, ended at 2017-11-04 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ammonia [Mass/volume] in Plasma: 52 (micromole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Thrombin time: 16.7 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 612 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 355 (unit per liter)\n- Prothrombin time (PT): 13.2 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.41 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.2 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 1.03 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 223 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.58 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 178 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant tumor of lymphoid hemopoietic and related tissue\n- Extranodal NK/T-cell lymphoma, nasal type\n- Blood coagulation disorder\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Disease of liver\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-07 00:00:00, ended at 2017-11-07 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Localized infection of skin AND/OR subcutaneous tissue\n- Neoplasm of uncertain behavior of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-07 10:19:00, ended at 2017-11-07 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16 (percent)\n- Prothrombin time (PT): 13.8 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.19 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 185 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.56 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 43.8 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 259 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.62 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 703 (microgram of fibrinogen equivalent unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.8 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 57 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Ammonia [Mass/volume] in Plasma: 67 (micromole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.92 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 241 (unit per liter)\n- Thrombin time: 16.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Localized infection of skin AND/OR subcutaneous tissue\n- Eruption\n- Neoplasm of uncertain behavior of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-07 11:12:56, ended at 2017-11-07 13:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-07 15:24:05, ended at 2017-11-07 16:06:44\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.118\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neoplasm of uncertain behavior of skin\n- Eruption\n- Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-11-07, presumably until 2017-11-12, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day for 5 days Please do not dispense generic form.\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2017-11-07, presumably until 2018-04-20, with intended 3 refill(s). Instructions: Apply topically as directed twice daily to affected area(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-11 00:00:00, ended at 2017-11-11 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-14 11:29:00, ended at 2017-11-14 17:58:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.56 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.68 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 59 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 381 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Ammonia [Mass/volume] in Plasma: 55 (micromole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 537 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.3 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 282 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 201 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n- Thrombin time: 13.3 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n\n### Procedure\n- Declotting by thrombolytic agent of implanted vascular access device or catheter\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-14 13:07:17, ended at 2017-11-14 14:23:18\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2018-04-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-11-14 17:59:00, ended at 2017-11-18 14:53:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.59 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Body height: 5' 4.961\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: 13 (per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 308 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.94 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 2 (per microliter)\n- Platelets [#/volume] in Blood by Automated count: 429 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Declotting by thrombolytic agent of implanted vascular access device or catheter\n- Chemotherapy administration, into CNS (eg, intrathecal), requiring and including spinal puncture\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Hospital discharge day management; more than 30 minutes\n\n### Condition\n- Hyperlipidemia\n- Disease of liver\n- Herpesvirus infection\n- Prediabetes\n- Localized edema\n- Chronic atrial fibrillation\n- Essential hypertension\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Disorder of the central nervous system\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2017-11-14\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2017-11-18\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2017-11-17\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2017-11-18\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-11-16, presumably until 2017-11-17\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2017-11-18, presumably until 2017-11-18\n- dexamethasone 1 MG Oral Tablet, started on 2017-11-15, presumably until 2017-11-16, with intended 0 refill(s). Instructions: Take 2 mg in the morning for 2 days then 1 mg in the morning for 2 days then 0.5 mg in the morning for 2 days then stop.\n- dexamethasone 2 MG Oral Tablet, started on 2017-11-15, presumably until 2017-12-16, with intended 0 refill(s). Instructions: Take 2 mg in morning and evening for 2 days ( 10/24 and 10/25)  then 2 mg in the morning for 2 days ( 10/26 and 10/27)  then 1 mg ( 1/2 tablet)  in the morning for 2 days ( 10/28 and 10/29).\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2017-11-18\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-11-15, presumably until 2017-11-16\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-11-15, presumably until 2017-12-16, with intended 0 refill(s). Instructions: inject 0.8 mL subcutaneous (under the skin) daily\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-11-17, presumably until 2017-11-17\n- mupirocin 0.02 MG/MG Topical Ointment, through Topical route, started on 2017-11-16, presumably until 2017-11-18\n- mesna 400 MG Oral Tablet, through Oral route, started on 2017-11-17, presumably until 2017-11-18\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-11-16, presumably until 2017-11-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-25 00:00:00, ended at 2017-11-25 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-25 07:28:00, ended at 2017-11-25 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.54 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 212 (unit per liter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.58 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 822 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.60 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.2 (percent)\n- Prothrombin time (PT): 12.5 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Thrombin time: 13.8 (second)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.1 (second)\n- Ammonia [Mass/volume] in Plasma: 31 (micromole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 107 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 213 (unit per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 523 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-29 00:00:00, ended at 2017-11-29 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea\n\n### Drug\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-11-29, presumably until 2017-12-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-12 10:50:00, ended at 2017-12-12 15:04:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 197 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.25 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 791 (microgram of fibrinogen equivalent unit per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.8 (percent)\n- Thrombin time: 17.9 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Ammonia [Mass/volume] in Plasma: 66 (micromole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 208 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 311 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.1 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 188 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.56 (milligram per deciliter)\n- Prothrombin time (PT): 13.3 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Extranodal NK/T-cell lymphoma, nasal type\n- Atrial fibrillation\n- Localized edema\n- Disease of liver\n- Herpesvirus infection\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-12 12:14:34, ended at 2017-12-12 14:25:45\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-12-12 15:05:00, ended at 2017-12-16 17:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCV [Entitic volume] by Automated count: 97.7 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Body height: 5' 5.157\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.38 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Thrombin time: 19.9 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Prothrombin time (PT): 14.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.6 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.70 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 950 (microgram of fibrinogen equivalent unit per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 184 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 4 (per microliter)\n- Platelets [#/volume] in Blood by Automated count: 227 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.69 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: <1 (per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n\n### Procedure\n- Inspection of Lower Back, External Approach\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; more than 30 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Chemotherapy administration, into CNS (eg, intrathecal), requiring and including spinal puncture\n\n### Condition\n- Hypervolemia\n- Disorder of the central nervous system\n- Enteropathy-associated T-cell lymphoma\n- Acquired absence of organ\n- Atrial fibrillation\n- Disorder of digestive system\n- Disseminated intravascular coagulation\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Hiccoughs\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-12-12, presumably until 2017-12-16\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-12-12, presumably until 2017-12-15\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-12-12, presumably until 2017-12-16\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-12-14, presumably until 2017-12-16\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-12-12, presumably until 2017-12-13\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-12-14, presumably until 2017-12-14\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2017-12-14, presumably until 2017-12-16\n- dexamethasone 2 MG Oral Tablet, started on 2017-12-16, presumably until 2018-02-07, with intended 0 refill(s). Instructions: Take 2 mg in morning and evening for 2 days (11/21 and 11/22)  then 2 mg in the morning for 2 days (11/24-11/25)  then 1 mg ( 1/2 tablet)  in the morning for 2 days (11/26-11/27).\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-12-15, presumably until 2017-12-16\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-12-12, presumably until 2017-12-16\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2017-12-16, presumably until 2018-02-07, with intended 0 refill(s). Instructions: Inject daily for 10 days starting 24-48h after completion of chemotherapy\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-12-12, presumably until 2017-12-16\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-12-12, presumably until 2017-12-15\n- mesna 400 MG Oral Tablet, through Oral route, started on 2017-12-15, presumably until 2017-12-16\n- leucovorin 25 MG Oral Tablet, through Oral route, started on 2017-12-14, presumably until 2017-12-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-18 00:00:00, ended at 2017-12-18 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea\n\n### Drug\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-12-18, presumably until 2017-12-29, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-23 00:00:00, ended at 2017-12-23 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-12-23, presumably until 2018-12-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-26 00:00:00, ended at 2017-12-26 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 07:38:00, ended at 2017-12-26 09:49:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Disorder of bone\n- Disorder of lower leg\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 07:38:00, ended at 2017-12-26 09:49:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 84 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 09:50:00, ended at 2017-12-26 10:50:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.8 (percent)\n- MCV [Entitic volume] by Automated count: 100.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 226 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 65 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 199 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.48 (million per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.2 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 8 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 22.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.4 (second)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 411 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 49 (thousand per microliter)\n- Prothrombin time (PT): 12.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.60 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.23 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 553 (microgram of fibrinogen equivalent unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.46 (thousand per microliter)\n- Thrombin time: 15.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Ammonia [Mass/volume] in Plasma: 51 (micromole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 10:51:00, ended at 2017-12-26 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- gadobenate, through Intravenous route, started on 2017-12-26, presumably until 2017-12-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-29 00:00:00, ended at 2017-12-29 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea\n\n### Drug\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-12-30, presumably until 2018-05-12, with intended 0 refill(s). Instructions: TAKE 2 TABS BY MOUTH EVERY BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-02 12:42:56, ended at 2018-01-02 15:30:22\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Disease of liver\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Hyperlipidemia\n- Localized edema\n- Herpesvirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-01-06 00:00:00, ended at 2018-01-06 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-14 14:00:00, ended at 2018-01-14 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Nutritional anemia\n- Poisoning by drug AND/OR medicinal substance\n- Accidental poisoning\n- Disorder of hematopoietic structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-15 08:52:00, ended at 2018-01-15 12:24:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 68.2 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Poisoning by drug AND/OR medicinal substance\n- Accidental poisoning\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-15 12:25:00, ended at 2018-01-15 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Ammonia [Mass/volume] in Plasma: 55 (micromole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.6 (picogram)\n- Thrombin time: 16.2 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 191 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 499 (microgram of fibrinogen equivalent unit per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 313 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 234 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- MCV [Entitic volume] by Automated count: 103.8 (femtoliter)\n- Prothrombin time (PT): 12.5 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.53 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 23.2 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Collection of venous blood by venipuncture\n- Diagnostic bone marrow; biopsy(ies)\n\n### Condition\n- Nutritional anemia\n- Neutropenia\n- Extranodal NK/T-cell lymphoma, nasal type\n- Thrombocytopenic disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-30 00:00:00, ended at 2018-01-30 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-Hodgkin's lymphoma (clinical)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-02-04 00:00:00, ended at 2018-02-04 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2018-02-04, presumably until 2018-02-04\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-02-04, presumably until 2018-02-04\n- midazolam 1 MG/ML Injectable Solution, started on 2018-02-04, presumably until 2018-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-04 06:38:00, ended at 2018-02-04 09:58:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Prediabetes\n- Secondary malignant neoplasm of bone\n- Essential hypertension\n- Paroxysmal atrial fibrillation\n- Hyperlipidemia\n- Mature T-cell AND/OR NK cell neoplasm\n- Secondary malignant neoplasm of small intestine\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-02-04, presumably until 2018-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-04 11:52:00, ended at 2018-02-04 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Paroxysmal atrial fibrillation\n- Herpesvirus infection\n- Localized edema\n- Disease of liver\n- Extranodal NK/T-cell lymphoma, nasal type\n- Non-Hodgkin's lymphoma (clinical)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-02-05 17:53:00, ended at 2018-02-07 16:22:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.81 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.4 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Base excess in Arterial blood by calculation: -9.6 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.95 (million per microliter)\n- Lactate [Moles/volume] in Blood: 8.3 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 96.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 360 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 182 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 215 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.58 (micro-international unit per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 5' 5.354\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 114 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- MCV [Entitic volume] by Automated count: 109.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Prothrombin time (PT): 14.3 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 16.2 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.67 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Thrombin time: 15.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 3308 (microgram of fibrinogen equivalent unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n\n### Procedure\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, abdomen; 1 view\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Hospital discharge day management; more than 30 minutes\n\n### Condition\n- Atrial fibrillation\n- Heart failure\n- Hyperlipidemia\n- Prediabetes\n- Electrocardiogram abnormal\n- Abdominal distension, gaseous\n- Chronic pulmonary edema\n- Low blood pressure\n- Disorder of digestive system\n- Essential hypertension\n- Paroxysmal atrial fibrillation\n- Acquired absence of organ\n- Drug-induced hypotension\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Hypovolemic shock\n- Elevated level of transaminase and lactic acid dehydrogenase\n\n### Drug\n- 1000 ML potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-02-05, presumably until 2018-02-05\n- hydrocortisone 100 MG Injection, started on 2018-02-06, presumably until 2018-02-06\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2018-02-06, presumably until 2018-02-06\n- etoposide 20 MG/ML Injectable Solution, through Intravenous route, started on 2018-02-05, presumably until 2018-02-05\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-02-06, presumably until 2018-02-07\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-02-05, presumably until 2018-02-06\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-02-05, presumably until 2018-02-07\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-02-05, presumably until 2018-02-06\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-02-05, presumably until 2018-02-05\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-02-07, presumably until 2018-02-07\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-02-07, presumably until 2018-02-07\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2018-02-06, presumably until 2018-02-07\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2018-02-06, presumably until 2018-02-06\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-02-06, presumably until 2018-02-07\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-02-06, presumably until 2018-02-07\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-02-05, presumably until 2018-02-05\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2018-02-06, presumably until 2018-02-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-06 08:09:00, ended at 2018-02-06 08:42:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-06 08:43:00, ended at 2018-02-06 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, abdomen; 1 view\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-08 11:00:00, ended at 2018-02-08 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 22.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.6 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.62 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 194 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 98.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- MCH [Entitic mass] by Automated count: 34.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 22.05 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Herpesvirus infection\n- Disease of liver\n- Paroxysmal atrial fibrillation\n- Localized edema\n\n### Drug\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-02-08, presumably until 2018-02-08\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-02-08, presumably until 2018-02-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-11 11:30:00, ended at 2018-02-11 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-12 11:45:00, ended at 2018-02-12 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-13 11:45:00, ended at 2018-02-13 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-14 11:30:00, ended at 2018-02-14 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-15 11:15:00, ended at 2018-02-15 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-16 11:30:00, ended at 2018-02-16 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-17 12:00:00, ended at 2018-02-17 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-18 12:00:00, ended at 2018-02-18 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-19 10:28:00, ended at 2018-02-19 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-20 11:58:00, ended at 2018-02-20 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-21 12:38:00, ended at 2018-02-21 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-03 00:00:00, ended at 2018-03-03 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-03 13:33:00, ended at 2018-03-03 13:43:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Pleural effusion\n- Atelectasis\n- Chronic pulmonary edema\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-03 13:44:00, ended at 2018-03-03 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 293 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 35.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.99 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-03-03, presumably until 2018-03-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-03 14:37:03, ended at 2018-03-03 15:56:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2018-02-25, presumably until 2018-03-31, with intended 0 refill(s). Instructions: take 200 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-12 16:54:00, ended at 2018-03-12 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2018-03-12, presumably until 2018-03-12\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2018-03-12, presumably until 2018-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-13 07:30:00, ended at 2018-03-13 17:58:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 16 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 14.74 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 156 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Body height: 5' 5.354\" (inch (US))\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 32 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- Leukocytes [#/volume] in Blood by Automated count: 92100 (per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 92.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.37 (thousand per microliter)\n\n### Procedure\n- Transplant preparation of hematopoietic progenitor cells; cryopreservation and storage\n- Collection of venous blood by venipuncture\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- sodium citrate, through Intravenous route, started on 2018-03-13, presumably until 2018-03-13\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-03-13, presumably until 2018-03-13\n- citric acid, through Intravenous route, started on 2018-03-13, presumably until 2018-03-13\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-03-13, presumably until 2018-03-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-13 17:59:00, ended at 2018-03-13 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2018-03-13, presumably until 2018-03-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-14 07:30:00, ended at 2018-03-14 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Body height: 5' 5.354\" (inch (US))\n- MCV [Entitic volume] by Automated count: 95.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 80 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 92.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Transplant preparation of hematopoietic progenitor cells; cryopreservation and storage\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- sodium citrate, through Intravenous route, started on 2018-03-14, presumably until 2018-03-14\n- citric acid, through Intravenous route, started on 2018-03-14, presumably until 2018-03-14\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-03-14, presumably until 2018-03-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-21 00:00:00, ended at 2018-03-21 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-03-27, presumably until 2018-03-27, with intended 2 refill(s). Instructions: 3 mL by Intravenous route every day Flush each lumen of double lumen catheter daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-27 00:00:00, ended at 2018-03-27 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-31 13:50:00, ended at 2018-03-31 14:14:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 1483 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.33 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.5 (second)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 37 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Thrombin time: 37.3 (second)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 64 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.41 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.0 (percent)\n- Prothrombin time (PT): 12.7 (second)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 37 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 341 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.72 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 108 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Ammonia [Mass/volume] in Plasma: 13 (micromole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 197 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pancytopenia due to antineoplastic chemotherapy\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-03-31, presumably until 2018-03-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-31 14:15:00, ended at 2018-03-31 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-04-01 17:10:00, ended at 2018-04-20 12:14:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 98.0 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Lactate [Moles/volume] in Blood: 1.8 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.91 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.5 (microgram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 189 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 161 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.24 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 9 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Body height: 5' 5.157\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 99.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Manual count: 0.39 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 68 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.050 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n\n### Procedure\n- Radiologic examination, chest; single view\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Radiologic examination, abdomen; 2 views\n- Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach\n- Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Hematopoietic progenitor cell (HPC); autologous transplantation\n- Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washing, per donor\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Hospital discharge day management; more than 30 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Sepsis\n- Tachycardia\n- Disorder of esophagus\n- Essential hypertension\n- Electrocardiogram abnormal\n- Fever\n- Low blood pressure\n- Neutropenia\n- Oral ulcerative mucositis due to antineoplastic therapy\n- Paroxysmal atrial fibrillation\n- Herpesvirus infection\n- Transplant present\n- Benign prostatic hyperplasia\n- Disorder of intestine\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Long QT syndrome\n- Pancytopenia due to antineoplastic chemotherapy\n- Abdominal distension, gaseous\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Hyperlipidemia\n- Hypervolemia\n- Inflammatory disorder of digestive tract\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2018-04-07, presumably until 2018-04-07\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2018-04-13, presumably until 2018-04-19\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2018-04-20\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2018-04-03, presumably until 2018-04-20, with intended 3 refill(s). Instructions: take 2 Caps by mouth 4 times a day as needed\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2018-04-16, presumably until 2018-04-18\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-04-07, presumably until 2018-04-07\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-19\n- melphalan 50 MG Injection, through Intravenous route, started on 2018-04-06, presumably until 2018-04-06\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2019-04-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2018-04-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-12, presumably until 2018-04-13\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-04-03, presumably until 2018-04-03\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2018-04-08, presumably until 2018-04-12\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-04-10, presumably until 2018-04-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2018-04-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 6 days\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2018-04-07\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-18\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2018-04-04, presumably until 2018-04-06\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-04-09, presumably until 2018-04-12\n- 1 ML dexamethasone phosphate 10 MG/ML Injection, started on 2018-04-18, presumably until 2018-04-18\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2018-04-03, presumably until 2019-04-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 10 ML furosemide 10 MG/ML Injection, started on 2018-04-07, presumably until 2018-04-19\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2018-04-03, presumably until 2018-04-20\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2018-04-20, presumably until 2018-07-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2018-04-14, presumably until 2018-04-17\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-18\n- atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet, through Oral route, started on 2018-04-14, presumably until 2018-04-19\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-04-02, presumably until 2018-04-20\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-04-01, presumably until 2018-04-20\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2018-04-19, presumably until 2018-04-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day for 6 days\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-04-12, presumably until 2018-04-20\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2018-04-01, presumably until 2018-04-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-04-02, presumably until 2018-04-02\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2018-04-08, presumably until 2018-04-12\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2018-04-01, presumably until 2018-04-18\n- loratadine 10 MG Oral Tablet, through Oral route, started on 2018-04-15, presumably until 2018-04-20\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2018-04-15, presumably until 2018-04-16\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2018-04-15, presumably until 2018-04-15\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2018-04-14, presumably until 2018-04-15\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2018-04-14, presumably until 2018-04-14\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2018-04-19, presumably until 2018-04-19\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2018-04-08, presumably until 2018-04-13\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2018-04-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-04 00:00:00, ended at 2018-04-04 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2018-04-08, presumably until 2018-04-08, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-22 16:33:00, ended at 2018-04-22 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.31 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.64 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.26 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 68 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 5 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Transfusion, blood or blood components\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-04-22, presumably until 2018-04-22\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-04-22, presumably until 2018-04-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-23 13:59:00, ended at 2018-04-23 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.61 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 19 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-04-23, presumably until 2018-04-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-24 15:40:00, ended at 2018-04-24 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 35 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.62 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.62 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 9 (thousand per microliter)\n\n### Procedure\n- Transfusion, blood or blood components\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Pancytopenia due to antineoplastic chemotherapy\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-04-24, presumably until 2018-04-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-04-24, presumably until 2018-04-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-27 15:06:00, ended at 2018-04-27 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 10 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 27.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.57 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 54.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Transfusion, blood or blood components\n\n### Condition\n- Paroxysmal atrial fibrillation\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2018-04-27, presumably until 2018-04-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-30 14:59:00, ended at 2018-04-30 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 25.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.65 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 23 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 33.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.92 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Paroxysmal atrial fibrillation\n\n### Drug\n- dibasic potassium phosphate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- potassium phosphate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- tribasic potassium phosphate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- tribasic sodium phosphate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-04-30, presumably until 2018-04-30\n- sodium phosphate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- sodium phosphate, monobasic, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- sodium phosphate, dibasic, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2018-04-30, presumably until 2018-05-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day for 30 days\n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-05 14:04:00, ended at 2018-05-05 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 40 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 24 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.8 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- Prothrombin time (PT): 12.5 (second)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.58 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.75 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.73 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.3 (second)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 40 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.02 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 1055 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.6 (percent)\n- Ammonia [Mass/volume] in Plasma: 19 (micromole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 13 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Thrombin time: 28.4 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 0.48 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 441 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-05-05, presumably until 2018-05-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-05 14:28:59, ended at 2018-05-05 16:48:36\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.16\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-12 10:40:00, ended at 2018-05-12 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.35 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.9 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 25 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 21.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-05-12, presumably until 2018-05-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-12 11:32:31, ended at 2018-05-12 12:50:33\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.157\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2018-05-12, presumably until 2018-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-20 00:00:00, ended at 2018-05-20 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-05-21, presumably until 2018-07-18, with intended 6 refill(s). Instructions: 3 mL by Intravenous route every day Flush each lumen of double lumen catheter daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-26 10:20:00, ended at 2018-05-26 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 40 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 49.1 (percent)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.16 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-05-26, presumably until 2018-05-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-25 00:00:00, ended at 2018-06-25 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-06-26, presumably until 2018-06-26, with intended 6 refill(s). Instructions: 3 mL by Intravenous route every day Flush each lumen of double lumen catheter daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-26 00:00:00, ended at 2018-06-26 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-06-26, presumably until 2018-07-07, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-07 08:44:00, ended at 2018-07-07 12:05:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 114 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-07 08:44:00, ended at 2018-07-07 12:05:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-07 12:06:00, ended at 2018-07-07 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 36.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 44 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.4 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.77 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 356 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 416 (microgram of fibrinogen equivalent unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.7 (percent)\n- MCV [Entitic volume] by Automated count: 106.3 (femtoliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Prothrombin time (PT): 12.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.96 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Thrombin time: 17.0 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-07 13:23:41, ended at 2018-07-07 14:11:17\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.118\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-07-07, presumably until 2018-08-11, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-18 12:18:00, ended at 2018-07-18 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.85 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 42 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.90 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 107.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.07 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.5 (percent)\n- MCH [Entitic mass] by Automated count: 36.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Polyneuropathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-18 12:54:41, ended at 2018-07-18 14:32:13\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Polyneuropathy\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, presumably until 2019-02-02, with intended 0 refill(s). Instructions: take by mouth\n- pregabalin 50 MG Oral Capsule, through Oral route, presumably until 2018-08-04, with intended 0 refill(s). Instructions: take by mouth daily Advised to titrate up to 100mg po daily starting 6/23   08/04/2018 150mg daily\n- celecoxib 200 MG Oral Capsule, through Oral route, presumably until 2020-09-14, with intended 0 refill(s). Instructions: take 400 mg by mouth every day\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2018-06-02, presumably until 2018-06-02, with intended 5 refill(s). Instructions: Take 1 capsule (0.4 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-04 14:19:00, ended at 2018-08-04 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 107.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.46 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.81 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 36.5 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 46 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.08 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Polyneuropathy due to drug\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-11 00:00:00, ended at 2018-08-11 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-08-12, presumably until 2018-09-15, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-11 00:00:00, ended at 2018-08-11 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Polyneuropathy due to drug\n\n### Drug\n- pregabalin 150 MG Oral Capsule, through Oral route, started on 2018-08-11, presumably until 2019-02-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-15 00:00:00, ended at 2018-09-15 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-09-15, presumably until 2018-10-21, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-19 00:00:00, ended at 2018-09-19 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- famotidine 20 MG Oral Tablet, started on 2018-09-19, presumably until 2019-02-02, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-20 14:00:00, ended at 2018-10-20 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.18 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 43 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 36.5 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- MCV [Entitic volume] by Automated count: 104.4 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-20 15:01:49, ended at 2018-10-20 16:09:07\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.118\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-21 00:00:00, ended at 2018-10-21 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-10-21, presumably until 2018-12-09, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-24 13:36:03, ended at 2018-10-24 14:56:06\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-04 10:26:00, ended at 2018-11-04 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 104.0 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.19 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.51 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 56 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Diagnostic bone marrow; biopsy(ies) and aspiration(s)\n\n### Condition\n- Thrombocytopenic disorder\n- Extranodal NK/T-cell lymphoma, nasal type\n- Nutritional anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-09 00:00:00, ended at 2018-12-09 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-12-15, presumably until 2020-01-14, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-07 11:05:00, ended at 2019-01-07 23:59:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-07 11:05:00, ended at 2019-01-07 23:59:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 117 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-11 00:00:00, ended at 2019-01-11 00:00:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Polyneuropathy due to drug\n\n### Drug\n- pregabalin 150 MG Oral Capsule, through Oral route, started on 2019-01-15, presumably until 2019-04-16, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-11 00:00:00, ended at 2019-01-11 00:00:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Polyneuropathy due to drug\n\n### Drug\n- pregabalin 150 MG Oral Capsule, started on 2019-01-15, presumably until 2019-01-15, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-02 13:58:00, ended at 2019-02-02 23:59:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.84 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.79 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.19 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 57 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 48.9 (percent)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 38.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-26 00:00:00, ended at 2019-03-26 00:00:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-30 10:25:00, ended at 2019-03-30 23:59:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 113 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-03 00:00:00, ended at 2017-09-03 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Mature T-cell AND/OR NK cell neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-10 00:00:00, ended at 2017-09-10 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-09-10, presumably until 2017-09-10, with intended 3 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-09-10 17:36:00, ended at 2017-09-17 16:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 39 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 4 (per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 413 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.25 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.8 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Prothrombin time (PT): 13.0 (second)\n- Thrombin time: 15.0 (second)\n- Urate [Mass/volume] in Serum or Plasma: <2.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 453 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Body height: 5' 4.764\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.67 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 1049 (microgram of fibrinogen equivalent unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: 1 (per microliter)\n\n### Procedure\n- Diagnostic bone marrow; biopsy(ies)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Extraction of Iliac Bone Marrow, Percutaneous Approach, Diagnostic\n- Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach\n- Hospital discharge day management; more than 30 minutes\n- Ultrasound, scrotum and contents\n- Collection of venous blood by venipuncture\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Chemotherapy administration, into CNS (eg, intrathecal), requiring and including spinal puncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n\n### Condition\n- Non-Hodgkin's lymphoma of extranodal site\n- Atrial fibrillation\n- Pleural effusion\n- Abnormal findings on diagnostic imaging of lung\n- Anemia in neoplastic disease\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Disorder of male genital organ\n- Abnormal cytological findings in CSF\n- Electrocardiogram abnormal\n- Anemia\n\n### Drug\n- benzocaine 15 MG / menthol 3.6 MG Oral Lozenge, through Submucosal route, started on 2017-09-15, presumably until 2017-09-15\n- sodium bicarbonate 650 MG Oral Tablet, started on 2017-09-16, presumably until 2017-09-19, with intended 0 refill(s). Instructions: Take 2 tabs the night before chemotherapy and the morning of chemotherapy.\n- metoclopramide 1 MG/ML Oral Solution, through Oral route, started on 2017-09-15, presumably until 2017-10-05, with intended 0 refill(s). Instructions: take 10 mL by mouth 3 times a day as needed (hiccups)\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-09-12, presumably until 2018-05-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2017-09-11, presumably until 2017-09-16\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-09-14, presumably until 2017-10-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed (Mild to moderate nausea/vomiting.)\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-09-12, presumably until 2017-10-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-09-11, presumably until 2017-09-17\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-09-12, presumably until 2017-09-14\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-09-11, presumably until 2017-09-15\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-09-11, presumably until 2017-09-11\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2017-09-17, presumably until 2017-10-04, with intended 3 refill(s). Instructions: take 1 Lozenge by mouth 5 times a day\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-09-13, presumably until 2017-09-16\n- sodium chloride 9 MG/ML Injection, started on 2017-09-16, presumably until 2017-09-16\n- gadobenate, through Intravenous route, started on 2017-09-11, presumably until 2017-09-11\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-09-10, presumably until 2017-09-17\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-09-10, presumably until 2017-09-16\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-09-11, presumably until 2017-10-05, with intended 4 refill(s). Instructions: inject 0.8 mL subcutaneous (under the skin) daily\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2017-09-14, presumably until 2017-10-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed (Mild to moderate nausea/vomiting)\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-09-15, presumably until 2017-09-15\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2017-09-16, presumably until 2018-02-07, with intended 1 refill(s). Instructions: take 1 Tab by mouth every day Do not take 24 hours prior to chemotherapy\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-09-13, presumably until 2017-09-13\n- mesna 400 MG Oral Tablet, through Oral route, started on 2017-09-15, presumably until 2017-09-15\n- leucovorin 25 MG Oral Tablet, through Oral route, started on 2017-09-15, presumably until 2017-09-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-09-13, presumably until 2017-09-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-19 00:00:00, ended at 2017-09-19 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2017-09-19, presumably until 2018-02-07, with intended 2 refill(s). Instructions: take 4 Tabs by mouth every 4 hours Starting at 6 am on the day of hospital admission\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-04 12:00:00, ended at 2017-10-04 15:36:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 187 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.68 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 163 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 147 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 91 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.0 (second)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.98 (thousand per microliter)\n- Prothrombin time (PT): 15.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 418 (unit per liter)\n- Thrombin time: 21.0 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 475 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- MCV [Entitic volume] by Automated count: 86.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 821 (microgram of fibrinogen equivalent unit per milliliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 240 (unit per liter)\n- MCH [Entitic mass] by Automated count: 29.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-04 12:43:33, ended at 2017-10-04 14:51:18\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.8 (milligram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 334 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-04 15:37:00, ended at 2017-10-05 17:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Thrombin time: 20.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.38 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 158 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Prothrombin time (PT): 16.0 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.7 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 439 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Body height: 5' 5.551\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 565 (microgram of fibrinogen equivalent unit per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 86 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 136 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n\n### Procedure\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination \n- Transfusion, blood or blood components\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; complete study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of bilirubin metabolism\n- Disease of liver\n- Fatigue\n- Headache\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Anemia of chronic disease\n- Atrial fibrillation\n- Nausea\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-10-04, presumably until 2017-10-05\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-10-04, presumably until 2017-10-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-10-04, presumably until 2017-10-05\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-10-04, presumably until 2017-10-05\n- gadobenate, through Intravenous route, started on 2017-10-04, presumably until 2017-10-04\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-10-04, presumably until 2017-10-05\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-10-04, presumably until 2018-04-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain (headache)\n- docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-10-05, presumably until 2018-04-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day as needed For constipation\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-07 07:40:00, ended at 2017-10-07 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.76 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 321 (unit per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.1 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Thrombin time: 18.6 (second)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.6 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 168 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 290 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.36 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.24 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 991 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 734 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Prothrombin time (PT): 13.1 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-11 12:12:00, ended at 2017-10-11 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 701 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 233 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.45 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 238 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.6 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.61 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 553 (microgram of fibrinogen equivalent unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- Thrombin time: 16.5 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 195 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.90 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 322 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-17 10:00:00, ended at 2017-10-17 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.51 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Thrombin time: 14.9 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 311 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 489 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.2 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 383 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.02 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Prothrombin time (PT): 12.2 (second)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 205 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 231 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 35.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 261 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-17 10:56:58, ended at 2017-10-17 13:31:27\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-18 00:00:00, ended at 2017-10-18 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-10-19 12:16:00, ended at 2017-10-23 15:30:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 1 (per microliter)\n- Thrombin time: 15.2 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Body height: 5' 5.157\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 469 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.62 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 193 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 357 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 227 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: <1 (per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Prothrombin time (PT): 12.5 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 271 (unit per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 368 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.55 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n\n### Procedure\n- Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach\n- Collection of blood specimen from a completely implantable venous access device\n- Hospital discharge day management; more than 30 minutes\n- Radiologic examination, chest; single view, frontal\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Chemotherapy administration, into CNS (eg, intrathecal), requiring and including spinal puncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n\n### Condition\n- Pleural effusion\n- Disease of liver\n- Essential hypertension\n- Disorder of the central nervous system\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Anemia due to and following chemotherapy\n- Chronic atrial fibrillation\n- Headache\n- Elevated level of transaminase and lactic acid dehydrogenase\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-10-19, presumably until 2017-10-23\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-10-21, presumably until 2018-04-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed (Mild to moderate nausea/vomiting.)\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-10-19, presumably until 2017-11-29, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-10-19, presumably until 2017-10-21\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2017-10-21, presumably until 2017-10-21\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-10-19, presumably until 2017-10-22\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-10-19, presumably until 2017-10-23\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2017-10-21, presumably until 2017-10-22\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2017-10-21, presumably until 2017-11-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-10-19, presumably until 2017-10-23\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-10-24, presumably until 2017-11-15, with intended 0 refill(s). Instructions: inject 0.8 mL subcutaneous (under the skin) daily For 10 days starting in the evening on 9/28\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-10-20, presumably until 2017-10-21\n- mesna 400 MG Oral Tablet, through Oral route, started on 2017-10-22, presumably until 2017-10-22\n- leucovorin 25 MG Oral Tablet, through Oral route, started on 2017-10-22, presumably until 2017-10-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-23 14:40:00, ended at 2017-10-23 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplastic disease of uncertain behavior\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-25 09:08:22, ended at 2017-10-25 10:28:31\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.118\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-01 00:00:00, ended at 2017-11-01 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-04 00:00:00, ended at 2017-11-04 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2017-11-04, presumably until 2017-11-14, with intended 1 refill(s). Instructions: take 30 mL by mouth 3 times a day as needed Titrate to 2 soft stools daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-04 07:46:00, ended at 2017-11-04 13:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 97 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-04 07:46:00, ended at 2017-11-04 13:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-04 13:01:06, ended at 2017-11-04 15:19:46\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.12\" (inch (US))\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm\n- Extranodal NK/T-cell lymphoma, nasal type\n- Primary diagnosis: Malignant tumor of lymphoid hemopoietic and related tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-04 14:00:00, ended at 2017-11-04 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ammonia [Mass/volume] in Plasma: 52 (micromole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Thrombin time: 16.7 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 612 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 355 (unit per liter)\n- Prothrombin time (PT): 13.2 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.41 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.2 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 1.03 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 223 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.58 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 178 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant tumor of lymphoid hemopoietic and related tissue\n- Extranodal NK/T-cell lymphoma, nasal type\n- Blood coagulation disorder\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Disease of liver\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-07 00:00:00, ended at 2017-11-07 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Localized infection of skin AND/OR subcutaneous tissue\n- Neoplasm of uncertain behavior of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-07 10:19:00, ended at 2017-11-07 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16 (percent)\n- Prothrombin time (PT): 13.8 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.19 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 185 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.56 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 43.8 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 259 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.62 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 703 (microgram of fibrinogen equivalent unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.8 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 57 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Ammonia [Mass/volume] in Plasma: 67 (micromole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.92 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 241 (unit per liter)\n- Thrombin time: 16.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Localized infection of skin AND/OR subcutaneous tissue\n- Eruption\n- Neoplasm of uncertain behavior of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-07 11:12:56, ended at 2017-11-07 13:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-07 15:24:05, ended at 2017-11-07 16:06:44\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.118\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neoplasm of uncertain behavior of skin\n- Eruption\n- Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-11-07, presumably until 2017-11-12, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day for 5 days Please do not dispense generic form.\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2017-11-07, presumably until 2018-04-20, with intended 3 refill(s). Instructions: Apply topically as directed twice daily to affected area(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-11 00:00:00, ended at 2017-11-11 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-14 11:29:00, ended at 2017-11-14 17:58:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.56 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.68 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 59 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 381 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Ammonia [Mass/volume] in Plasma: 55 (micromole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 537 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.3 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 282 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 201 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n- Thrombin time: 13.3 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n\n### Procedure\n- Declotting by thrombolytic agent of implanted vascular access device or catheter\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-14 13:07:17, ended at 2017-11-14 14:23:18\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2018-04-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-11-14 17:59:00, ended at 2017-11-18 14:53:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.59 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Body height: 5' 4.961\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: 13 (per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 308 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.94 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 2 (per microliter)\n- Platelets [#/volume] in Blood by Automated count: 429 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Declotting by thrombolytic agent of implanted vascular access device or catheter\n- Chemotherapy administration, into CNS (eg, intrathecal), requiring and including spinal puncture\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Hospital discharge day management; more than 30 minutes\n\n### Condition\n- Hyperlipidemia\n- Disease of liver\n- Herpesvirus infection\n- Prediabetes\n- Localized edema\n- Chronic atrial fibrillation\n- Essential hypertension\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Disorder of the central nervous system\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2017-11-14\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2017-11-18\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2017-11-17\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2017-11-18\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-11-16, presumably until 2017-11-17\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2017-11-18, presumably until 2017-11-18\n- dexamethasone 1 MG Oral Tablet, started on 2017-11-15, presumably until 2017-11-16, with intended 0 refill(s). Instructions: Take 2 mg in the morning for 2 days then 1 mg in the morning for 2 days then 0.5 mg in the morning for 2 days then stop.\n- dexamethasone 2 MG Oral Tablet, started on 2017-11-15, presumably until 2017-12-16, with intended 0 refill(s). Instructions: Take 2 mg in morning and evening for 2 days ( 10/24 and 10/25)  then 2 mg in the morning for 2 days ( 10/26 and 10/27)  then 1 mg ( 1/2 tablet)  in the morning for 2 days ( 10/28 and 10/29).\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-11-14, presumably until 2017-11-18\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-11-15, presumably until 2017-11-16\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-11-15, presumably until 2017-12-16, with intended 0 refill(s). Instructions: inject 0.8 mL subcutaneous (under the skin) daily\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-11-17, presumably until 2017-11-17\n- mupirocin 0.02 MG/MG Topical Ointment, through Topical route, started on 2017-11-16, presumably until 2017-11-18\n- mesna 400 MG Oral Tablet, through Oral route, started on 2017-11-17, presumably until 2017-11-18\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-11-16, presumably until 2017-11-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-25 00:00:00, ended at 2017-11-25 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-25 07:28:00, ended at 2017-11-25 23:59:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.54 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 212 (unit per liter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.58 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 822 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.60 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.2 (percent)\n- Prothrombin time (PT): 12.5 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Thrombin time: 13.8 (second)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.1 (second)\n- Ammonia [Mass/volume] in Plasma: 31 (micromole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 107 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 213 (unit per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 523 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-29 00:00:00, ended at 2017-11-29 00:00:00\nThe patient in this visit was 65 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea\n\n### Drug\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-11-29, presumably until 2017-12-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-12 10:50:00, ended at 2017-12-12 15:04:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 197 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.25 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 791 (microgram of fibrinogen equivalent unit per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.8 (percent)\n- Thrombin time: 17.9 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Ammonia [Mass/volume] in Plasma: 66 (micromole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 208 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 311 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.1 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 188 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.56 (milligram per deciliter)\n- Prothrombin time (PT): 13.3 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Extranodal NK/T-cell lymphoma, nasal type\n- Atrial fibrillation\n- Localized edema\n- Disease of liver\n- Herpesvirus infection\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-12 12:14:34, ended at 2017-12-12 14:25:45\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-12-12 15:05:00, ended at 2017-12-16 17:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCV [Entitic volume] by Automated count: 97.7 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Body height: 5' 5.157\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.38 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Thrombin time: 19.9 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Prothrombin time (PT): 14.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.6 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.70 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 950 (microgram of fibrinogen equivalent unit per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 184 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 4 (per microliter)\n- Platelets [#/volume] in Blood by Automated count: 227 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.69 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: <1 (per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n\n### Procedure\n- Inspection of Lower Back, External Approach\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; more than 30 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Chemotherapy administration, into CNS (eg, intrathecal), requiring and including spinal puncture\n\n### Condition\n- Hypervolemia\n- Disorder of the central nervous system\n- Enteropathy-associated T-cell lymphoma\n- Acquired absence of organ\n- Atrial fibrillation\n- Disorder of digestive system\n- Disseminated intravascular coagulation\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Hiccoughs\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-12-12, presumably until 2017-12-16\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-12-12, presumably until 2017-12-15\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-12-12, presumably until 2017-12-16\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-12-14, presumably until 2017-12-16\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-12-12, presumably until 2017-12-13\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-12-14, presumably until 2017-12-14\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2017-12-14, presumably until 2017-12-16\n- dexamethasone 2 MG Oral Tablet, started on 2017-12-16, presumably until 2018-02-07, with intended 0 refill(s). Instructions: Take 2 mg in morning and evening for 2 days (11/21 and 11/22)  then 2 mg in the morning for 2 days (11/24-11/25)  then 1 mg ( 1/2 tablet)  in the morning for 2 days (11/26-11/27).\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-12-15, presumably until 2017-12-16\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-12-12, presumably until 2017-12-16\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2017-12-16, presumably until 2018-02-07, with intended 0 refill(s). Instructions: Inject daily for 10 days starting 24-48h after completion of chemotherapy\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-12-12, presumably until 2017-12-16\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-12-12, presumably until 2017-12-15\n- mesna 400 MG Oral Tablet, through Oral route, started on 2017-12-15, presumably until 2017-12-16\n- leucovorin 25 MG Oral Tablet, through Oral route, started on 2017-12-14, presumably until 2017-12-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-18 00:00:00, ended at 2017-12-18 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea\n\n### Drug\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-12-18, presumably until 2017-12-29, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-23 00:00:00, ended at 2017-12-23 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-12-23, presumably until 2018-12-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-26 00:00:00, ended at 2017-12-26 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 07:38:00, ended at 2017-12-26 09:49:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Disorder of bone\n- Disorder of lower leg\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 07:38:00, ended at 2017-12-26 09:49:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 84 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 09:50:00, ended at 2017-12-26 10:50:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.8 (percent)\n- MCV [Entitic volume] by Automated count: 100.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 226 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 65 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 199 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.48 (million per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.2 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 8 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 22.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.4 (second)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 411 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 49 (thousand per microliter)\n- Prothrombin time (PT): 12.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.60 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.23 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 553 (microgram of fibrinogen equivalent unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.46 (thousand per microliter)\n- Thrombin time: 15.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Ammonia [Mass/volume] in Plasma: 51 (micromole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 10:51:00, ended at 2017-12-26 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- gadobenate, through Intravenous route, started on 2017-12-26, presumably until 2017-12-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-29 00:00:00, ended at 2017-12-29 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea\n\n### Drug\n- olanzapine 2.5 MG Oral Tablet, through Oral route, started on 2017-12-30, presumably until 2018-05-12, with intended 0 refill(s). Instructions: TAKE 2 TABS BY MOUTH EVERY BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-02 12:42:56, ended at 2018-01-02 15:30:22\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Disease of liver\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Hyperlipidemia\n- Localized edema\n- Herpesvirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-01-06 00:00:00, ended at 2018-01-06 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-14 14:00:00, ended at 2018-01-14 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Nutritional anemia\n- Poisoning by drug AND/OR medicinal substance\n- Accidental poisoning\n- Disorder of hematopoietic structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-15 08:52:00, ended at 2018-01-15 12:24:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 68.2 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Poisoning by drug AND/OR medicinal substance\n- Accidental poisoning\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-15 12:25:00, ended at 2018-01-15 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Ammonia [Mass/volume] in Plasma: 55 (micromole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.6 (picogram)\n- Thrombin time: 16.2 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 191 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 499 (microgram of fibrinogen equivalent unit per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 313 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 234 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- MCV [Entitic volume] by Automated count: 103.8 (femtoliter)\n- Prothrombin time (PT): 12.5 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.53 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 23.2 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Collection of venous blood by venipuncture\n- Diagnostic bone marrow; biopsy(ies)\n\n### Condition\n- Nutritional anemia\n- Neutropenia\n- Extranodal NK/T-cell lymphoma, nasal type\n- Thrombocytopenic disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-30 00:00:00, ended at 2018-01-30 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-Hodgkin's lymphoma (clinical)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-02-04 00:00:00, ended at 2018-02-04 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2018-02-04, presumably until 2018-02-04\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-02-04, presumably until 2018-02-04\n- midazolam 1 MG/ML Injectable Solution, started on 2018-02-04, presumably until 2018-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-04 06:38:00, ended at 2018-02-04 09:58:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Prediabetes\n- Secondary malignant neoplasm of bone\n- Essential hypertension\n- Paroxysmal atrial fibrillation\n- Hyperlipidemia\n- Mature T-cell AND/OR NK cell neoplasm\n- Secondary malignant neoplasm of small intestine\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-02-04, presumably until 2018-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-04 11:52:00, ended at 2018-02-04 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Paroxysmal atrial fibrillation\n- Herpesvirus infection\n- Localized edema\n- Disease of liver\n- Extranodal NK/T-cell lymphoma, nasal type\n- Non-Hodgkin's lymphoma (clinical)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-02-05 17:53:00, ended at 2018-02-07 16:22:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.81 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.4 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Base excess in Arterial blood by calculation: -9.6 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.95 (million per microliter)\n- Lactate [Moles/volume] in Blood: 8.3 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 96.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 360 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 182 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 215 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.58 (micro-international unit per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 5' 5.354\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 114 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- MCV [Entitic volume] by Automated count: 109.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Prothrombin time (PT): 14.3 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 16.2 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.67 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Thrombin time: 15.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 3308 (microgram of fibrinogen equivalent unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n\n### Procedure\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, abdomen; 1 view\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Hospital discharge day management; more than 30 minutes\n\n### Condition\n- Atrial fibrillation\n- Heart failure\n- Hyperlipidemia\n- Prediabetes\n- Electrocardiogram abnormal\n- Abdominal distension, gaseous\n- Chronic pulmonary edema\n- Low blood pressure\n- Disorder of digestive system\n- Essential hypertension\n- Paroxysmal atrial fibrillation\n- Acquired absence of organ\n- Drug-induced hypotension\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Hypovolemic shock\n- Elevated level of transaminase and lactic acid dehydrogenase\n\n### Drug\n- 1000 ML potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-02-05, presumably until 2018-02-05\n- hydrocortisone 100 MG Injection, started on 2018-02-06, presumably until 2018-02-06\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2018-02-06, presumably until 2018-02-06\n- etoposide 20 MG/ML Injectable Solution, through Intravenous route, started on 2018-02-05, presumably until 2018-02-05\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-02-06, presumably until 2018-02-07\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-02-05, presumably until 2018-02-06\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-02-05, presumably until 2018-02-07\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-02-05, presumably until 2018-02-06\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-02-05, presumably until 2018-02-05\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-02-07, presumably until 2018-02-07\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-02-07, presumably until 2018-02-07\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2018-02-06, presumably until 2018-02-07\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2018-02-06, presumably until 2018-02-06\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-02-06, presumably until 2018-02-07\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-02-06, presumably until 2018-02-07\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-02-05, presumably until 2018-02-05\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2018-02-06, presumably until 2018-02-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-06 08:09:00, ended at 2018-02-06 08:42:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-06 08:43:00, ended at 2018-02-06 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, abdomen; 1 view\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-08 11:00:00, ended at 2018-02-08 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 22.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.6 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.62 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 194 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 98.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- MCH [Entitic mass] by Automated count: 34.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 22.05 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Herpesvirus infection\n- Disease of liver\n- Paroxysmal atrial fibrillation\n- Localized edema\n\n### Drug\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-02-08, presumably until 2018-02-08\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-02-08, presumably until 2018-02-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-11 11:30:00, ended at 2018-02-11 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-12 11:45:00, ended at 2018-02-12 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-13 11:45:00, ended at 2018-02-13 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-14 11:30:00, ended at 2018-02-14 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-15 11:15:00, ended at 2018-02-15 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-16 11:30:00, ended at 2018-02-16 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-17 12:00:00, ended at 2018-02-17 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-18 12:00:00, ended at 2018-02-18 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-19 10:28:00, ended at 2018-02-19 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-20 11:58:00, ended at 2018-02-20 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-21 12:38:00, ended at 2018-02-21 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-03 00:00:00, ended at 2018-03-03 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-03 13:33:00, ended at 2018-03-03 13:43:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Pleural effusion\n- Atelectasis\n- Chronic pulmonary edema\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-03 13:44:00, ended at 2018-03-03 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 293 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 35.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.99 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-03-03, presumably until 2018-03-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-03 14:37:03, ended at 2018-03-03 15:56:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2018-02-25, presumably until 2018-03-31, with intended 0 refill(s). Instructions: take 200 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-12 16:54:00, ended at 2018-03-12 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2018-03-12, presumably until 2018-03-12\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2018-03-12, presumably until 2018-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-13 07:30:00, ended at 2018-03-13 17:58:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 16 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 14.74 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 156 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Body height: 5' 5.354\" (inch (US))\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 32 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- Leukocytes [#/volume] in Blood by Automated count: 92100 (per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 92.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.37 (thousand per microliter)\n\n### Procedure\n- Transplant preparation of hematopoietic progenitor cells; cryopreservation and storage\n- Collection of venous blood by venipuncture\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- sodium citrate, through Intravenous route, started on 2018-03-13, presumably until 2018-03-13\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-03-13, presumably until 2018-03-13\n- citric acid, through Intravenous route, started on 2018-03-13, presumably until 2018-03-13\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-03-13, presumably until 2018-03-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-13 17:59:00, ended at 2018-03-13 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2018-03-13, presumably until 2018-03-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-14 07:30:00, ended at 2018-03-14 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Body height: 5' 5.354\" (inch (US))\n- MCV [Entitic volume] by Automated count: 95.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 80 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 92.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Transplant preparation of hematopoietic progenitor cells; cryopreservation and storage\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- sodium citrate, through Intravenous route, started on 2018-03-14, presumably until 2018-03-14\n- citric acid, through Intravenous route, started on 2018-03-14, presumably until 2018-03-14\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-03-14, presumably until 2018-03-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-21 00:00:00, ended at 2018-03-21 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-03-27, presumably until 2018-03-27, with intended 2 refill(s). Instructions: 3 mL by Intravenous route every day Flush each lumen of double lumen catheter daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-27 00:00:00, ended at 2018-03-27 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-31 13:50:00, ended at 2018-03-31 14:14:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 1483 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.33 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.5 (second)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 37 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Thrombin time: 37.3 (second)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 64 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.41 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.0 (percent)\n- Prothrombin time (PT): 12.7 (second)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 37 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 341 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.72 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 108 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Ammonia [Mass/volume] in Plasma: 13 (micromole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 197 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pancytopenia due to antineoplastic chemotherapy\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-03-31, presumably until 2018-03-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-31 14:15:00, ended at 2018-03-31 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-04-01 17:10:00, ended at 2018-04-20 12:14:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 98.0 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Lactate [Moles/volume] in Blood: 1.8 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.91 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.5 (microgram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 189 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 161 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.24 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 9 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Body height: 5' 5.157\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 99.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Manual count: 0.39 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 68 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.050 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n\n### Procedure\n- Radiologic examination, chest; single view\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Radiologic examination, abdomen; 2 views\n- Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach\n- Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Hematopoietic progenitor cell (HPC); autologous transplantation\n- Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, without washing, per donor\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Hospital discharge day management; more than 30 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Sepsis\n- Tachycardia\n- Disorder of esophagus\n- Essential hypertension\n- Electrocardiogram abnormal\n- Fever\n- Low blood pressure\n- Neutropenia\n- Oral ulcerative mucositis due to antineoplastic therapy\n- Paroxysmal atrial fibrillation\n- Herpesvirus infection\n- Transplant present\n- Benign prostatic hyperplasia\n- Disorder of intestine\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Long QT syndrome\n- Pancytopenia due to antineoplastic chemotherapy\n- Abdominal distension, gaseous\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n- Hyperlipidemia\n- Hypervolemia\n- Inflammatory disorder of digestive tract\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2018-04-07, presumably until 2018-04-07\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2018-04-13, presumably until 2018-04-19\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2018-04-20\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2018-04-03, presumably until 2018-04-20, with intended 3 refill(s). Instructions: take 2 Caps by mouth 4 times a day as needed\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2018-04-16, presumably until 2018-04-18\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-04-07, presumably until 2018-04-07\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-19\n- melphalan 50 MG Injection, through Intravenous route, started on 2018-04-06, presumably until 2018-04-06\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2019-04-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2018-04-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-12, presumably until 2018-04-13\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-04-03, presumably until 2018-04-03\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2018-04-08, presumably until 2018-04-12\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-04-10, presumably until 2018-04-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2018-04-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 6 days\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2018-04-07\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-18\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2018-04-04, presumably until 2018-04-06\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-04-09, presumably until 2018-04-12\n- 1 ML dexamethasone phosphate 10 MG/ML Injection, started on 2018-04-18, presumably until 2018-04-18\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2018-04-03, presumably until 2019-04-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 10 ML furosemide 10 MG/ML Injection, started on 2018-04-07, presumably until 2018-04-19\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2018-04-03, presumably until 2018-04-20\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2018-04-20, presumably until 2018-07-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2018-04-14, presumably until 2018-04-17\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-18\n- atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet, through Oral route, started on 2018-04-14, presumably until 2018-04-19\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-04-02, presumably until 2018-04-20\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-04-01, presumably until 2018-04-20\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2018-04-19, presumably until 2018-04-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day for 6 days\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-04-12, presumably until 2018-04-20\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2018-04-01, presumably until 2018-04-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-04-02, presumably until 2018-04-02\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2018-04-08, presumably until 2018-04-12\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2018-04-01, presumably until 2018-04-18\n- loratadine 10 MG Oral Tablet, through Oral route, started on 2018-04-15, presumably until 2018-04-20\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2018-04-15, presumably until 2018-04-16\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2018-04-15, presumably until 2018-04-15\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2018-04-14, presumably until 2018-04-15\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2018-04-14, presumably until 2018-04-14\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2018-04-19, presumably until 2018-04-19\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2018-04-08, presumably until 2018-04-13\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2018-04-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-04 00:00:00, ended at 2018-04-04 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2018-04-08, presumably until 2018-04-08, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-22 16:33:00, ended at 2018-04-22 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.31 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.64 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.26 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 68 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 5 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Transfusion, blood or blood components\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-04-22, presumably until 2018-04-22\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-04-22, presumably until 2018-04-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-23 13:59:00, ended at 2018-04-23 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.61 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 19 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-04-23, presumably until 2018-04-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-24 15:40:00, ended at 2018-04-24 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 35 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.62 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.62 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 9 (thousand per microliter)\n\n### Procedure\n- Transfusion, blood or blood components\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Pancytopenia due to antineoplastic chemotherapy\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-04-24, presumably until 2018-04-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-04-24, presumably until 2018-04-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-27 15:06:00, ended at 2018-04-27 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 10 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 27.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.57 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 54.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Transfusion, blood or blood components\n\n### Condition\n- Paroxysmal atrial fibrillation\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2018-04-27, presumably until 2018-04-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-30 14:59:00, ended at 2018-04-30 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 25.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.65 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 23 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 33.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.92 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Paroxysmal atrial fibrillation\n\n### Drug\n- dibasic potassium phosphate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- potassium phosphate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- tribasic potassium phosphate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- tribasic sodium phosphate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-04-30, presumably until 2018-04-30\n- sodium phosphate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- sodium phosphate, monobasic, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- sodium phosphate, dibasic, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2018-04-30, presumably until 2018-05-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day for 30 days\n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2018-04-30, presumably until 2018-04-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-05 14:04:00, ended at 2018-05-05 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 40 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 24 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.8 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- Prothrombin time (PT): 12.5 (second)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.58 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.75 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.73 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.3 (second)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 40 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.02 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 1055 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.6 (percent)\n- Ammonia [Mass/volume] in Plasma: 19 (micromole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 13 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Thrombin time: 28.4 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 0.48 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 441 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-05-05, presumably until 2018-05-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-05 14:28:59, ended at 2018-05-05 16:48:36\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.16\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-12 10:40:00, ended at 2018-05-12 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.35 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.9 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 25 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 21.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-05-12, presumably until 2018-05-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-12 11:32:31, ended at 2018-05-12 12:50:33\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.157\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2018-05-12, presumably until 2018-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-20 00:00:00, ended at 2018-05-20 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-05-21, presumably until 2018-07-18, with intended 6 refill(s). Instructions: 3 mL by Intravenous route every day Flush each lumen of double lumen catheter daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-26 10:20:00, ended at 2018-05-26 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 40 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 49.1 (percent)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.16 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-05-26, presumably until 2018-05-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-25 00:00:00, ended at 2018-06-25 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2018-06-26, presumably until 2018-06-26, with intended 6 refill(s). Instructions: 3 mL by Intravenous route every day Flush each lumen of double lumen catheter daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-26 00:00:00, ended at 2018-06-26 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-06-26, presumably until 2018-07-07, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-07 08:44:00, ended at 2018-07-07 12:05:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 114 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-07 08:44:00, ended at 2018-07-07 12:05:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-07 12:06:00, ended at 2018-07-07 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 36.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 44 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.4 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.77 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 356 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 416 (microgram of fibrinogen equivalent unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.7 (percent)\n- MCV [Entitic volume] by Automated count: 106.3 (femtoliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Prothrombin time (PT): 12.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.96 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Thrombin time: 17.0 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-07 13:23:41, ended at 2018-07-07 14:11:17\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.118\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-07-07, presumably until 2018-08-11, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-18 12:18:00, ended at 2018-07-18 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.85 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 42 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.90 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 107.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.07 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.5 (percent)\n- MCH [Entitic mass] by Automated count: 36.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Polyneuropathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-18 12:54:41, ended at 2018-07-18 14:32:13\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Polyneuropathy\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, presumably until 2019-02-02, with intended 0 refill(s). Instructions: take by mouth\n- pregabalin 50 MG Oral Capsule, through Oral route, presumably until 2018-08-04, with intended 0 refill(s). Instructions: take by mouth daily Advised to titrate up to 100mg po daily starting 6/23   08/04/2018 150mg daily\n- celecoxib 200 MG Oral Capsule, through Oral route, presumably until 2020-09-14, with intended 0 refill(s). Instructions: take 400 mg by mouth every day\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2018-06-02, presumably until 2018-06-02, with intended 5 refill(s). Instructions: Take 1 capsule (0.4 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-04 14:19:00, ended at 2018-08-04 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 107.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.46 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.81 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 36.5 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 46 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.08 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n- Polyneuropathy due to drug\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-11 00:00:00, ended at 2018-08-11 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-08-12, presumably until 2018-09-15, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-11 00:00:00, ended at 2018-08-11 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Polyneuropathy due to drug\n\n### Drug\n- pregabalin 150 MG Oral Capsule, through Oral route, started on 2018-08-11, presumably until 2019-02-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-15 00:00:00, ended at 2018-09-15 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-09-15, presumably until 2018-10-21, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-19 00:00:00, ended at 2018-09-19 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- famotidine 20 MG Oral Tablet, started on 2018-09-19, presumably until 2019-02-02, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-20 14:00:00, ended at 2018-10-20 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.18 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 43 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 36.5 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- MCV [Entitic volume] by Automated count: 104.4 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-20 15:01:49, ended at 2018-10-20 16:09:07\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.118\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-21 00:00:00, ended at 2018-10-21 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-10-21, presumably until 2018-12-09, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-24 13:36:03, ended at 2018-10-24 14:56:06\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-04 10:26:00, ended at 2018-11-04 23:59:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 104.0 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.19 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.51 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 56 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Diagnostic bone marrow; biopsy(ies) and aspiration(s)\n\n### Condition\n- Thrombocytopenic disorder\n- Extranodal NK/T-cell lymphoma, nasal type\n- Nutritional anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-09 00:00:00, ended at 2018-12-09 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2018-12-15, presumably until 2020-01-14, with intended 3 refill(s). Instructions: 10 ml prefilled syringes. Flush each lumen with 10 ml daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-07 11:05:00, ended at 2019-01-07 23:59:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-07 11:05:00, ended at 2019-01-07 23:59:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 117 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-11 00:00:00, ended at 2019-01-11 00:00:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Polyneuropathy due to drug\n\n### Drug\n- pregabalin 150 MG Oral Capsule, through Oral route, started on 2019-01-15, presumably until 2019-04-16, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-11 00:00:00, ended at 2019-01-11 00:00:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Polyneuropathy due to drug\n\n### Drug\n- pregabalin 150 MG Oral Capsule, started on 2019-01-15, presumably until 2019-01-15, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-02 13:58:00, ended at 2019-02-02 23:59:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.84 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.79 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.19 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 57 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 48.9 (percent)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 38.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-26 00:00:00, ended at 2019-03-26 00:00:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-30 10:25:00, ended at 2019-03-30 23:59:00\nThe patient in this visit was 67 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 113 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n\n### Condition\n- Extranodal NK/T-cell lymphoma, nasal type\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of intestinal_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "f0fed55365c82011e24e6ed13e00c7b080aa452bc57dfe80de0946755bbe1c63", "prompt_hash": "17d196d5171691036703bd450b507c4c9a40323e618f8afc1925474140f19cb0", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115968945, "visit_occurrence_id": 41847305, "death_date": null, "visit_concept_name": "Emergency Room and Inpatient Visit", "visit_start_datetime": "2010-11-30 16:02:00", "visit_end_datetime": "2010-12-05 11:55:00", "visit_length_in_hours": 115.88333333333334, "integrated_visit_record": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n", "approximate_token_count": 2316, "patient_first_visit_date": "2008-07-01 02:25:00", "patient_last_visit_date": "2013-11-26 07:55:00", "end_obs_date": "2011-12-05", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 50, "cumulated_visit_num": 50, "cumulated_approximate_token_count": 16603, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-01 02:25:00, ended at 2008-07-07 17:35:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.77 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- MCV [Entitic volume] by Automated count: 81.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Base deficit in Blood: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 58.3 (second)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' .11\" (inch (US))\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Osmolality of Urine: 462 (milliosmole per kilogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Essential hypertension\n- Iron deficiency anemia\n- Infective pneumonia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2008-07-01, presumably until 2008-07-02\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2008-07-01, presumably until 2008-07-07\n- haloperidol 5 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2008-07-04, presumably until 2008-07-04\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 15.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 8 hours as needed 1-2 tab prn nausea q6hr \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-01-03, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-06\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-07\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2008-07-05, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Packets by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-07-01, presumably until 2008-07-07\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2008-07-02, presumably until 2009-07-07, with intended 0 refill(s). Instructions: 3 mL by Inhalation route every 4 hours. \n- 10 ML furosemide 10 MG/ML Injection, started on 2008-07-04, presumably until 2008-07-04\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2008-07-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2008-07-06, presumably until 2008-07-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2008-07-01, presumably until 2008-07-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-07-05, presumably until 2008-07-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-01\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2008-07-02, presumably until 2009-01-03, with quantity of 120.0, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 hours as needed for Diarrhea. \n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2008-07-06, presumably until 2008-07-06\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-07-01, presumably until 2008-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-07-03, presumably until 2008-07-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-04, presumably until 2009-01-03, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2008-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 07:41:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-24 07:27:00, ended at 2009-10-24 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Iron deficiency anemia\n\n### Drug\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-10-24, presumably until 2009-10-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-02 08:06:18, ended at 2010-01-02 12:05:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2011-01-02, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 08:19:00, ended at 2010-01-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 496 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.74 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 367 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-08 00:00:00, ended at 2010-01-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 08:10:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-27 08:43:00, ended at 2010-01-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Hematochezia\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 08:02:34, ended at 2010-02-13 09:09:37\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Disorder of plasma protein metabolism\n- Left lower quadrant pain\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-28 06:26:00, ended at 2010-02-28 08:03:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report\n\n### Condition\n- Abdominal pain\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- vitamin E 90 MG Oral Tablet, through Oral route, presumably until 2013-05-28. Instructions: take by mouth. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2010-09-28. Instructions: take by mouth. \n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2010-12-07. Instructions: take 150 mg by mouth every bedtime. \n- morphine sulfate 10 MG Extended Release Oral Capsule, through Oral route, presumably until 2010-06-27. Instructions: take by mouth. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- zolpidem tartrate 12.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2010-02-28, presumably until 2010-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-06 08:51:00, ended at 2010-03-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Abdominal aortic aneurysm\n- Abdominal pain\n- Disorder of biliary tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-03-09 00:00:00, ended at 2010-03-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of intestine\n- Generalized abdominal pain\n- Iron deficiency anemia\n- Disorder of plasma protein metabolism\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-29 07:00:00, ended at 2010-03-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Generalized abdominal pain\n- Disorder of lung\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Abdominal aortic aneurysm\n- Disorder of biliary tract\n- Disorder of intestine\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-03 13:36:57, ended at 2010-04-03 14:59:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of biliary tract\n- Angiodysplasia of intestine\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 15:02:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 427 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Prothrombin time (PT): 14.3 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Angiodysplasia of intestine\n- Left lower quadrant pain\n- Diarrhea\n- Disorder of biliary tract\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Disorder of intestine\n- Generalized abdominal pain\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-04-09 17:45:00, ended at 2010-04-10 00:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 406 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.8 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Malaise\n- Dehydration\n- Cerebellar ataxia\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-17 11:35:32, ended at 2010-04-17 13:01:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 12:56:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.1 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: <2 (nanogram per milliliter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.28 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 15.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 11.74 (thousand per microliter)\n- Prothrombin time (PT): 14.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 15 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; molecular isolation or extraction, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-19 14:39:15, ended at 2010-06-19 16:42:24\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-27 11:46:00, ended at 2010-06-27 16:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Abdominal pain\n- Gastrojejunal ulcer without hemorrhage AND without perforation but with obstruction\n- Postprocedural state finding\n- Nausea and vomiting\n- Ulceration of intestine\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-06-27, presumably until 2010-06-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-06-27, presumably until 2010-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-07 08:36:00, ended at 2010-07-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-28 08:03:00, ended at 2010-07-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulceration of intestine\n- Postprocedural state finding\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-07-28 18:00:00, ended at 2010-07-28 19:19:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure reading\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 07:20:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Postgastric surgery syndrome\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-08 00:00:00, ended at 2010-08-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-11 08:11:00, ended at 2010-08-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Abdominal pain\n- Primary malignant neoplasm of colon\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-25 07:52:00, ended at 2010-08-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-30 10:19:00, ended at 2010-08-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-09-05 06:05:00, ended at 2010-09-12 12:15:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- Enteral infusion of concentrated nutritional substances\n- Collection of venous blood by venipuncture\n- Other enterostomy\n- Exploratory laparotomy\n\n### Condition\n- Depressive disorder\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Abdominal pain\n- Left lower quadrant pain\n- Malnutrition (calorie)\n- Adult failure to thrive syndrome\n- Chronic pain\n- Disorder of plasma protein metabolism\n- Disorder of function of stomach\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Benign essential hypertension\n- Vascular insufficiency of intestine\n- Abnormality of secretion of gastrin\n- Diarrhea\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-08\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-09-09, presumably until 2010-09-09\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2010-09-12, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2010-09-10, presumably until 2010-09-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-12-05, with quantity of 120.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-09\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11. Instructions: take 50 mg by mouth every bedtime.\n- heparin sodium, porcine 5000 UNT/ML Injectable Solution, through Intravenous route, started on 2010-09-05, presumably until 2010-09-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-09-06, presumably until 2010-09-11\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2010-09-10, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-11-17, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-18 09:43:58, ended at 2010-09-18 12:24:03\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 08:39:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-25 08:15:04, ended at 2010-09-25 08:49:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; more than 7 lesions\n- Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)\n\n### Condition\n- Periumbilical pain\n- Left lower quadrant pain\n- Abdominal pain\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2010-09-25, presumably until 2010-09-26, with quantity of 1.0, with intended 0 refill(s). Instructions: 20 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-09-28 18:19:00, ended at 2010-09-28 20:19:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication of internal prosthetic device\n- Late effect of complications of procedure\n\n### Drug\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. 4 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 15:00:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Postgastric surgery syndrome\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-10 08:16:54, ended at 2010-10-10 16:33:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- opium tincture 100 MG/ML Oral Solution, through Oral route, presumably until 2010-11-30. Instructions: take by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-13 15:55:35, ended at 2010-10-13 16:51:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n- Injection or infusion of other therapeutic or prophylactic substance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s); single or multiple trigger point(s), 3 or more muscles\n- Ultrasonography of digestive system\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Application of a modality to 1 or more areas; ultrasound, each 15 minutes\n\n### Condition\n- Stoma malfunction\n- Primary diagnosis: Abdominal pain\n- Chronic postoperative pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-10-17 12:11:00, ended at 2010-10-17 18:37:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Postgastric surgery syndrome\n- Intestinal volvulus\n- Abdominal pain\n- Disorder of biliary tract\n- Intestinal obstruction\n- Nausea and vomiting\n- Lumbosacral spondylosis without myelopathy\n- Abdominal aortic aneurysm\n- Imaging of gastrointestinal tract abnormal\n- Left lower quadrant pain\n- Vomiting\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, presumably until 2010-11-30. Instructions: take 1 Tab by mouth daily. \n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-10-17, presumably until 2010-10-17\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-10-17, presumably until 2010-10-17\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, presumably until 2011-03-06. Instructions: take 200 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 08:42:00, ended at 2010-10-20 09:47:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Disorder of plasma protein metabolism\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 09:48:00, ended at 2010-10-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postgastric surgery syndrome\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:22:00, ended at 2010-10-25 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of aorta\n- Disorder of biliary tract\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:27:00, ended at 2010-10-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of biliary tract\n- Atherosclerosis of aorta\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-06 14:36:24, ended at 2010-11-06 16:10:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-07 10:55:00, ended at 2010-11-07 14:38:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Stoma malfunction\n\n### Drug\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-07, presumably until 2010-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-10 15:48:00, ended at 2010-11-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-15 09:46:00, ended at 2010-11-15 15:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Mechanical complication of gastrostomy\n- Stoma malfunction\n- Nausea and vomiting\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-17 00:00:00, ended at 2010-11-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2010-11-17, presumably until 2010-11-30, with quantity of 1.0, with intended 0 refill(s). Instructions: 100 Units by Injection route One Time. For delivery from Los Altos Pharmacy for self-pay scar injection \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 08:15:01, ended at 2010-11-17 09:14:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take 5 mg by mouth. 1 tab  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-22 09:29:48, ended at 2010-11-22 16:34:58\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-22 16:40:00, ended at 2010-11-22 21:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Syncope and collapse\n- Diarrhea\n- Chronic pain\n- Chronic peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Generalized abdominal pain\n- Primary diagnosis: Seizure\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-22, presumably until 2010-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-01 02:25:00, ended at 2008-07-07 17:35:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.77 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- MCV [Entitic volume] by Automated count: 81.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Base deficit in Blood: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 58.3 (second)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' .11\" (inch (US))\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Osmolality of Urine: 462 (milliosmole per kilogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Essential hypertension\n- Iron deficiency anemia\n- Infective pneumonia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2008-07-01, presumably until 2008-07-02\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2008-07-01, presumably until 2008-07-07\n- haloperidol 5 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2008-07-04, presumably until 2008-07-04\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 15.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 8 hours as needed 1-2 tab prn nausea q6hr \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-01-03, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-06\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-07\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2008-07-05, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Packets by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-07-01, presumably until 2008-07-07\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2008-07-02, presumably until 2009-07-07, with intended 0 refill(s). Instructions: 3 mL by Inhalation route every 4 hours. \n- 10 ML furosemide 10 MG/ML Injection, started on 2008-07-04, presumably until 2008-07-04\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2008-07-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2008-07-06, presumably until 2008-07-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2008-07-01, presumably until 2008-07-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-07-05, presumably until 2008-07-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-01\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2008-07-02, presumably until 2009-01-03, with quantity of 120.0, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 hours as needed for Diarrhea. \n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2008-07-06, presumably until 2008-07-06\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-07-01, presumably until 2008-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-07-03, presumably until 2008-07-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-04, presumably until 2009-01-03, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2008-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 07:41:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-24 07:27:00, ended at 2009-10-24 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Iron deficiency anemia\n\n### Drug\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-10-24, presumably until 2009-10-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-02 08:06:18, ended at 2010-01-02 12:05:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2011-01-02, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 08:19:00, ended at 2010-01-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 496 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.74 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 367 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-08 00:00:00, ended at 2010-01-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 08:10:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-27 08:43:00, ended at 2010-01-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Hematochezia\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 08:02:34, ended at 2010-02-13 09:09:37\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Disorder of plasma protein metabolism\n- Left lower quadrant pain\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-28 06:26:00, ended at 2010-02-28 08:03:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report\n\n### Condition\n- Abdominal pain\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- vitamin E 90 MG Oral Tablet, through Oral route, presumably until 2013-05-28. Instructions: take by mouth. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2010-09-28. Instructions: take by mouth. \n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2010-12-07. Instructions: take 150 mg by mouth every bedtime. \n- morphine sulfate 10 MG Extended Release Oral Capsule, through Oral route, presumably until 2010-06-27. Instructions: take by mouth. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- zolpidem tartrate 12.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2010-02-28, presumably until 2010-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-06 08:51:00, ended at 2010-03-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Abdominal aortic aneurysm\n- Abdominal pain\n- Disorder of biliary tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-03-09 00:00:00, ended at 2010-03-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of intestine\n- Generalized abdominal pain\n- Iron deficiency anemia\n- Disorder of plasma protein metabolism\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-29 07:00:00, ended at 2010-03-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Generalized abdominal pain\n- Disorder of lung\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Abdominal aortic aneurysm\n- Disorder of biliary tract\n- Disorder of intestine\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-03 13:36:57, ended at 2010-04-03 14:59:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of biliary tract\n- Angiodysplasia of intestine\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 15:02:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 427 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Prothrombin time (PT): 14.3 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Angiodysplasia of intestine\n- Left lower quadrant pain\n- Diarrhea\n- Disorder of biliary tract\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Disorder of intestine\n- Generalized abdominal pain\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-04-09 17:45:00, ended at 2010-04-10 00:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 406 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.8 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Malaise\n- Dehydration\n- Cerebellar ataxia\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-17 11:35:32, ended at 2010-04-17 13:01:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 12:56:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.1 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: <2 (nanogram per milliliter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.28 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 15.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 11.74 (thousand per microliter)\n- Prothrombin time (PT): 14.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 15 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; molecular isolation or extraction, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-19 14:39:15, ended at 2010-06-19 16:42:24\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-27 11:46:00, ended at 2010-06-27 16:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Abdominal pain\n- Gastrojejunal ulcer without hemorrhage AND without perforation but with obstruction\n- Postprocedural state finding\n- Nausea and vomiting\n- Ulceration of intestine\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-06-27, presumably until 2010-06-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-06-27, presumably until 2010-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-07 08:36:00, ended at 2010-07-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-28 08:03:00, ended at 2010-07-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulceration of intestine\n- Postprocedural state finding\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-07-28 18:00:00, ended at 2010-07-28 19:19:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure reading\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 07:20:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Postgastric surgery syndrome\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-08 00:00:00, ended at 2010-08-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-11 08:11:00, ended at 2010-08-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Abdominal pain\n- Primary malignant neoplasm of colon\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-25 07:52:00, ended at 2010-08-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-30 10:19:00, ended at 2010-08-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-09-05 06:05:00, ended at 2010-09-12 12:15:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- Enteral infusion of concentrated nutritional substances\n- Collection of venous blood by venipuncture\n- Other enterostomy\n- Exploratory laparotomy\n\n### Condition\n- Depressive disorder\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Abdominal pain\n- Left lower quadrant pain\n- Malnutrition (calorie)\n- Adult failure to thrive syndrome\n- Chronic pain\n- Disorder of plasma protein metabolism\n- Disorder of function of stomach\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Benign essential hypertension\n- Vascular insufficiency of intestine\n- Abnormality of secretion of gastrin\n- Diarrhea\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-08\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-09-09, presumably until 2010-09-09\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2010-09-12, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2010-09-10, presumably until 2010-09-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-12-05, with quantity of 120.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-09\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11. Instructions: take 50 mg by mouth every bedtime.\n- heparin sodium, porcine 5000 UNT/ML Injectable Solution, through Intravenous route, started on 2010-09-05, presumably until 2010-09-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-09-06, presumably until 2010-09-11\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2010-09-10, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-11-17, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-18 09:43:58, ended at 2010-09-18 12:24:03\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 08:39:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-25 08:15:04, ended at 2010-09-25 08:49:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; more than 7 lesions\n- Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)\n\n### Condition\n- Periumbilical pain\n- Left lower quadrant pain\n- Abdominal pain\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2010-09-25, presumably until 2010-09-26, with quantity of 1.0, with intended 0 refill(s). Instructions: 20 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-09-28 18:19:00, ended at 2010-09-28 20:19:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication of internal prosthetic device\n- Late effect of complications of procedure\n\n### Drug\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. 4 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 15:00:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Postgastric surgery syndrome\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-10 08:16:54, ended at 2010-10-10 16:33:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- opium tincture 100 MG/ML Oral Solution, through Oral route, presumably until 2010-11-30. Instructions: take by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-13 15:55:35, ended at 2010-10-13 16:51:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n- Injection or infusion of other therapeutic or prophylactic substance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s); single or multiple trigger point(s), 3 or more muscles\n- Ultrasonography of digestive system\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Application of a modality to 1 or more areas; ultrasound, each 15 minutes\n\n### Condition\n- Stoma malfunction\n- Primary diagnosis: Abdominal pain\n- Chronic postoperative pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-10-17 12:11:00, ended at 2010-10-17 18:37:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Postgastric surgery syndrome\n- Intestinal volvulus\n- Abdominal pain\n- Disorder of biliary tract\n- Intestinal obstruction\n- Nausea and vomiting\n- Lumbosacral spondylosis without myelopathy\n- Abdominal aortic aneurysm\n- Imaging of gastrointestinal tract abnormal\n- Left lower quadrant pain\n- Vomiting\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, presumably until 2010-11-30. Instructions: take 1 Tab by mouth daily. \n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-10-17, presumably until 2010-10-17\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-10-17, presumably until 2010-10-17\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, presumably until 2011-03-06. Instructions: take 200 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 08:42:00, ended at 2010-10-20 09:47:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Disorder of plasma protein metabolism\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 09:48:00, ended at 2010-10-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postgastric surgery syndrome\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:22:00, ended at 2010-10-25 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of aorta\n- Disorder of biliary tract\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:27:00, ended at 2010-10-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of biliary tract\n- Atherosclerosis of aorta\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-06 14:36:24, ended at 2010-11-06 16:10:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-07 10:55:00, ended at 2010-11-07 14:38:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Stoma malfunction\n\n### Drug\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-07, presumably until 2010-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-10 15:48:00, ended at 2010-11-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-15 09:46:00, ended at 2010-11-15 15:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Mechanical complication of gastrostomy\n- Stoma malfunction\n- Nausea and vomiting\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-17 00:00:00, ended at 2010-11-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2010-11-17, presumably until 2010-11-30, with quantity of 1.0, with intended 0 refill(s). Instructions: 100 Units by Injection route One Time. For delivery from Los Altos Pharmacy for self-pay scar injection \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 08:15:01, ended at 2010-11-17 09:14:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take 5 mg by mouth. 1 tab  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-22 09:29:48, ended at 2010-11-22 16:34:58\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-22 16:40:00, ended at 2010-11-22 21:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Syncope and collapse\n- Diarrhea\n- Chronic pain\n- Chronic peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Generalized abdominal pain\n- Primary diagnosis: Seizure\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-22, presumably until 2010-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of intestinal_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "d8c873cd38fa139f2c72860e17bbaed4ce73aaeda7054f32e1a655755b2f4620", "prompt_hash": "edc15f92274ef630d69787cb5d7c0fab63ca84e43dcf2552b4ded5dd55d8de7a", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 4, "doc": {"person_id": 115971630, "visit_occurrence_id": 106395696, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2017-07-26 00:00:00", "visit_end_datetime": "2017-07-26 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-26 00:00:00, ended at 2017-07-26 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 91, "patient_first_visit_date": "2014-12-19 11:01:00", "patient_last_visit_date": "2020-02-01 14:11:59", "end_obs_date": "2018-07-26", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 1, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 1, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 32, "cumulated_visit_num": 32, "cumulated_approximate_token_count": 7016, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-19 11:01:00, ended at 2014-12-19 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7.52\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Anemia due to chronic blood loss\n- Benign neoplasm of adrenal gland\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- vitamin E, through Oral route, with intended 0 refill(s). Instructions: take 1,200 mg by mouth daily at noon.\n- folic acid 1 MG Oral Tablet, through Oral route, presumably until 2016-07-28, with intended 0 refill(s). Instructions: take 1 mg by mouth daily.\n- cholecalciferol 0.025 MG Oral Capsule, through Oral route, presumably until 2019-02-26, with intended 0 refill(s). Instructions: take 1,000 Units by mouth.\n- ipratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route 2 times a day.\n- chromium picolinate 1 MG Oral Tablet, through Oral route, presumably until 2019-02-19, with intended 0 refill(s). Instructions: take 1,000 mcg/day by mouth.\n- wheat germ oil, through Oral route, with intended 0 refill(s). Instructions: take 1,200 mg by mouth daily at noon.\n- citalopram 20 MG Oral Tablet, through Oral route, presumably until 2017-02-03, with intended 0 refill(s). Instructions: take 20 mg by mouth daily.\n- alpha tocopherol, through Oral route, with intended 0 refill(s). Instructions: take 1,200 mg by mouth daily at noon.\n- omega-3 acid ethyl esters (USP), through Oral route, with intended 0 refill(s). Instructions: take 1,200 mg by mouth daily at noon.\n- omega-3 fatty acids, through Oral route, with intended 0 refill(s). Instructions: take 1,200 mg by mouth daily at noon.\n- vitamin B12 0.1 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mcg by mouth daily Every other day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-24 00:00:00, ended at 2014-12-24 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-25 09:17:00, ended at 2014-12-25 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Benign neoplasm of colon\n- Anal and rectal polyp\n- Atrophic gastritis\n- Primary malignant neoplasm of ascending colon\n- Benign neoplasm of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-01 00:00:00, ended at 2015-01-01 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.50 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.47 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-01-08 00:00:00, ended at 2015-01-08 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-01-08, presumably until 2015-01-08\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2015-01-08, presumably until 2015-01-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-01-08 00:00:00, ended at 2015-01-08 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of ascending colon\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2015-01-08, presumably until 2015-01-08\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2015-01-08, presumably until 2015-01-08\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2015-01-08, presumably until 2015-01-08\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2015-01-08, presumably until 2015-01-08\n- ertapenem 1000 MG Injection, started on 2015-01-08, presumably until 2015-01-08\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2015-01-08, presumably until 2015-01-08\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2015-01-08, presumably until 2015-01-08\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2015-01-08, presumably until 2015-01-08\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-01-08, presumably until 2015-01-08\n- midazolam 1 MG/ML Injectable Solution, started on 2015-01-08, presumably until 2015-01-08\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2015-01-08, presumably until 2015-01-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-01-08 09:30:00, ended at 2015-01-10 11:47:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.60 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.28 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Body height: 5' 8\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- Laparoscopic-assisted right colectomy\n- Collection of venous blood by venipuncture\n- Physical therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n\n### Condition\n- Disorder of bone and articular cartilage\n- Depressive disorder\n- Primary malignant neoplasm of ascending colon\n- Primary malignant neoplasm of cecum\n- Anemia in neoplastic disease\n- Primary malignant neoplasm of colon\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2015-01-08, presumably until 2015-01-09\n- 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Ma..., through Intramuscular route, started on 2015-01-10, presumably until 2015-01-10\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2015-01-08, presumably until 2015-01-10\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-01-08, presumably until 2015-01-09\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-01-09, presumably until 2015-01-10\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2015-01-09, presumably until 2015-01-23, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- thiocyanate, through Submucosal route, started on 2015-01-10, presumably until 2015-01-10\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2015-01-08, presumably until 2015-01-09\n- glucose oxidase, through Submucosal route, started on 2015-01-10, presumably until 2015-01-10\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2015-01-08, presumably until 2015-01-10\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2015-01-08, presumably until 2015-01-08\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-01-09, presumably until 2015-01-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-01-08, presumably until 2015-01-08\n- alvimopan 12 MG Oral Capsule, through Oral route, started on 2015-01-08, presumably until 2015-01-10\n- lactoperoxidase, through Submucosal route, started on 2015-01-10, presumably until 2015-01-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-11 02:20:00, ended at 2015-01-11 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-13 00:00:00, ended at 2015-01-13 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-15 11:33:00, ended at 2015-01-15 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.535\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-22 15:40:00, ended at 2015-01-22 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Osteoarthritis\n- Lung field abnormal\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-23 09:31:00, ended at 2015-01-23 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.535\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-16 10:27:00, ended at 2015-04-16 10:29:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 1 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.37 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.78 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-16 10:30:00, ended at 2015-04-16 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.89\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-30 00:00:00, ended at 2015-06-30 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-06 14:52:04, ended at 2015-07-06 15:48:28\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Finding of head and neck region\n- Primary diagnosis: Swelling / lump finding\n- Disorder of nasal cavity\n\n### Drug\n- mupirocin 0.02 MG/MG Nasal Ointment, through Nasal route, started on 2015-07-06, presumably until 2016-01-13, with intended 0 refill(s). Instructions: by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-17 13:25:00, ended at 2015-07-17 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-23 10:15:25, ended at 2015-07-23 12:09:49\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.929\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, presumably until 2016-07-28, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-27 09:26:46, ended at 2015-08-27 10:14:24\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cataract\n- Primary malignant neoplasm of colon\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-26 00:00:00, ended at 2015-12-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-26 00:00:00, ended at 2015-12-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-12-26, presumably until 2015-12-26, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-01-13 00:00:00, ended at 2016-01-13 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-01-13, presumably until 2016-01-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-13 07:05:00, ended at 2016-01-13 09:29:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Inspection of Lower Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n\n### Condition\n- No conditions.\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-01-13, presumably until 2016-01-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-23 12:54:00, ended at 2016-01-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-28 12:32:11, ended at 2016-01-28 14:34:31\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.732\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-22 00:00:00, ended at 2016-07-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-22 00:00:00, ended at 2016-07-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ascending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-28 08:35:02, ended at 2016-07-28 09:33:18\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7.52\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ascending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-28 10:14:00, ended at 2017-01-28 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-03 10:47:51, ended at 2017-02-03 12:16:29\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.26 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1536 (cells per microliter)\n- Body height: 5' 7.52\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.9 (percent)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 163 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 352 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: <0.5 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2310 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.9 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 88.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ascending colon\n\n### Drug\n- sertraline 50 MG Oral Tablet, started on 2017-01-03, presumably until 2017-01-03, with intended 2 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-23 00:00:00, ended at 2017-06-23 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pruritic rash\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-26 00:00:00, ended at 2017-07-26 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-19 11:01:00, ended at 2014-12-19 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7.52\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Anemia due to chronic blood loss\n- Benign neoplasm of adrenal gland\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- vitamin E, through Oral route, with intended 0 refill(s). Instructions: take 1,200 mg by mouth daily at noon.\n- folic acid 1 MG Oral Tablet, through Oral route, presumably until 2016-07-28, with intended 0 refill(s). Instructions: take 1 mg by mouth daily.\n- cholecalciferol 0.025 MG Oral Capsule, through Oral route, presumably until 2019-02-26, with intended 0 refill(s). Instructions: take 1,000 Units by mouth.\n- ipratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route 2 times a day.\n- chromium picolinate 1 MG Oral Tablet, through Oral route, presumably until 2019-02-19, with intended 0 refill(s). Instructions: take 1,000 mcg/day by mouth.\n- wheat germ oil, through Oral route, with intended 0 refill(s). Instructions: take 1,200 mg by mouth daily at noon.\n- citalopram 20 MG Oral Tablet, through Oral route, presumably until 2017-02-03, with intended 0 refill(s). Instructions: take 20 mg by mouth daily.\n- alpha tocopherol, through Oral route, with intended 0 refill(s). Instructions: take 1,200 mg by mouth daily at noon.\n- omega-3 acid ethyl esters (USP), through Oral route, with intended 0 refill(s). Instructions: take 1,200 mg by mouth daily at noon.\n- omega-3 fatty acids, through Oral route, with intended 0 refill(s). Instructions: take 1,200 mg by mouth daily at noon.\n- vitamin B12 0.1 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mcg by mouth daily Every other day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-24 00:00:00, ended at 2014-12-24 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-25 09:17:00, ended at 2014-12-25 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Benign neoplasm of colon\n- Anal and rectal polyp\n- Atrophic gastritis\n- Primary malignant neoplasm of ascending colon\n- Benign neoplasm of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-01 00:00:00, ended at 2015-01-01 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.50 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.47 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-01-08 00:00:00, ended at 2015-01-08 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-01-08, presumably until 2015-01-08\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2015-01-08, presumably until 2015-01-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-01-08 00:00:00, ended at 2015-01-08 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of ascending colon\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2015-01-08, presumably until 2015-01-08\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2015-01-08, presumably until 2015-01-08\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2015-01-08, presumably until 2015-01-08\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2015-01-08, presumably until 2015-01-08\n- ertapenem 1000 MG Injection, started on 2015-01-08, presumably until 2015-01-08\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2015-01-08, presumably until 2015-01-08\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2015-01-08, presumably until 2015-01-08\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2015-01-08, presumably until 2015-01-08\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-01-08, presumably until 2015-01-08\n- midazolam 1 MG/ML Injectable Solution, started on 2015-01-08, presumably until 2015-01-08\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2015-01-08, presumably until 2015-01-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-01-08 09:30:00, ended at 2015-01-10 11:47:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.60 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.28 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Body height: 5' 8\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- Laparoscopic-assisted right colectomy\n- Collection of venous blood by venipuncture\n- Physical therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n\n### Condition\n- Disorder of bone and articular cartilage\n- Depressive disorder\n- Primary malignant neoplasm of ascending colon\n- Primary malignant neoplasm of cecum\n- Anemia in neoplastic disease\n- Primary malignant neoplasm of colon\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2015-01-08, presumably until 2015-01-09\n- 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Ma..., through Intramuscular route, started on 2015-01-10, presumably until 2015-01-10\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2015-01-08, presumably until 2015-01-10\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-01-08, presumably until 2015-01-09\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-01-09, presumably until 2015-01-10\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2015-01-09, presumably until 2015-01-23, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- thiocyanate, through Submucosal route, started on 2015-01-10, presumably until 2015-01-10\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2015-01-08, presumably until 2015-01-09\n- glucose oxidase, through Submucosal route, started on 2015-01-10, presumably until 2015-01-10\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2015-01-08, presumably until 2015-01-10\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2015-01-08, presumably until 2015-01-08\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-01-09, presumably until 2015-01-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-01-08, presumably until 2015-01-08\n- alvimopan 12 MG Oral Capsule, through Oral route, started on 2015-01-08, presumably until 2015-01-10\n- lactoperoxidase, through Submucosal route, started on 2015-01-10, presumably until 2015-01-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-11 02:20:00, ended at 2015-01-11 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-13 00:00:00, ended at 2015-01-13 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-15 11:33:00, ended at 2015-01-15 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.535\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-22 15:40:00, ended at 2015-01-22 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Osteoarthritis\n- Lung field abnormal\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-23 09:31:00, ended at 2015-01-23 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.535\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-16 10:27:00, ended at 2015-04-16 10:29:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 1 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.37 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.78 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-16 10:30:00, ended at 2015-04-16 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.89\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-30 00:00:00, ended at 2015-06-30 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-06 14:52:04, ended at 2015-07-06 15:48:28\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Finding of head and neck region\n- Primary diagnosis: Swelling / lump finding\n- Disorder of nasal cavity\n\n### Drug\n- mupirocin 0.02 MG/MG Nasal Ointment, through Nasal route, started on 2015-07-06, presumably until 2016-01-13, with intended 0 refill(s). Instructions: by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-17 13:25:00, ended at 2015-07-17 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-23 10:15:25, ended at 2015-07-23 12:09:49\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.929\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, presumably until 2016-07-28, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-27 09:26:46, ended at 2015-08-27 10:14:24\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cataract\n- Primary malignant neoplasm of colon\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-26 00:00:00, ended at 2015-12-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-26 00:00:00, ended at 2015-12-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-12-26, presumably until 2015-12-26, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-01-13 00:00:00, ended at 2016-01-13 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-01-13, presumably until 2016-01-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-13 07:05:00, ended at 2016-01-13 09:29:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Inspection of Lower Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n\n### Condition\n- No conditions.\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-01-13, presumably until 2016-01-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-23 12:54:00, ended at 2016-01-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-28 12:32:11, ended at 2016-01-28 14:34:31\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.732\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-22 00:00:00, ended at 2016-07-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-22 00:00:00, ended at 2016-07-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ascending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-28 08:35:02, ended at 2016-07-28 09:33:18\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7.52\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ascending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-28 10:14:00, ended at 2017-01-28 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-03 10:47:51, ended at 2017-02-03 12:16:29\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.26 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1536 (cells per microliter)\n- Body height: 5' 7.52\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.9 (percent)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 163 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 352 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: <0.5 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2310 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.9 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 88.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ascending colon\n\n### Drug\n- sertraline 50 MG Oral Tablet, started on 2017-01-03, presumably until 2017-01-03, with intended 2 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-23 00:00:00, ended at 2017-06-23 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pruritic rash\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-26 00:00:00, ended at 2017-07-26 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of intestinal_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "6cf7e1e0a46623e614d70394596cb22161cb284a53ec6c8e1cc090818137a965", "prompt_hash": "810b57330495073240fa7a010fd8f90e35a12f9b59b062460a5d01c3b8dc169b", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 5, "doc": {"person_id": 115973205, "visit_occurrence_id": 158472964, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2020-04-22 00:00:00", "visit_end_datetime": "2020-04-22 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-22 00:00:00, ended at 2020-04-22 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 94, "patient_first_visit_date": "2011-07-29 14:58:00", "patient_last_visit_date": "2021-08-21 00:00:00", "end_obs_date": "2021-04-22", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "recurrent", "pancreatic_cancer_one_year_diagnosis": 1, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 1, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "recurrent", "lung_cancer_one_year_diagnosis": 1, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 181, "cumulated_visit_num": 181, "cumulated_approximate_token_count": 64029, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-29 14:58:00, ended at 2011-07-29 23:59:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .5\" (inch (US))\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Benign neoplasm of stomach\n- Carcinoma in situ of colon\n- Primary malignant neoplasm of colon\n- Benign neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-08-07 00:00:00, ended at 2011-08-07 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2011-08-07, presumably until 2011-08-18, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-10 10:02:00, ended at 2011-08-10 13:29:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique\n- Endoscopic polypectomy of large intestine\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopic biopsy of large intestine\n- Colonoscopy, flexible; with biopsy, single or multiple\n\n### Condition\n- Benign neoplasm of rectum and anal canal\n- Primary malignant neoplasm of transverse colon\n- Benign neoplasm of colon\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-08-10, presumably until 2011-08-10\n- midazolam 1 MG/ML Injectable Solution, started on 2011-08-10, presumably until 2011-08-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-08-11 07:37:00, ended at 2011-08-18 12:30:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 28.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.14 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 6' 1\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.47 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 74.1 (femtoliter)\n\n### Procedure\n- Rigid proctosigmoidoscopy\n- Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Laparoscopic total intra-abdominal colectomy\n- Molecular diagnostics; amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (List separately in addition to code for primary procedure)\n- Other small-to-large intestinal anastomosis\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; separation and identification by high resolution technique (eg, capillary electrophoresis), each nucleic acid preparation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Benign neoplasm of colon\n- Neoplasm of intrapelvic lymph node\n- Neoplasm of intra-abdominal lymph nodes\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of splenic flexure of colon\n- Anemia in neoplastic disease\n- Primary malignant neoplasm of rectosigmoid junction\n\n### Drug\n- psyllium, through Oral route, started on 2011-08-18, presumably until 2012-06-14. Instructions: take 1 Packet by mouth 3 times a day.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-08-11, presumably until 2011-08-16\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-08-14, presumably until 2011-08-17\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-08-12, presumably until 2011-08-17\n- ispaghula husk, through Oral route, started on 2011-08-18, presumably until 2012-06-14. Instructions: take 1 Packet by mouth 3 times a day.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-08-13, presumably until 2011-08-13\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2011-08-11, presumably until 2011-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-08-11, presumably until 2011-08-11\n- Plantago seed, through Oral route, started on 2011-08-18, presumably until 2012-06-14. Instructions: take 1 Packet by mouth 3 times a day.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-08-13, presumably until 2011-08-14\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-08-14, presumably until 2011-08-14\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-08-13, presumably until 2012-02-14, with intended 2 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-18 00:00:00, ended at 2011-08-18 00:00:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-02 13:55:00, ended at 2011-09-02 23:59:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.25\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign neoplasm of colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-14 15:07:00, ended at 2011-09-14 23:59:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.25\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n- Benign neoplasm of colon\n\n### Drug\n- capecitabine 500 MG Oral Tablet, through Oral route, started on 2011-09-14, presumably until 2012-06-14, with intended 5 refill(s). Instructions: take 4 Tabs by mouth 2 times a day. Take 2 times daily for 2 weeks and then 1 week off.\n- ondansetron 8 MG Oral Tablet, through Oral route, presumably until 2012-06-14, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea and vomiting.\n- lorazepam 1 MG Oral Tablet, through Oral route, presumably until 2012-06-14, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed. For nausea and vomiting.\n- prochlorperazine 10 MG Oral Tablet, through Oral route, presumably until 2012-06-14, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-17 00:00:00, ended at 2011-09-17 00:00:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-20 08:00:00, ended at 2011-09-20 13:19:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 1 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 20.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.75 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.3 (percent)\n- MCV [Entitic volume] by Automated count: 66.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-09-20, presumably until 2011-09-20\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-09-20, presumably until 2011-09-20\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2011-09-20, presumably until 2011-09-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-20 13:20:00, ended at 2011-09-20 23:59:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-08 00:00:00, ended at 2011-10-08 00:00:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-08 09:45:00, ended at 2011-10-08 11:10:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.228\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Chromosome analysis, cytogenetic procedure AND/OR molecular biology method\n- Genetic counseling\n\n### Condition\n- Benign neoplasm of colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-12 12:00:00, ended at 2011-10-12 12:18:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.11 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 35.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- MCH [Entitic mass] by Automated count: 20.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 65.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-12 12:19:00, ended at 2011-10-12 23:59:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n- Benign neoplasm of colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-10-12, presumably until 2011-10-12\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-10-12, presumably until 2011-10-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2011-10-12, presumably until 2011-10-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-20 00:00:00, ended at 2011-10-20 00:00:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-06-01 00:00:00, ended at 2012-06-01 00:00:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-14 10:10:00, ended at 2012-06-14 13:39:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- Endoscopic polypectomy of large intestine\n- [Endoscopic] polypectomy of rectum\n- Sigmoidoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Benign neoplasm of colon\n- Benign neoplasm of rectum and anal canal\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2012-06-14, presumably until 2012-06-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-20 00:00:00, ended at 2013-03-20 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-03-28 00:00:00, ended at 2013-03-28 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2013-03-28, presumably until 2013-03-28\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2013-03-28, presumably until 2013-03-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-28 09:47:00, ended at 2013-03-28 13:50:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- [Endoscopic] polypectomy of rectum\n- Flexible fiberoptic sigmoidoscopy\n- Sigmoidoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Primary malignant neoplasm of colon\n- Benign neoplasm of rectum and anal canal\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2013-03-28, presumably until 2013-03-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-18 00:00:00, ended at 2014-11-18 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-03-05 00:00:00, ended at 2016-03-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-03-29 14:20:00, ended at 2018-03-31 17:26:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCH [Entitic mass] by Automated count: 26.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 79.1 (femtoliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.6 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.94 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Chromogranin A [Moles/volume] in Serum or Plasma: 49 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.95 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 6' 2\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 8 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Lactate [Moles/volume] in Serum or Plasma: 1.0 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.04 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.00 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of rectosigmoid junction\n- Nausea and vomiting\n- Primary diagnosis: Intestinal obstruction\n- Primary malignant neoplasm of colon\n- Acquired absence of organ\n- Secondary malignant neoplasm of intra-abdominal lymph nodes\n- Primary malignant neoplasm of descending colon\n- Benign neoplasm of colon\n- Secondary malignant neoplasm of left lung\n- Benign neoplasm of transverse colon\n- Primary malignant neoplasm of splenic flexure of colon\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Secondary malignant neoplasm of small intestine\n- Disorder of digestive system\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2018-03-29, presumably until 2018-03-31\n- barium sulfate, through Oral route, started on 2018-03-30, presumably until 2018-03-30\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2018-03-29, presumably until 2018-03-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-10 00:00:00, ended at 2018-04-10 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-10 08:42:18, ended at 2018-04-10 10:04:02\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intestinal obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-10 09:55:46, ended at 2018-04-10 11:10:59\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-10 11:13:00, ended at 2018-04-10 13:53:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- MCV [Entitic volume] by Automated count: 79.0 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.22 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.46 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 51.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.4 (picogram)\n- Prothrombin time (PT): 13.1 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.8 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-10 13:54:00, ended at 2018-04-10 18:24:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-04-10 18:25:00, ended at 2018-04-25 15:19:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 2.7 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 250 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 308 (thousand per microliter)\n- Body height: 6' 2.016\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 634 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 80.6 (femtoliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.1 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.09 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.01 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Oxygen [Partial pressure] in Arterial blood: 155.0 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Prothrombin time (PT): 13.8 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 35.8 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 25.9 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.3 (percent)\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material\n- Excision of Stomach, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Excision of Pancreas, Open Approach\n- Drainage of Peritoneal Cavity with Drainage Device, Percutaneous Approach\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Collection of venous blood by venipuncture\n- Radiologic examination, abdomen; 1 view\n- Morphometric analysis, tumor\n- Excision of Aortic Lymphatic, Open Approach\n- Radiologic examination, chest; 2 views\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Excision of Right Lobe Liver, Open Approach\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Sigmoidoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Excision of Duodenum, Open Approach\n- Radiologic examination, abdomen; 2 views\n- Destruction of Right Lobe Liver, Open Approach\n- Excision of Rectum, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Image-guided fluid collection drainage by catheter (eg, abscess, hematoma, seroma, lymphocele, cyst); peritoneal or retroperitoneal, percutaneous\n\n### Condition\n- Disorder of digestive system\n- Secondary malignant neoplasm of intra-abdominal lymph nodes\n- Secondary malignant neoplasm of small intestine\n- Adult hypertrophic pyloric stenosis\n- Gastrointestinal complication\n- Steatosis of liver\n- Benign neoplasm of colon\n- Rectal polyp\n- Acquired absence of organ\n- Primary malignant neoplasm of small intestine\n- Abnormal findings on diagnostic imaging of lung\n- Ascites\n- Benign neoplasm of rectum\n- Overlapping malignant neoplasm of pancreas\n- Abdominal distension, gaseous\n- Abscess of peritoneum\n- Late effect of complications of procedure\n- Primary malignant neoplasm of colon\n- Abdominal pain\n- Gastric polyp\n- Intestinal obstruction\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2018-04-10, presumably until 2018-04-13\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2018-04-21, presumably until 2018-04-21\n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-18\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2018-04-17, presumably until 2018-04-20\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-04-11, presumably until 2018-04-25\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2018-04-13, presumably until 2018-04-13\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2018-04-14, presumably until 2018-04-24\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-04-13, presumably until 2019-10-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 8 hours\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2018-04-16, presumably until 2018-04-16\n- diatrizoate, through Oral route, started on 2018-04-25, presumably until 2018-04-25\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-04-17, presumably until 2018-04-20\n- diatrizoic acid, through Oral route, started on 2018-04-25, presumably until 2018-04-25\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2018-04-14, presumably until 2018-04-21\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2018-04-20, presumably until 2018-04-20\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2018-04-20, presumably until 2018-04-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2018-04-14, presumably until 2018-04-15\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-04-13, presumably until 2018-04-13\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-04-13, presumably until 2018-05-08, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-22\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2018-04-14, presumably until 2018-04-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2018-04-17, presumably until 2018-04-17\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-04-13, presumably until 2018-07-18, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2018-04-17, presumably until 2018-04-21\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-04-23, presumably until 2018-05-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2018-04-18, presumably until 2018-04-18\n- 0.5 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-04-13, presumably until 2018-04-13\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2018-04-23, presumably until 2018-04-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-04-12 00:00:00, ended at 2018-04-12 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for combined upper and lower gastrointestinal endoscopic procedures, endoscope introduced both proximal to and distal to the duodenum\n\n### Condition\n- Rectal polyp\n- Gastric polyp\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-12, presumably until 2018-04-12\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-04-12, presumably until 2018-04-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-04-12, presumably until 2018-04-12\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2018-04-12, presumably until 2018-04-12\n- 2 ML alfentanil 0.5 MG/ML Injection, started on 2018-04-12, presumably until 2018-04-12\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2018-04-12, presumably until 2018-04-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-04-13 00:00:00, ended at 2018-04-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; partial hepatectomy or management of liver hemorrhage (excluding liver biopsy)\n\n### Condition\n- Primary malignant neoplasm of transverse colon\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2018-04-13, presumably until 2018-04-13\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 10 ML methylene blue 5 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-13\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-13\n- ketamine 100 MG/ML Injectable Solution, started on 2018-04-13, presumably until 2018-04-13\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- midazolam 1 MG/ML Injectable Solution, started on 2018-04-13, presumably until 2018-04-13\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-13\n- 2 ML alfentanil 0.5 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-13\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2018-04-13, presumably until 2018-04-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-04-13 12:38:00, ended at 2018-04-13 12:38:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign neoplasm of colon\n- Primary malignant neoplasm of colon\n- Primary diagnosis: Intestinal obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-04-20 00:00:00, ended at 2018-04-20 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-04-20, presumably until 2018-04-20\n- midazolam 1 MG/ML Injectable Solution, started on 2018-04-20, presumably until 2018-04-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-08 09:47:16, ended at 2018-05-08 11:06:42\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Epigastric pain\n- Primary malignant neoplasm of colon\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-07-18, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 11:11:00, ended at 2018-05-08 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 124 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.4 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.40 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Prothrombin time (PT): 13.6 (second)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 77.7 (femtoliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Epigastric pain\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-22 07:06:00, ended at 2018-05-22 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of duodenum\n- Epigastric pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-22 08:21:46, ended at 2018-05-22 12:20:05\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-26 00:00:00, ended at 2018-05-26 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-06-13 00:00:00, ended at 2018-06-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection, started on 2018-06-13, presumably until 2018-06-13\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-06-13, presumably until 2018-06-13\n- midazolam 1 MG/ML Injectable Solution, started on 2018-06-13, presumably until 2018-06-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-06-13 00:00:00, ended at 2018-06-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intestinal obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-13 14:13:00, ended at 2018-06-13 18:42:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.26 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.7 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Body height: 6' 2\" (inch (US))\n- MCV [Entitic volume] by Automated count: 73.1 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.4 (percent)\n- MCH [Entitic mass] by Automated count: 23.1 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.11 (thousand per microliter)\n\n### Procedure\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Insertion of Totally Implantable Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach\n- Collection of venous blood by venipuncture\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion of tunneled centrally inserted central venous access device, with subcutaneous port; age 5 years or older\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-20 09:30:00, ended at 2018-06-20 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.75 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.06 (thousand per microliter)\n- Prothrombin time (PT): 13.7 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 72.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.52 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 234 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.47 (million per microliter)\n- MCH [Entitic mass] by Automated count: 23.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.6 (second)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Intestinal obstruction\n- Primary malignant neoplasm of transverse colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-06-20, presumably until 2018-06-20\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-06-20, presumably until 2018-06-20\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-06-20, presumably until 2018-06-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-20 10:19:33, ended at 2018-06-20 11:50:53\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Colon, NOS\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-06-20, presumably until 2018-08-02, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-06-20, presumably until 2018-11-21, with intended 2 refill(s). Instructions: take 0.5 Tabs by mouth every 6 hours as needed For nausea and vomiting.\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2018-06-20, presumably until 2018-11-21, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-22 16:56:00, ended at 2018-06-22 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-23 00:00:00, ended at 2018-06-23 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2018-06-23, presumably until 2019-06-23, with intended 0 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-04 00:00:00, ended at 2018-07-04 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-04 12:21:00, ended at 2018-07-04 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.64 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 73.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.6 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.9 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.42 (million per microliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3.05 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Prothrombin time (PT): 12.6 (second)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of transverse colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-07-04, presumably until 2018-07-04\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-07-04, presumably until 2018-07-04\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-07-04, presumably until 2018-07-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-06 16:49:00, ended at 2018-07-06 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of splenic flexure of colon\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-18 11:30:00, ended at 2018-07-18 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Prothrombin time (PT): 13.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.6 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.30 (million per microliter)\n- MCV [Entitic volume] by Automated count: 73.7 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.26 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.53 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-07-18, presumably until 2018-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-20 16:10:00, ended at 2018-07-20 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-01 00:00:00, ended at 2018-08-01 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2018-08-01, presumably until 2018-08-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime Take 1 tab Q HS x 5 days after each infusion. Don't take with Ativan.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-01 11:12:00, ended at 2018-08-01 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.07 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.3 (percent)\n- MCH [Entitic mass] by Automated count: 23.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 73.3 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Body height: 6' 1.031\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.58 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.52 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-08-01, presumably until 2018-08-01\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-08-01, presumably until 2018-08-01\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-08-01, presumably until 2018-08-01\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-08-01, presumably until 2018-08-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-02 00:00:00, ended at 2018-08-02 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-08-02, presumably until 2019-10-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-03 16:30:00, ended at 2018-08-03 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of splenic flexure of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-14 12:20:00, ended at 2018-08-14 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-15 10:53:00, ended at 2018-08-15 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Body height: 6' .835\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 159 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.3 (percent)\n- MCV [Entitic volume] by Automated count: 74.4 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.77 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.0 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.26 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Prothrombin time (PT): 13.1 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.4 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-08-15, presumably until 2018-08-15\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-08-15, presumably until 2018-08-15\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-08-15, presumably until 2018-08-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-08-15, presumably until 2018-08-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-15 11:19:37, ended at 2018-08-15 14:19:08\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-17 16:52:00, ended at 2018-08-17 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-21 00:00:00, ended at 2018-08-21 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2018-08-21, presumably until 2019-07-02, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime Take 1 tab Q HS x 5 days after each infusion. Don't take with Ativan.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-29 10:20:00, ended at 2018-08-29 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 74.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.68 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.40 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 167 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-08-29, presumably until 2018-08-29\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-08-29, presumably until 2018-08-29\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-08-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-08-29, presumably until 2018-08-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-31 16:01:00, ended at 2018-08-31 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-12 08:38:00, ended at 2018-09-12 11:10:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.44 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 75.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.76 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Prothrombin time (PT): 12.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.31 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 162 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 185 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.8 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-12 09:05:43, ended at 2018-09-12 10:09:59\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .835\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-12 11:11:00, ended at 2018-09-12 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-09-12, presumably until 2018-09-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-09-12, presumably until 2018-09-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-09-12, presumably until 2018-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-14 15:19:00, ended at 2018-09-14 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-26 11:50:00, ended at 2018-09-26 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Body height: 6' 1.504\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.79 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 162 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.18 (million per microliter)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.3 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-09-26, presumably until 2018-09-26\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-09-26, presumably until 2018-09-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-28 15:57:00, ended at 2018-09-28 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-10 11:31:00, ended at 2018-10-10 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.13 (million per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 133 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.11 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 77.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.75 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.7 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-10-10, presumably until 2018-10-10\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-10-10, presumably until 2018-10-10\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-10-10, presumably until 2018-10-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-10-10, presumably until 2018-10-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-10 13:00:42, ended at 2018-10-10 15:02:01\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.543\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-12 18:43:00, ended at 2018-10-12 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-24 09:58:00, ended at 2018-10-24 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-24 12:13:13, ended at 2018-10-24 14:07:08\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.543\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-21 08:38:00, ended at 2018-11-21 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Disorder of digestive system\n- Acquired absence of organ\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-21 08:38:00, ended at 2018-11-21 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 179 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- No conditions.\n\n### Drug\n- barium sulfate, through Oral route, started on 2018-11-21, presumably until 2018-11-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-05 10:12:27, ended at 2019-02-05 11:31:01\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-05 12:54:00, ended at 2019-02-05 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of transverse colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-02-05, presumably until 2019-02-05\n- 0.5 ML meperidine hydrochloride 50 MG/ML Injection, started on 2019-02-05, presumably until 2019-02-05\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2019-02-05, presumably until 2019-02-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-02-05, presumably until 2019-02-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-02-05, presumably until 2019-02-05\n- methylprednisolone 125 MG Injection, started on 2019-02-05, presumably until 2019-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-26 12:37:00, ended at 2019-02-26 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.57 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.4 (percent)\n- MCV [Entitic volume] by Automated count: 81.7 (femtoliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 108 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.81 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.2 (second)\n- MCH [Entitic mass] by Automated count: 26.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.60 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 44.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-02-26, presumably until 2019-02-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-02-26, presumably until 2019-02-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-26 12:59:39, ended at 2019-02-26 17:00:57\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-15 00:00:00, ended at 2019-03-15 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-16 07:30:00, ended at 2019-03-16 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 48.6 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Accidental poisoning\n- Primary malignant neoplasm of colon\n- Poisoning by drug AND/OR medicinal substance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-17 13:00:00, ended at 2019-03-17 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 192 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.97 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 169 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.79 (million per microliter)\n- MCV [Entitic volume] by Automated count: 80.5 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Body height: 6' 1.504\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.3 (picogram)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-03-17, presumably until 2019-03-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-03-17, presumably until 2019-03-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-09 09:57:00, ended at 2019-04-09 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.6 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.03 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.5 (femtoliter)\n- Prothrombin time (PT): 13.2 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.62 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.09 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-04-09, presumably until 2019-04-09\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-04-09, presumably until 2019-04-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-04-09, presumably until 2019-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-09 10:20:40, ended at 2019-04-09 11:08:08\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-30 09:07:00, ended at 2019-04-30 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-04-30, presumably until 2019-04-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-04-30, presumably until 2019-04-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-21 10:55:00, ended at 2019-05-21 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.46 (million per microliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- MCV [Entitic volume] by Automated count: 84.4 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.21 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-05-21, presumably until 2019-05-21\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-05-21, presumably until 2019-05-21\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-05-21, presumably until 2019-05-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-21 11:11:47, ended at 2019-05-21 13:37:08\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-22 11:26:00, ended at 2019-05-22 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-08 00:00:00, ended at 2019-06-08 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-11 07:07:00, ended at 2019-06-11 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 162 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.24 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.93 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.5 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.84 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.40 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-06-11, presumably until 2019-06-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-06-11, presumably until 2019-06-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-11 07:46:03, ended at 2019-06-11 08:55:05\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-25 16:25:00, ended at 2019-06-25 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disease of liver\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of colon\n- Disorder of pancreas\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-02 09:30:00, ended at 2019-07-02 12:05:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 164 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.39 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-02 10:16:37, ended at 2019-07-02 11:16:50\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.268\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-02 12:06:00, ended at 2019-07-02 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-07-02, presumably until 2019-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-30 14:00:00, ended at 2019-07-30 16:05:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.77 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.4 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.14 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- MCH [Entitic mass] by Automated count: 28.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.22 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-30 14:53:10, ended at 2019-07-30 15:46:45\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.268\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-30 16:06:00, ended at 2019-07-30 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-07-30, presumably until 2019-07-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-07-30, presumably until 2019-07-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-16 00:00:00, ended at 2019-08-16 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-20 13:03:00, ended at 2019-08-20 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 84.5 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.43 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 48.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.75 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.3 (percent)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.82 (thousand per microliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-08-20, presumably until 2019-08-20\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-08-20, presumably until 2019-08-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-10 00:00:00, ended at 2019-09-10 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-10 12:00:00, ended at 2019-09-10 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.26 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.28 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.37 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-09-10, presumably until 2019-09-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-09-10, presumably until 2019-09-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-10 13:29:19, ended at 2019-09-10 15:37:13\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.268\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-25 00:00:00, ended at 2019-09-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 51.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-25 13:38:00, ended at 2019-09-25 14:26:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Disorder of adrenal gland\n- Primary malignant neoplasm of colon\n- Secondary malignant neoplasm of lung\n- Primary malignant neoplasm of descending colon\n- Localized enlarged lymph nodes\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-25 14:27:00, ended at 2019-09-25 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Accidental poisoning\n- Poisoning by drug AND/OR medicinal substance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-01 08:33:00, ended at 2019-10-01 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 203 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 237 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.16 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.42 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 218 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.26 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-01 08:50:28, ended at 2019-10-01 12:02:55\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.268\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-05 00:00:00, ended at 2019-10-05 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-22 11:43:00, ended at 2019-10-22 14:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.15 (million per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.83 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 228 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 240 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.70 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 167 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-24 14:27:00, ended at 2019-10-24 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.68 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 278 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.35 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 8 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- Prothrombin time (PT): 12.0 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 137 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n- Secondary malignant neoplasm of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-25 08:32:49, ended at 2019-10-25 11:16:33\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Secondary malignant neoplasm of left lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-29 00:00:00, ended at 2019-10-29 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-09 00:00:00, ended at 2019-11-09 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-12 12:00:00, ended at 2019-11-12 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.75 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 16.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 10 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.82 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.84 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 322 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 312 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.22 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2019-11-12, presumably until 2019-11-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-11-12, presumably until 2019-11-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-11-12, presumably until 2019-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-13 09:00:00, ended at 2019-11-13 10:20:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 97 (milligram per deciliter)\n\n### Procedure\n- Therapeutic radiology simulation-aided field setting; complex\n\n### Condition\n- Secondary malignant neoplasm of left lung\n- Primary malignant neoplasm of rectosigmoid junction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-13 10:21:00, ended at 2019-11-13 10:21:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign neoplasm of colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-13 10:22:00, ended at 2019-11-13 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- barium sulfate, through Oral route, started on 2019-11-13, presumably until 2019-11-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-13 10:22:00, ended at 2019-11-13 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-19 00:00:00, ended at 2019-11-19 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-20 00:00:00, ended at 2019-11-20 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- regorafenib 40 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2019-12-10, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day for 3 weeks on and 1 week off.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-21 00:00:00, ended at 2019-11-21 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- regorafenib 40 MG Oral Tablet, through Oral route, started on 2019-11-21, presumably until 2020-01-08, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day for 3 weeks on and 1 week off.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-12-03 00:00:00, ended at 2019-12-03 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-10 10:20:00, ended at 2019-12-10 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Secondary malignant neoplasm of left lung\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-17 09:20:00, ended at 2019-12-17 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 236 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.39 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 425 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 29 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 85.2 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.26 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-17 09:43:25, ended at 2019-12-17 13:19:34\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-18 00:00:00, ended at 2019-12-18 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2019-12-18, presumably until 2019-12-21, with intended 2 refill(s). Instructions: take 1-2 Tabs (0.5-1 mg total) by mouth every 6 hours as needed For nausea and vomitting\n- capecitabine 500 MG Oral Tablet, started on 2019-12-18, presumably until 2019-12-20, with intended 3 refill(s). Instructions: 4 tabs (2000 mg) in the AM and the evening, for 7 days, then 7 days off\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2019-12-18, presumably until 2019-12-21, with intended 6 refill(s). Instructions: take 1 Tab (8 mg total) by mouth every 8 hours as needed (For nausea and vomitting)\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2019-12-18, presumably until 2019-12-21, with intended 6 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every 6 hours as needed for Nausea/Vomiting\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-20 00:00:00, ended at 2019-12-20 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- capecitabine 500 MG Oral Tablet, started on 2019-12-20, presumably until 2019-12-21, with intended 3 refill(s). Instructions: 4 tabs (2000 mg) in the AM and the evening, for 7 days, then 7 days off\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-21 00:00:00, ended at 2019-12-21 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-25 00:00:00, ended at 2019-12-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-25 00:00:00, ended at 2019-12-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-26 00:00:00, ended at 2019-12-26 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-26 00:00:00, ended at 2019-12-26 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-26 12:03:00, ended at 2019-12-26 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 4.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Lutropin [Units/volume] in Serum or Plasma: 4.2 (milli-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 554 (unit per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 559 (nanogram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.48 (million per microliter)\n- Follitropin [Units/volume] in Serum or Plasma: 7.4 (milli-international unit per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Corticotropin [Mass/volume] in Plasma: 58.8 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 266 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.0 (percent)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.18 (micro-international unit per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 20.3 (microgram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.53 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.40 (nanogram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 348 (milligram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n- Hyperglycemia\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-12-26, presumably until 2019-12-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-28 00:00:00, ended at 2019-12-28 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 194 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 143 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.0 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 614 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-08 12:14:48, ended at 2020-01-08 14:10:15\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- regorafenib 40 MG Oral Tablet, started on 2020-01-08, presumably until 2020-01-22, with intended 3 refill(s). Instructions: Take 1 tab in the morning and 2 tabs in the evening for 3 weeks on and 1 week off.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-08 13:45:00, ended at 2020-01-08 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.84 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 228 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.72 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 5.52 (micro-international unit per milliliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.66 (nanogram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 654 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.2 (percent)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 40 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 16.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.7 (picogram)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 331 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 272 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-09 00:00:00, ended at 2020-01-09 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-11 00:00:00, ended at 2020-01-11 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2020-01-13 19:43:00, ended at 2020-01-16 10:16:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Acetaminophen [Presence] in Urine: <5.0 (microgram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 181 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 997 (unit per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.60 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 324 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 235 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.64 (thousand per microliter)\n- Body height: 6' .835\" (inch (US))\n- Glucose [Mass/volume] in Blood: 345 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.8 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.3 (gram per deciliter)\n- Prothrombin time (PT): 11.8 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 8.33 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 339 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- MCH [Entitic mass] by Automated count: 28.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.80 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 48.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n\n### Procedure\n- Hospital discharge day management; more than 30 minutes\n- Dilation of Pancreatic Duct with Intraluminal Device, Via Natural or Artificial Opening Endoscopic\n- Endoscopic retrograde cholangiopancreatography (ERCP); with placement of endoscopic stent into biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Combined endoscopic catheterization of the biliary and pancreatic ductal systems, radiological supervision and interpretation\n- Dilation of Common Bile Duct with Intraluminal Device, Via Natural or Artificial Opening Endoscopic\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n\n### Condition\n- Acquired absence of spleen\n- Disorder of digestive system\n- Hepatic failure\n- Hypoinsulinemia following procedure\n- Jaundice\n- Hypokalemia\n- Secondary malignant neoplasm of right lung\n- Acquired absence of organ\n- Genetic predisposition\n- Secondary malignant neoplasm of left lung\n- Generalized abdominal pain\n- Primary diagnosis: Obstruction of bile duct\n- Pruritic rash\n- Primary malignant neoplasm of colon\n- Secondary malignant neoplasm of intra-abdominal lymph nodes\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2020-01-14, presumably until 2020-01-15\n- ondansetron 8 MG Oral Tablet, through Oral route, presumably until 2020-12-13, with intended 0 refill(s). Instructions: take 8 mg by mouth every 8 hours as needed\n- indomethacin 50 MG Rectal Suppository, through Rectal route, started on 2020-01-15, presumably until 2020-01-15\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-01-14, presumably until 2020-01-14\n- 3 ML insulin detemir 100 UNT/ML Pen Injector, through Subcutaneous route, presumably until 2020-03-17, with intended 0 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2020-01-16, presumably until 2020-01-16\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2020-01-14, presumably until 2020-01-15\n- amylase 120000 UNT / lipase 24000 UNT / protease 76000 UNT Delayed Release Oral Capsule, through Oral route, started on 2020-01-15, presumably until 2020-06-13, with intended 0 refill(s). Instructions: Take 3 caps by mouth 3 times a day with meals.\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2020-01-14, presumably until 2020-01-16\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, presumably until 2020-03-17, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-01-15 00:00:00, ended at 2020-01-15 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; endoscopic retrograde cholangiopancreatography (ERCP)\n\n### Condition\n- Jaundice\n- Disorder caused by alcohol\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-01-15, presumably until 2020-01-15\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-01-15, presumably until 2020-01-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-01-15, presumably until 2020-01-15\n- midazolam 1 MG/ML Injectable Solution, started on 2020-01-15, presumably until 2020-01-15\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2020-01-15, presumably until 2020-01-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-01-15 00:00:00, ended at 2020-01-15 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endoscopic retrograde cholangiopancreatography (ERCP); with placement of endoscopic stent into biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-16 00:00:00, ended at 2020-01-16 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2020-01-19 16:08:00, ended at 2020-01-22 18:14:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 266 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 1.2 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Body height: 6' 1.228\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.5 (percent)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 258 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 165.00 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Osmolality of Urine: 883 (milliosmole per kilogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 17.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.57 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.33 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Osmolality of Serum or Plasma: 285 (milliosmole per kilogram)\n- Prothrombin time (PT): 13.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 1183 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.61 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.9 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 250 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 276 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.2 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 67 (millimole per liter)\n\n### Procedure\n- Combined endoscopic catheterization of the biliary and pancreatic ductal systems, radiological supervision and interpretation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Hospital discharge day management; 30 minutes or less\n- Endoscopic catheterization of the biliary ductal system, radiological supervision and interpretation\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal and exchange of stent(s), biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent exchang\n- Endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s) (List separately in addition to code(s) for primary procedure)\n- Dilation of Common Bile Duct with Intraluminal Device, Via Natural or Artificial Opening Endoscopic\n- Collection of venous blood by venipuncture\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Removal of Intraluminal Device from Hepatobiliary Duct, Via Natural or Artificial Opening Endoscopic\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Abdominal distension, gaseous\n- Benign neoplasm of colon\n- Hypo-osmolality and or hyponatremia\n- Secondary malignant neoplasm of bone\n- Secondary malignant neoplasm of intra-abdominal lymph nodes\n- Type 2 diabetes mellitus without complication\n- Secondary malignant neoplasm of unknown site\n- Acquired absence of organ\n- Primary diagnosis: Primary malignant neoplasm of colon\n- Fever\n- Obstruction of bile duct\n- Disorder of digestive system\n- Jaundice\n- Tachycardia\n- Hypoinsulinemia following procedure\n- Primary malignant neoplasm of descending colon\n- Pruritic rash\n- Cholangitis\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-20\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-01-20, presumably until 2020-01-20\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2020-01-19, presumably until 2020-01-27, with intended 0 refill(s). Instructions: take 1 Tab (500 mg total) by mouth 2 times a day for 5 days\n- calcium chloride 0.001 MEQ/ML / glucose 50 MG/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2020-01-19, presumably until 2020-01-20\n- cholestyramine resin 4000 MG Powder for Oral Suspension, through Oral route, started on 2020-01-19, presumably until 2020-01-21\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 1 Tab (500 mg total) by mouth every 8 hours for 7 doses\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2020-01-19, presumably until 2020-01-21\n- amylase 120000 UNT / lipase 24000 UNT / protease 76000 UNT Delayed Release Oral Capsule, through Oral route, started on 2020-01-20, presumably until 2020-01-21\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; endoscopic retrograde cholangiopancreatography (ERCP)\n\n### Condition\n- Obstruction of bile duct\n- Jaundice\n- Disorder caused by alcohol\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-01-22, presumably until 2020-01-22\n- midazolam 1 MG/ML Injectable Solution, started on 2020-01-22, presumably until 2020-01-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s) (List separately in addition to code(s) for primary procedure)\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal and exchange of stent(s), biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent exchang\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-23 00:00:00, ended at 2020-01-23 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 276 (cells per microliter)\n- Globulin [Mass/volume] in Serum: 5.0 (gram per deciliter calculated)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Band form neutrophils [#/volume] in Blood: 276 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.16 (million per liter)\n- Monocytes [#/volume] in Blood by Automated count: 828 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.4 (femtoliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 0.6 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 83.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Band form neutrophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6164 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1656 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 28.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Platelets [#/volume] in Blood by Automated count: 408 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 754 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 300 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-28 00:00:00, ended at 2020-01-28 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-01 00:00:00, ended at 2020-02-01 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-04 00:00:00, ended at 2020-02-04 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2020-02-04, presumably until 2020-06-03, with intended 11 refill(s). Instructions: take 1 Kadiyala (2 mg total) by mouth every 4 hours as needed for Diarrhea\n- capecitabine 500 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-03-04, with intended 10 refill(s). Instructions: take 4 Tabs (2,000 mg total) by mouth 2 times a day Take 4 tabs twice daily x 7 days every other week. Cytotoxic: Take with food.\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-06-03, with intended 11 refill(s). Instructions: take 1 Tab (8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-04 08:29:00, ended at 2020-02-04 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 108 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 663 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.01 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 30 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 2.14 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.55 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.38 (nanogram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 222 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.6 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.51 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n- Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 08:35:26, ended at 2020-02-04 10:00:13\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2020-02-04, presumably until 2020-02-04, with intended 11 refill(s). Instructions: take 1 Dupre (2 mg total) by mouth every 4 hours as needed for Diarrhea\n- capecitabine 500 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-02-04, with intended 10 refill(s). Instructions: take 4 Tabs (2,000 mg total) by mouth 2 times a day Take 4 tabs twice daily x 7 days every other week. Cytotoxic: Take with food.\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-02-04, with intended 11 refill(s). Instructions: take 1 Tab (8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-11 10:42:09, ended at 2020-02-11 12:09:05\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-12 00:00:00, ended at 2020-02-12 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-12 08:08:00, ended at 2020-02-12 10:42:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 235 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.66 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.86 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 594 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.85 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-12 08:22:59, ended at 2020-02-12 10:35:18\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- doxycycline hyclate 100 MG Oral Tablet, through Oral route, started on 2020-02-12, presumably until 2020-02-26, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-26 00:00:00, ended at 2020-02-26 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-02-26, presumably until 2020-04-18, with intended 1 refill(s). Instructions: take 2 Tabs (50 mg total) by mouth 2 times a day Take 1 tab am & pm\n- clindamycin 0.01 MG/MG Topical Gel, through Topical route, started on 2020-02-26, presumably until 2020-10-08, with intended 10 refill(s). Instructions: by Topical route 2 times a day use thin film on affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-26 08:27:00, ended at 2020-02-26 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Body height: 6' 1.031\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 648 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.29 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 217 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.19 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.4 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.81 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 276 (milligram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Collection of blood specimen from a completely implantable venous access device\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2020-02-26, presumably until 2020-02-26\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2020-02-26, presumably until 2020-02-26\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2020-02-26, presumably until 2020-02-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-02-26, presumably until 2020-02-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-02 13:40:00, ended at 2020-03-02 15:34:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.27 (million per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.62 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 541 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Lactate [Moles/volume] in Blood: 2.0 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 192 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 139 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.07 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of blood specimen from a completely implantable venous access device\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Fever\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-03-02, presumably until 2020-03-02\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-03-02, presumably until 2020-03-02\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-03-02, presumably until 2020-03-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-03-02, presumably until 2020-03-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-02 15:35:00, ended at 2020-03-02 18:39:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-03-02 18:40:00, ended at 2020-03-04 13:12:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 0.53 (microgram of fibrinogen equivalent unit per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 47.5 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 544 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 220 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.12 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 120 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 14.0 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 474 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.94 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Thrombin time: 18.5 (second)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n\n### Procedure\n- Hospital discharge day management; more than 30 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n\n### Condition\n- Deficiency of macronutrients\n- Eruption\n- Fatigue\n- Nausea and vomiting\n- Obstruction of bile duct\n- Secondary thrombocytopenia\n- Sepsis\n- Disorder due to infection\n- Hypo-osmolality and or hyponatremia\n- Acquired absence of organ\n- Fever\n- Diabetes mellitus without complication\n- Disorder of digestive system\n- Hypokalemia\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-03-02, presumably until 2020-03-04\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-03-03, presumably until 2020-03-03\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-03-02, presumably until 2020-03-03\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2020-03-12, with intended 0 refill(s). Instructions: take 1 Tab (500 mg total) by mouth 2 times a day for 8 days\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-03-03, presumably until 2020-03-03\n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2020-03-02, presumably until 2020-03-03\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2020-03-02, presumably until 2020-03-04\n- clindamycin 0.01 MG/MG Topical Gel, through Topical route, started on 2020-03-02, presumably until 2020-03-04\n- amylase 120000 UNT / lipase 24000 UNT / protease 76000 UNT Delayed Release Oral Capsule, through Oral route, started on 2020-03-04, presumably until 2020-03-04\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2020-03-03, presumably until 2020-03-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-10 00:00:00, ended at 2020-03-10 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-11 09:10:00, ended at 2020-03-11 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 7 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.26 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.57 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 189 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.6 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 562 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2020-03-11, presumably until 2020-03-11\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2020-03-11, presumably until 2020-03-11\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2020-03-11, presumably until 2020-03-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-03-11, presumably until 2020-03-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-17 14:29:59, ended at 2020-03-17 14:37:02\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-17, presumably until 2020-03-24, with intended 5 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) daily in the evening\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-17, presumably until 2020-09-05, with intended 5 refill(s). Instructions: inject 10-14 Units subcutaneous (under the skin) 3 times a day 10 units with breakfast and dinner, 12 units with lunch, Add 2 units if BG>200\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-24 00:00:00, ended at 2020-03-24 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-24, presumably until 2020-06-03, with intended 3 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-25 08:49:00, ended at 2020-03-25 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.53 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.26 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 601 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Body height: 6' 1.228\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 189 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.82 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 177 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2020-03-25, presumably until 2020-03-25\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2020-03-25, presumably until 2020-03-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-03-25, presumably until 2020-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-25 10:18:08, ended at 2020-03-25 10:36:20\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n- Neoplasm defined only by topography: Colon, NOS\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-01 15:42:57, ended at 2020-04-01 17:17:35\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: COVID-19\n- Nausea and vomiting\n- Primary diagnosis: Disorder of respiratory system\n- Type 2 diabetes mellitus\n- Obstruction of bile duct\n- Complication due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-04 08:05:00, ended at 2020-04-04 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Secondary malignant neoplasm of bone\n- Primary malignant neoplasm of descending colon\n- Secondary malignant neoplasm of left lung\n- Localized enlarged lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-08 00:00:00, ended at 2020-04-08 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-08 08:41:00, ended at 2020-04-08 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 116 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.12 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 235 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 534 (unit per liter)\n- Body height: 6' .835\" (inch (US))\n- MCV [Entitic volume] by Automated count: 86.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.48 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.75 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.80 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 16.3 (gram per deciliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2020-04-08, presumably until 2020-04-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-08 09:43:03, ended at 2020-04-08 11:10:25\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-12 13:15:16, ended at 2020-04-12 13:15:22\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- COVID-19\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-04-15 00:00:00, ended at 2020-04-15 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal and exchange of stent(s), biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent exchang\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-15 00:00:00, ended at 2020-04-15 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; endoscopic retrograde cholangiopancreatography (ERCP)\n\n### Condition\n- Disorder caused by alcohol\n- Obstruction of bile duct\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-04-15, presumably until 2020-04-15\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2020-04-15, presumably until 2020-04-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-15 07:54:00, ended at 2020-04-15 11:43:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.75\" (inch (US))\n\n### Procedure\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal and exchange of stent(s), biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent exchang\n- Endoscopic catheterization of the biliary ductal system, radiological supervision and interpretation\n\n### Condition\n- Gastritis\n- Hypoinsulinemia following procedure\n- Complication due to diabetes mellitus\n- Diabetes mellitus\n- Obstruction of bile duct\n- Secondary malignant neoplasm of bone\n- Acquired absence of organ\n- Disorder of digestive system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-16 00:00:00, ended at 2020-04-16 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-18 00:00:00, ended at 2020-04-18 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-04-18, presumably until 2020-04-25, with intended 1 refill(s). Instructions: take 2 Tabs (50 mg total) by mouth 2 times a day Take 1 tab am & pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-22 00:00:00, ended at 2020-04-22 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-29 14:58:00, ended at 2011-07-29 23:59:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .5\" (inch (US))\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Benign neoplasm of stomach\n- Carcinoma in situ of colon\n- Primary malignant neoplasm of colon\n- Benign neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-08-07 00:00:00, ended at 2011-08-07 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2011-08-07, presumably until 2011-08-18, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-10 10:02:00, ended at 2011-08-10 13:29:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique\n- Endoscopic polypectomy of large intestine\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopic biopsy of large intestine\n- Colonoscopy, flexible; with biopsy, single or multiple\n\n### Condition\n- Benign neoplasm of rectum and anal canal\n- Primary malignant neoplasm of transverse colon\n- Benign neoplasm of colon\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-08-10, presumably until 2011-08-10\n- midazolam 1 MG/ML Injectable Solution, started on 2011-08-10, presumably until 2011-08-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-08-11 07:37:00, ended at 2011-08-18 12:30:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 28.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.14 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 6' 1\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.47 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 74.1 (femtoliter)\n\n### Procedure\n- Rigid proctosigmoidoscopy\n- Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Laparoscopic total intra-abdominal colectomy\n- Molecular diagnostics; amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (List separately in addition to code for primary procedure)\n- Other small-to-large intestinal anastomosis\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; separation and identification by high resolution technique (eg, capillary electrophoresis), each nucleic acid preparation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Benign neoplasm of colon\n- Neoplasm of intrapelvic lymph node\n- Neoplasm of intra-abdominal lymph nodes\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of splenic flexure of colon\n- Anemia in neoplastic disease\n- Primary malignant neoplasm of rectosigmoid junction\n\n### Drug\n- psyllium, through Oral route, started on 2011-08-18, presumably until 2012-06-14. Instructions: take 1 Packet by mouth 3 times a day.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-08-11, presumably until 2011-08-16\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-08-14, presumably until 2011-08-17\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-08-12, presumably until 2011-08-17\n- ispaghula husk, through Oral route, started on 2011-08-18, presumably until 2012-06-14. Instructions: take 1 Packet by mouth 3 times a day.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-08-13, presumably until 2011-08-13\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2011-08-11, presumably until 2011-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-08-11, presumably until 2011-08-11\n- Plantago seed, through Oral route, started on 2011-08-18, presumably until 2012-06-14. Instructions: take 1 Packet by mouth 3 times a day.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-08-13, presumably until 2011-08-14\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-08-14, presumably until 2011-08-14\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-08-13, presumably until 2012-02-14, with intended 2 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-18 00:00:00, ended at 2011-08-18 00:00:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-02 13:55:00, ended at 2011-09-02 23:59:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.25\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign neoplasm of colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-14 15:07:00, ended at 2011-09-14 23:59:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.25\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n- Benign neoplasm of colon\n\n### Drug\n- capecitabine 500 MG Oral Tablet, through Oral route, started on 2011-09-14, presumably until 2012-06-14, with intended 5 refill(s). Instructions: take 4 Tabs by mouth 2 times a day. Take 2 times daily for 2 weeks and then 1 week off.\n- ondansetron 8 MG Oral Tablet, through Oral route, presumably until 2012-06-14, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea and vomiting.\n- lorazepam 1 MG Oral Tablet, through Oral route, presumably until 2012-06-14, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed. For nausea and vomiting.\n- prochlorperazine 10 MG Oral Tablet, through Oral route, presumably until 2012-06-14, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-17 00:00:00, ended at 2011-09-17 00:00:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-20 08:00:00, ended at 2011-09-20 13:19:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 1 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 20.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.75 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.3 (percent)\n- MCV [Entitic volume] by Automated count: 66.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-09-20, presumably until 2011-09-20\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-09-20, presumably until 2011-09-20\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2011-09-20, presumably until 2011-09-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-20 13:20:00, ended at 2011-09-20 23:59:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-08 00:00:00, ended at 2011-10-08 00:00:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-08 09:45:00, ended at 2011-10-08 11:10:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.228\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Chromosome analysis, cytogenetic procedure AND/OR molecular biology method\n- Genetic counseling\n\n### Condition\n- Benign neoplasm of colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-12 12:00:00, ended at 2011-10-12 12:18:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.11 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 35.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- MCH [Entitic mass] by Automated count: 20.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 65.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-12 12:19:00, ended at 2011-10-12 23:59:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n- Benign neoplasm of colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-10-12, presumably until 2011-10-12\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-10-12, presumably until 2011-10-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2011-10-12, presumably until 2011-10-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-20 00:00:00, ended at 2011-10-20 00:00:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-06-01 00:00:00, ended at 2012-06-01 00:00:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-14 10:10:00, ended at 2012-06-14 13:39:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- Endoscopic polypectomy of large intestine\n- [Endoscopic] polypectomy of rectum\n- Sigmoidoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Benign neoplasm of colon\n- Benign neoplasm of rectum and anal canal\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2012-06-14, presumably until 2012-06-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-20 00:00:00, ended at 2013-03-20 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-03-28 00:00:00, ended at 2013-03-28 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2013-03-28, presumably until 2013-03-28\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2013-03-28, presumably until 2013-03-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-28 09:47:00, ended at 2013-03-28 13:50:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- [Endoscopic] polypectomy of rectum\n- Flexible fiberoptic sigmoidoscopy\n- Sigmoidoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Primary malignant neoplasm of colon\n- Benign neoplasm of rectum and anal canal\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2013-03-28, presumably until 2013-03-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-18 00:00:00, ended at 2014-11-18 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-03-05 00:00:00, ended at 2016-03-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-03-29 14:20:00, ended at 2018-03-31 17:26:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCH [Entitic mass] by Automated count: 26.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 79.1 (femtoliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.6 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.94 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Chromogranin A [Moles/volume] in Serum or Plasma: 49 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.95 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 6' 2\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 8 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Lactate [Moles/volume] in Serum or Plasma: 1.0 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.04 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.00 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of rectosigmoid junction\n- Nausea and vomiting\n- Primary diagnosis: Intestinal obstruction\n- Primary malignant neoplasm of colon\n- Acquired absence of organ\n- Secondary malignant neoplasm of intra-abdominal lymph nodes\n- Primary malignant neoplasm of descending colon\n- Benign neoplasm of colon\n- Secondary malignant neoplasm of left lung\n- Benign neoplasm of transverse colon\n- Primary malignant neoplasm of splenic flexure of colon\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Secondary malignant neoplasm of small intestine\n- Disorder of digestive system\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2018-03-29, presumably until 2018-03-31\n- barium sulfate, through Oral route, started on 2018-03-30, presumably until 2018-03-30\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2018-03-29, presumably until 2018-03-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-10 00:00:00, ended at 2018-04-10 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-10 08:42:18, ended at 2018-04-10 10:04:02\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intestinal obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-10 09:55:46, ended at 2018-04-10 11:10:59\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-10 11:13:00, ended at 2018-04-10 13:53:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- MCV [Entitic volume] by Automated count: 79.0 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.22 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.46 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 51.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.4 (picogram)\n- Prothrombin time (PT): 13.1 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.8 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-10 13:54:00, ended at 2018-04-10 18:24:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-04-10 18:25:00, ended at 2018-04-25 15:19:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 2.7 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 250 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 308 (thousand per microliter)\n- Body height: 6' 2.016\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 634 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 80.6 (femtoliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.1 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.09 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.01 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Oxygen [Partial pressure] in Arterial blood: 155.0 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Prothrombin time (PT): 13.8 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 35.8 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 25.9 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.3 (percent)\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material\n- Excision of Stomach, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Excision of Pancreas, Open Approach\n- Drainage of Peritoneal Cavity with Drainage Device, Percutaneous Approach\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Collection of venous blood by venipuncture\n- Radiologic examination, abdomen; 1 view\n- Morphometric analysis, tumor\n- Excision of Aortic Lymphatic, Open Approach\n- Radiologic examination, chest; 2 views\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Excision of Right Lobe Liver, Open Approach\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Sigmoidoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Excision of Duodenum, Open Approach\n- Radiologic examination, abdomen; 2 views\n- Destruction of Right Lobe Liver, Open Approach\n- Excision of Rectum, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Image-guided fluid collection drainage by catheter (eg, abscess, hematoma, seroma, lymphocele, cyst); peritoneal or retroperitoneal, percutaneous\n\n### Condition\n- Disorder of digestive system\n- Secondary malignant neoplasm of intra-abdominal lymph nodes\n- Secondary malignant neoplasm of small intestine\n- Adult hypertrophic pyloric stenosis\n- Gastrointestinal complication\n- Steatosis of liver\n- Benign neoplasm of colon\n- Rectal polyp\n- Acquired absence of organ\n- Primary malignant neoplasm of small intestine\n- Abnormal findings on diagnostic imaging of lung\n- Ascites\n- Benign neoplasm of rectum\n- Overlapping malignant neoplasm of pancreas\n- Abdominal distension, gaseous\n- Abscess of peritoneum\n- Late effect of complications of procedure\n- Primary malignant neoplasm of colon\n- Abdominal pain\n- Gastric polyp\n- Intestinal obstruction\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2018-04-10, presumably until 2018-04-13\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2018-04-21, presumably until 2018-04-21\n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-18\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2018-04-17, presumably until 2018-04-20\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-04-11, presumably until 2018-04-25\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2018-04-13, presumably until 2018-04-13\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2018-04-14, presumably until 2018-04-24\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-04-13, presumably until 2019-10-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 8 hours\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2018-04-16, presumably until 2018-04-16\n- diatrizoate, through Oral route, started on 2018-04-25, presumably until 2018-04-25\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-04-17, presumably until 2018-04-20\n- diatrizoic acid, through Oral route, started on 2018-04-25, presumably until 2018-04-25\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2018-04-14, presumably until 2018-04-21\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2018-04-20, presumably until 2018-04-20\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2018-04-20, presumably until 2018-04-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2018-04-14, presumably until 2018-04-15\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-04-13, presumably until 2018-04-13\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-04-13, presumably until 2018-05-08, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-22\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2018-04-14, presumably until 2018-04-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2018-04-17, presumably until 2018-04-17\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-04-13, presumably until 2018-07-18, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2018-04-17, presumably until 2018-04-21\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-04-23, presumably until 2018-05-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2018-04-18, presumably until 2018-04-18\n- 0.5 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-04-13, presumably until 2018-04-13\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2018-04-23, presumably until 2018-04-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-04-12 00:00:00, ended at 2018-04-12 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for combined upper and lower gastrointestinal endoscopic procedures, endoscope introduced both proximal to and distal to the duodenum\n\n### Condition\n- Rectal polyp\n- Gastric polyp\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-12, presumably until 2018-04-12\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-04-12, presumably until 2018-04-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-04-12, presumably until 2018-04-12\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2018-04-12, presumably until 2018-04-12\n- 2 ML alfentanil 0.5 MG/ML Injection, started on 2018-04-12, presumably until 2018-04-12\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2018-04-12, presumably until 2018-04-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-04-13 00:00:00, ended at 2018-04-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; partial hepatectomy or management of liver hemorrhage (excluding liver biopsy)\n\n### Condition\n- Primary malignant neoplasm of transverse colon\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2018-04-13, presumably until 2018-04-13\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 10 ML methylene blue 5 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-13\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-13\n- ketamine 100 MG/ML Injectable Solution, started on 2018-04-13, presumably until 2018-04-13\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2018-04-13, presumably until 2018-04-13\n- midazolam 1 MG/ML Injectable Solution, started on 2018-04-13, presumably until 2018-04-13\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-13\n- 2 ML alfentanil 0.5 MG/ML Injection, started on 2018-04-13, presumably until 2018-04-13\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2018-04-13, presumably until 2018-04-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-04-13 12:38:00, ended at 2018-04-13 12:38:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign neoplasm of colon\n- Primary malignant neoplasm of colon\n- Primary diagnosis: Intestinal obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-04-20 00:00:00, ended at 2018-04-20 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-04-20, presumably until 2018-04-20\n- midazolam 1 MG/ML Injectable Solution, started on 2018-04-20, presumably until 2018-04-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-08 09:47:16, ended at 2018-05-08 11:06:42\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Epigastric pain\n- Primary malignant neoplasm of colon\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-07-18, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 11:11:00, ended at 2018-05-08 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 124 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.4 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.40 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Prothrombin time (PT): 13.6 (second)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 77.7 (femtoliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Epigastric pain\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-22 07:06:00, ended at 2018-05-22 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of duodenum\n- Epigastric pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-22 08:21:46, ended at 2018-05-22 12:20:05\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-26 00:00:00, ended at 2018-05-26 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-06-13 00:00:00, ended at 2018-06-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection, started on 2018-06-13, presumably until 2018-06-13\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-06-13, presumably until 2018-06-13\n- midazolam 1 MG/ML Injectable Solution, started on 2018-06-13, presumably until 2018-06-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-06-13 00:00:00, ended at 2018-06-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intestinal obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-13 14:13:00, ended at 2018-06-13 18:42:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.26 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.7 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Body height: 6' 2\" (inch (US))\n- MCV [Entitic volume] by Automated count: 73.1 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.4 (percent)\n- MCH [Entitic mass] by Automated count: 23.1 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.11 (thousand per microliter)\n\n### Procedure\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Insertion of Totally Implantable Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach\n- Collection of venous blood by venipuncture\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion of tunneled centrally inserted central venous access device, with subcutaneous port; age 5 years or older\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-20 09:30:00, ended at 2018-06-20 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.75 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.06 (thousand per microliter)\n- Prothrombin time (PT): 13.7 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 72.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.52 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 234 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.47 (million per microliter)\n- MCH [Entitic mass] by Automated count: 23.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.6 (second)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Intestinal obstruction\n- Primary malignant neoplasm of transverse colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-06-20, presumably until 2018-06-20\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-06-20, presumably until 2018-06-20\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-06-20, presumably until 2018-06-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-20 10:19:33, ended at 2018-06-20 11:50:53\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Colon, NOS\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-06-20, presumably until 2018-08-02, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-06-20, presumably until 2018-11-21, with intended 2 refill(s). Instructions: take 0.5 Tabs by mouth every 6 hours as needed For nausea and vomiting.\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2018-06-20, presumably until 2018-11-21, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-22 16:56:00, ended at 2018-06-22 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-23 00:00:00, ended at 2018-06-23 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2018-06-23, presumably until 2019-06-23, with intended 0 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-04 00:00:00, ended at 2018-07-04 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-04 12:21:00, ended at 2018-07-04 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.64 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 73.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.6 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.9 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.42 (million per microliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3.05 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Prothrombin time (PT): 12.6 (second)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of transverse colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-07-04, presumably until 2018-07-04\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-07-04, presumably until 2018-07-04\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-07-04, presumably until 2018-07-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-06 16:49:00, ended at 2018-07-06 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of splenic flexure of colon\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-18 11:30:00, ended at 2018-07-18 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Prothrombin time (PT): 13.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.6 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.30 (million per microliter)\n- MCV [Entitic volume] by Automated count: 73.7 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.26 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.53 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-07-18, presumably until 2018-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-20 16:10:00, ended at 2018-07-20 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-01 00:00:00, ended at 2018-08-01 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2018-08-01, presumably until 2018-08-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime Take 1 tab Q HS x 5 days after each infusion. Don't take with Ativan.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-01 11:12:00, ended at 2018-08-01 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.07 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.3 (percent)\n- MCH [Entitic mass] by Automated count: 23.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 73.3 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Body height: 6' 1.031\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.58 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.52 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-08-01, presumably until 2018-08-01\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-08-01, presumably until 2018-08-01\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-08-01, presumably until 2018-08-01\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-08-01, presumably until 2018-08-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-02 00:00:00, ended at 2018-08-02 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-08-02, presumably until 2019-10-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-03 16:30:00, ended at 2018-08-03 23:59:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of splenic flexure of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-14 12:20:00, ended at 2018-08-14 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-15 10:53:00, ended at 2018-08-15 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Body height: 6' .835\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 159 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.3 (percent)\n- MCV [Entitic volume] by Automated count: 74.4 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.77 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.0 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.26 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Prothrombin time (PT): 13.1 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.4 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-08-15, presumably until 2018-08-15\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-08-15, presumably until 2018-08-15\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-08-15, presumably until 2018-08-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-08-15, presumably until 2018-08-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-15 11:19:37, ended at 2018-08-15 14:19:08\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-17 16:52:00, ended at 2018-08-17 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-21 00:00:00, ended at 2018-08-21 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2018-08-21, presumably until 2019-07-02, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime Take 1 tab Q HS x 5 days after each infusion. Don't take with Ativan.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-29 10:20:00, ended at 2018-08-29 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 74.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.68 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.40 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 167 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-08-29, presumably until 2018-08-29\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-08-29, presumably until 2018-08-29\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-08-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-08-29, presumably until 2018-08-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-31 16:01:00, ended at 2018-08-31 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-12 08:38:00, ended at 2018-09-12 11:10:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.44 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 75.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.76 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Prothrombin time (PT): 12.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.31 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 162 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 185 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.8 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-12 09:05:43, ended at 2018-09-12 10:09:59\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .835\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-12 11:11:00, ended at 2018-09-12 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-09-12, presumably until 2018-09-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-09-12, presumably until 2018-09-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-09-12, presumably until 2018-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-14 15:19:00, ended at 2018-09-14 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-26 11:50:00, ended at 2018-09-26 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Body height: 6' 1.504\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.79 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 162 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.18 (million per microliter)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.3 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-09-26, presumably until 2018-09-26\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-09-26, presumably until 2018-09-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-28 15:57:00, ended at 2018-09-28 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-10 11:31:00, ended at 2018-10-10 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.13 (million per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 133 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.11 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 77.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.75 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.7 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-10-10, presumably until 2018-10-10\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2018-10-10, presumably until 2018-10-10\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-10-10, presumably until 2018-10-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-10-10, presumably until 2018-10-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-10 13:00:42, ended at 2018-10-10 15:02:01\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.543\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-12 18:43:00, ended at 2018-10-12 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-24 09:58:00, ended at 2018-10-24 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of colon\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-24 12:13:13, ended at 2018-10-24 14:07:08\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.543\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-21 08:38:00, ended at 2018-11-21 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Disorder of digestive system\n- Acquired absence of organ\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-21 08:38:00, ended at 2018-11-21 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 179 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- No conditions.\n\n### Drug\n- barium sulfate, through Oral route, started on 2018-11-21, presumably until 2018-11-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-05 10:12:27, ended at 2019-02-05 11:31:01\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-05 12:54:00, ended at 2019-02-05 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of transverse colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-02-05, presumably until 2019-02-05\n- 0.5 ML meperidine hydrochloride 50 MG/ML Injection, started on 2019-02-05, presumably until 2019-02-05\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2019-02-05, presumably until 2019-02-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-02-05, presumably until 2019-02-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-02-05, presumably until 2019-02-05\n- methylprednisolone 125 MG Injection, started on 2019-02-05, presumably until 2019-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-26 12:37:00, ended at 2019-02-26 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.57 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.4 (percent)\n- MCV [Entitic volume] by Automated count: 81.7 (femtoliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 108 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.81 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.2 (second)\n- MCH [Entitic mass] by Automated count: 26.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.60 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 44.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-02-26, presumably until 2019-02-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-02-26, presumably until 2019-02-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-26 12:59:39, ended at 2019-02-26 17:00:57\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-15 00:00:00, ended at 2019-03-15 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-16 07:30:00, ended at 2019-03-16 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 48.6 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Accidental poisoning\n- Primary malignant neoplasm of colon\n- Poisoning by drug AND/OR medicinal substance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-17 13:00:00, ended at 2019-03-17 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 192 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.97 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 169 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.79 (million per microliter)\n- MCV [Entitic volume] by Automated count: 80.5 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Body height: 6' 1.504\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.3 (picogram)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-03-17, presumably until 2019-03-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-03-17, presumably until 2019-03-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-09 09:57:00, ended at 2019-04-09 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.6 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.03 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.5 (femtoliter)\n- Prothrombin time (PT): 13.2 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.62 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.09 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-04-09, presumably until 2019-04-09\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-04-09, presumably until 2019-04-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-04-09, presumably until 2019-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-09 10:20:40, ended at 2019-04-09 11:08:08\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-30 09:07:00, ended at 2019-04-30 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-04-30, presumably until 2019-04-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-04-30, presumably until 2019-04-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-21 10:55:00, ended at 2019-05-21 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.46 (million per microliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- MCV [Entitic volume] by Automated count: 84.4 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.21 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of transverse colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-05-21, presumably until 2019-05-21\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-05-21, presumably until 2019-05-21\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-05-21, presumably until 2019-05-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-21 11:11:47, ended at 2019-05-21 13:37:08\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-22 11:26:00, ended at 2019-05-22 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-08 00:00:00, ended at 2019-06-08 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-11 07:07:00, ended at 2019-06-11 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 162 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.24 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.93 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.5 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.84 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.40 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-06-11, presumably until 2019-06-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-06-11, presumably until 2019-06-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-11 07:46:03, ended at 2019-06-11 08:55:05\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-25 16:25:00, ended at 2019-06-25 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disease of liver\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of colon\n- Disorder of pancreas\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-02 09:30:00, ended at 2019-07-02 12:05:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 164 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.39 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-02 10:16:37, ended at 2019-07-02 11:16:50\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.268\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-02 12:06:00, ended at 2019-07-02 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-07-02, presumably until 2019-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-30 14:00:00, ended at 2019-07-30 16:05:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.77 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.4 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.14 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- MCH [Entitic mass] by Automated count: 28.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.22 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-30 14:53:10, ended at 2019-07-30 15:46:45\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.268\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-30 16:06:00, ended at 2019-07-30 23:59:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-07-30, presumably until 2019-07-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-07-30, presumably until 2019-07-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-16 00:00:00, ended at 2019-08-16 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-20 13:03:00, ended at 2019-08-20 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 84.5 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.43 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 48.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.75 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.3 (percent)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.82 (thousand per microliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-08-20, presumably until 2019-08-20\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-08-20, presumably until 2019-08-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-10 00:00:00, ended at 2019-09-10 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-10 12:00:00, ended at 2019-09-10 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.26 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.28 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.37 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-09-10, presumably until 2019-09-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-09-10, presumably until 2019-09-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-10 13:29:19, ended at 2019-09-10 15:37:13\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.268\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-25 00:00:00, ended at 2019-09-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 51.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-25 13:38:00, ended at 2019-09-25 14:26:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Disorder of adrenal gland\n- Primary malignant neoplasm of colon\n- Secondary malignant neoplasm of lung\n- Primary malignant neoplasm of descending colon\n- Localized enlarged lymph nodes\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-25 14:27:00, ended at 2019-09-25 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Accidental poisoning\n- Poisoning by drug AND/OR medicinal substance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-01 08:33:00, ended at 2019-10-01 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 203 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 237 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.16 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.42 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 218 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.26 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-01 08:50:28, ended at 2019-10-01 12:02:55\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.268\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-05 00:00:00, ended at 2019-10-05 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-22 11:43:00, ended at 2019-10-22 14:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.15 (million per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.83 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 228 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 240 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.70 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 167 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-24 14:27:00, ended at 2019-10-24 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.68 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 278 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.35 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 8 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- Prothrombin time (PT): 12.0 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 137 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n- Secondary malignant neoplasm of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-25 08:32:49, ended at 2019-10-25 11:16:33\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Secondary malignant neoplasm of left lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-29 00:00:00, ended at 2019-10-29 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-09 00:00:00, ended at 2019-11-09 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-12 12:00:00, ended at 2019-11-12 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.75 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 16.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 10 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.82 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.84 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 322 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 312 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.22 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2019-11-12, presumably until 2019-11-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-11-12, presumably until 2019-11-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-11-12, presumably until 2019-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-13 09:00:00, ended at 2019-11-13 10:20:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 97 (milligram per deciliter)\n\n### Procedure\n- Therapeutic radiology simulation-aided field setting; complex\n\n### Condition\n- Secondary malignant neoplasm of left lung\n- Primary malignant neoplasm of rectosigmoid junction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-13 10:21:00, ended at 2019-11-13 10:21:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign neoplasm of colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-13 10:22:00, ended at 2019-11-13 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- barium sulfate, through Oral route, started on 2019-11-13, presumably until 2019-11-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-13 10:22:00, ended at 2019-11-13 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-19 00:00:00, ended at 2019-11-19 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-20 00:00:00, ended at 2019-11-20 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- regorafenib 40 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2019-12-10, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day for 3 weeks on and 1 week off.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-21 00:00:00, ended at 2019-11-21 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- regorafenib 40 MG Oral Tablet, through Oral route, started on 2019-11-21, presumably until 2020-01-08, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day for 3 weeks on and 1 week off.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-12-03 00:00:00, ended at 2019-12-03 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-10 10:20:00, ended at 2019-12-10 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Secondary malignant neoplasm of left lung\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-17 09:20:00, ended at 2019-12-17 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 236 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.39 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 425 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 29 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 85.2 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.26 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-17 09:43:25, ended at 2019-12-17 13:19:34\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-18 00:00:00, ended at 2019-12-18 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2019-12-18, presumably until 2019-12-21, with intended 2 refill(s). Instructions: take 1-2 Tabs (0.5-1 mg total) by mouth every 6 hours as needed For nausea and vomitting\n- capecitabine 500 MG Oral Tablet, started on 2019-12-18, presumably until 2019-12-20, with intended 3 refill(s). Instructions: 4 tabs (2000 mg) in the AM and the evening, for 7 days, then 7 days off\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2019-12-18, presumably until 2019-12-21, with intended 6 refill(s). Instructions: take 1 Tab (8 mg total) by mouth every 8 hours as needed (For nausea and vomitting)\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2019-12-18, presumably until 2019-12-21, with intended 6 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every 6 hours as needed for Nausea/Vomiting\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-20 00:00:00, ended at 2019-12-20 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- capecitabine 500 MG Oral Tablet, started on 2019-12-20, presumably until 2019-12-21, with intended 3 refill(s). Instructions: 4 tabs (2000 mg) in the AM and the evening, for 7 days, then 7 days off\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-21 00:00:00, ended at 2019-12-21 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-25 00:00:00, ended at 2019-12-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-25 00:00:00, ended at 2019-12-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-26 00:00:00, ended at 2019-12-26 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-26 00:00:00, ended at 2019-12-26 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-26 12:03:00, ended at 2019-12-26 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 4.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Lutropin [Units/volume] in Serum or Plasma: 4.2 (milli-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 554 (unit per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 559 (nanogram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.48 (million per microliter)\n- Follitropin [Units/volume] in Serum or Plasma: 7.4 (milli-international unit per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Corticotropin [Mass/volume] in Plasma: 58.8 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 266 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.0 (percent)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.18 (micro-international unit per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 20.3 (microgram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.53 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.40 (nanogram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 348 (milligram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n- Hyperglycemia\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-12-26, presumably until 2019-12-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-28 00:00:00, ended at 2019-12-28 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 194 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 143 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.0 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 614 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-08 12:14:48, ended at 2020-01-08 14:10:15\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- regorafenib 40 MG Oral Tablet, started on 2020-01-08, presumably until 2020-01-22, with intended 3 refill(s). Instructions: Take 1 tab in the morning and 2 tabs in the evening for 3 weeks on and 1 week off.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-08 13:45:00, ended at 2020-01-08 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.84 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 228 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.72 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 5.52 (micro-international unit per milliliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.66 (nanogram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 654 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.2 (percent)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 40 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 16.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.7 (picogram)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 331 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 272 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-09 00:00:00, ended at 2020-01-09 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-11 00:00:00, ended at 2020-01-11 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2020-01-13 19:43:00, ended at 2020-01-16 10:16:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Acetaminophen [Presence] in Urine: <5.0 (microgram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 181 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 997 (unit per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.60 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 324 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 235 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.64 (thousand per microliter)\n- Body height: 6' .835\" (inch (US))\n- Glucose [Mass/volume] in Blood: 345 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.8 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.3 (gram per deciliter)\n- Prothrombin time (PT): 11.8 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 8.33 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 339 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- MCH [Entitic mass] by Automated count: 28.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.80 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 48.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n\n### Procedure\n- Hospital discharge day management; more than 30 minutes\n- Dilation of Pancreatic Duct with Intraluminal Device, Via Natural or Artificial Opening Endoscopic\n- Endoscopic retrograde cholangiopancreatography (ERCP); with placement of endoscopic stent into biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Combined endoscopic catheterization of the biliary and pancreatic ductal systems, radiological supervision and interpretation\n- Dilation of Common Bile Duct with Intraluminal Device, Via Natural or Artificial Opening Endoscopic\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n\n### Condition\n- Acquired absence of spleen\n- Disorder of digestive system\n- Hepatic failure\n- Hypoinsulinemia following procedure\n- Jaundice\n- Hypokalemia\n- Secondary malignant neoplasm of right lung\n- Acquired absence of organ\n- Genetic predisposition\n- Secondary malignant neoplasm of left lung\n- Generalized abdominal pain\n- Primary diagnosis: Obstruction of bile duct\n- Pruritic rash\n- Primary malignant neoplasm of colon\n- Secondary malignant neoplasm of intra-abdominal lymph nodes\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2020-01-14, presumably until 2020-01-15\n- ondansetron 8 MG Oral Tablet, through Oral route, presumably until 2020-12-13, with intended 0 refill(s). Instructions: take 8 mg by mouth every 8 hours as needed\n- indomethacin 50 MG Rectal Suppository, through Rectal route, started on 2020-01-15, presumably until 2020-01-15\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-01-14, presumably until 2020-01-14\n- 3 ML insulin detemir 100 UNT/ML Pen Injector, through Subcutaneous route, presumably until 2020-03-17, with intended 0 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2020-01-16, presumably until 2020-01-16\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2020-01-14, presumably until 2020-01-15\n- amylase 120000 UNT / lipase 24000 UNT / protease 76000 UNT Delayed Release Oral Capsule, through Oral route, started on 2020-01-15, presumably until 2020-06-13, with intended 0 refill(s). Instructions: Take 3 caps by mouth 3 times a day with meals.\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2020-01-14, presumably until 2020-01-16\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, presumably until 2020-03-17, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-01-15 00:00:00, ended at 2020-01-15 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; endoscopic retrograde cholangiopancreatography (ERCP)\n\n### Condition\n- Jaundice\n- Disorder caused by alcohol\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-01-15, presumably until 2020-01-15\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-01-15, presumably until 2020-01-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-01-15, presumably until 2020-01-15\n- midazolam 1 MG/ML Injectable Solution, started on 2020-01-15, presumably until 2020-01-15\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2020-01-15, presumably until 2020-01-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-01-15 00:00:00, ended at 2020-01-15 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endoscopic retrograde cholangiopancreatography (ERCP); with placement of endoscopic stent into biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-16 00:00:00, ended at 2020-01-16 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2020-01-19 16:08:00, ended at 2020-01-22 18:14:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 266 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 1.2 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Body height: 6' 1.228\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.5 (percent)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 258 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 165.00 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Osmolality of Urine: 883 (milliosmole per kilogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 17.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.57 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.33 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Osmolality of Serum or Plasma: 285 (milliosmole per kilogram)\n- Prothrombin time (PT): 13.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 1183 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.61 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.9 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 250 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 276 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.2 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 67 (millimole per liter)\n\n### Procedure\n- Combined endoscopic catheterization of the biliary and pancreatic ductal systems, radiological supervision and interpretation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Hospital discharge day management; 30 minutes or less\n- Endoscopic catheterization of the biliary ductal system, radiological supervision and interpretation\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal and exchange of stent(s), biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent exchang\n- Endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s) (List separately in addition to code(s) for primary procedure)\n- Dilation of Common Bile Duct with Intraluminal Device, Via Natural or Artificial Opening Endoscopic\n- Collection of venous blood by venipuncture\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Removal of Intraluminal Device from Hepatobiliary Duct, Via Natural or Artificial Opening Endoscopic\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Abdominal distension, gaseous\n- Benign neoplasm of colon\n- Hypo-osmolality and or hyponatremia\n- Secondary malignant neoplasm of bone\n- Secondary malignant neoplasm of intra-abdominal lymph nodes\n- Type 2 diabetes mellitus without complication\n- Secondary malignant neoplasm of unknown site\n- Acquired absence of organ\n- Primary diagnosis: Primary malignant neoplasm of colon\n- Fever\n- Obstruction of bile duct\n- Disorder of digestive system\n- Jaundice\n- Tachycardia\n- Hypoinsulinemia following procedure\n- Primary malignant neoplasm of descending colon\n- Pruritic rash\n- Cholangitis\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-20\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-01-20, presumably until 2020-01-20\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2020-01-19, presumably until 2020-01-27, with intended 0 refill(s). Instructions: take 1 Tab (500 mg total) by mouth 2 times a day for 5 days\n- calcium chloride 0.001 MEQ/ML / glucose 50 MG/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2020-01-19, presumably until 2020-01-20\n- cholestyramine resin 4000 MG Powder for Oral Suspension, through Oral route, started on 2020-01-19, presumably until 2020-01-21\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 1 Tab (500 mg total) by mouth every 8 hours for 7 doses\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2020-01-19, presumably until 2020-01-21\n- amylase 120000 UNT / lipase 24000 UNT / protease 76000 UNT Delayed Release Oral Capsule, through Oral route, started on 2020-01-20, presumably until 2020-01-21\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; endoscopic retrograde cholangiopancreatography (ERCP)\n\n### Condition\n- Obstruction of bile duct\n- Jaundice\n- Disorder caused by alcohol\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-01-22, presumably until 2020-01-22\n- midazolam 1 MG/ML Injectable Solution, started on 2020-01-22, presumably until 2020-01-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s) (List separately in addition to code(s) for primary procedure)\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal and exchange of stent(s), biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent exchang\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-23 00:00:00, ended at 2020-01-23 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 276 (cells per microliter)\n- Globulin [Mass/volume] in Serum: 5.0 (gram per deciliter calculated)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Band form neutrophils [#/volume] in Blood: 276 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.16 (million per liter)\n- Monocytes [#/volume] in Blood by Automated count: 828 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.4 (femtoliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 0.6 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 83.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Band form neutrophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6164 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1656 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 28.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Platelets [#/volume] in Blood by Automated count: 408 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 754 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 300 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-28 00:00:00, ended at 2020-01-28 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-01 00:00:00, ended at 2020-02-01 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-04 00:00:00, ended at 2020-02-04 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2020-02-04, presumably until 2020-06-03, with intended 11 refill(s). Instructions: take 1 Kadiyala (2 mg total) by mouth every 4 hours as needed for Diarrhea\n- capecitabine 500 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-03-04, with intended 10 refill(s). Instructions: take 4 Tabs (2,000 mg total) by mouth 2 times a day Take 4 tabs twice daily x 7 days every other week. Cytotoxic: Take with food.\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-06-03, with intended 11 refill(s). Instructions: take 1 Tab (8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-04 08:29:00, ended at 2020-02-04 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 108 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 663 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.01 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 30 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 2.14 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.55 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.38 (nanogram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 222 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.6 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.51 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n- Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 08:35:26, ended at 2020-02-04 10:00:13\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2020-02-04, presumably until 2020-02-04, with intended 11 refill(s). Instructions: take 1 Dupre (2 mg total) by mouth every 4 hours as needed for Diarrhea\n- capecitabine 500 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-02-04, with intended 10 refill(s). Instructions: take 4 Tabs (2,000 mg total) by mouth 2 times a day Take 4 tabs twice daily x 7 days every other week. Cytotoxic: Take with food.\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-02-04, with intended 11 refill(s). Instructions: take 1 Tab (8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-11 10:42:09, ended at 2020-02-11 12:09:05\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-12 00:00:00, ended at 2020-02-12 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-12 08:08:00, ended at 2020-02-12 10:42:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 235 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.66 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.86 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 594 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.85 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of descending colon\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-12 08:22:59, ended at 2020-02-12 10:35:18\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- doxycycline hyclate 100 MG Oral Tablet, through Oral route, started on 2020-02-12, presumably until 2020-02-26, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-26 00:00:00, ended at 2020-02-26 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-02-26, presumably until 2020-04-18, with intended 1 refill(s). Instructions: take 2 Tabs (50 mg total) by mouth 2 times a day Take 1 tab am & pm\n- clindamycin 0.01 MG/MG Topical Gel, through Topical route, started on 2020-02-26, presumably until 2020-10-08, with intended 10 refill(s). Instructions: by Topical route 2 times a day use thin film on affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-26 08:27:00, ended at 2020-02-26 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Body height: 6' 1.031\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 648 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.29 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 217 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.19 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.4 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.81 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 276 (milligram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Collection of blood specimen from a completely implantable venous access device\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2020-02-26, presumably until 2020-02-26\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2020-02-26, presumably until 2020-02-26\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2020-02-26, presumably until 2020-02-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-02-26, presumably until 2020-02-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-02 13:40:00, ended at 2020-03-02 15:34:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.27 (million per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.62 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 541 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Lactate [Moles/volume] in Blood: 2.0 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 192 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 139 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.07 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of blood specimen from a completely implantable venous access device\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Fever\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-03-02, presumably until 2020-03-02\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-03-02, presumably until 2020-03-02\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-03-02, presumably until 2020-03-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-03-02, presumably until 2020-03-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-02 15:35:00, ended at 2020-03-02 18:39:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-03-02 18:40:00, ended at 2020-03-04 13:12:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 0.53 (microgram of fibrinogen equivalent unit per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 47.5 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 544 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 220 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.12 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 120 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 14.0 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 474 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.94 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Thrombin time: 18.5 (second)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n\n### Procedure\n- Hospital discharge day management; more than 30 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n\n### Condition\n- Deficiency of macronutrients\n- Eruption\n- Fatigue\n- Nausea and vomiting\n- Obstruction of bile duct\n- Secondary thrombocytopenia\n- Sepsis\n- Disorder due to infection\n- Hypo-osmolality and or hyponatremia\n- Acquired absence of organ\n- Fever\n- Diabetes mellitus without complication\n- Disorder of digestive system\n- Hypokalemia\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-03-02, presumably until 2020-03-04\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-03-03, presumably until 2020-03-03\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-03-02, presumably until 2020-03-03\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2020-03-12, with intended 0 refill(s). Instructions: take 1 Tab (500 mg total) by mouth 2 times a day for 8 days\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-03-03, presumably until 2020-03-03\n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2020-03-02, presumably until 2020-03-03\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2020-03-02, presumably until 2020-03-04\n- clindamycin 0.01 MG/MG Topical Gel, through Topical route, started on 2020-03-02, presumably until 2020-03-04\n- amylase 120000 UNT / lipase 24000 UNT / protease 76000 UNT Delayed Release Oral Capsule, through Oral route, started on 2020-03-04, presumably until 2020-03-04\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2020-03-03, presumably until 2020-03-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-10 00:00:00, ended at 2020-03-10 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-11 09:10:00, ended at 2020-03-11 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 7 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.26 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.57 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 189 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.6 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 562 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2020-03-11, presumably until 2020-03-11\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2020-03-11, presumably until 2020-03-11\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2020-03-11, presumably until 2020-03-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-03-11, presumably until 2020-03-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-17 14:29:59, ended at 2020-03-17 14:37:02\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-17, presumably until 2020-03-24, with intended 5 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) daily in the evening\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-17, presumably until 2020-09-05, with intended 5 refill(s). Instructions: inject 10-14 Units subcutaneous (under the skin) 3 times a day 10 units with breakfast and dinner, 12 units with lunch, Add 2 units if BG>200\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-24 00:00:00, ended at 2020-03-24 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-24, presumably until 2020-06-03, with intended 3 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-25 08:49:00, ended at 2020-03-25 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.53 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.26 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 601 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Body height: 6' 1.228\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 189 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.82 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 177 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2020-03-25, presumably until 2020-03-25\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2020-03-25, presumably until 2020-03-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-03-25, presumably until 2020-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-25 10:18:08, ended at 2020-03-25 10:36:20\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n- Neoplasm defined only by topography: Colon, NOS\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-01 15:42:57, ended at 2020-04-01 17:17:35\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: COVID-19\n- Nausea and vomiting\n- Primary diagnosis: Disorder of respiratory system\n- Type 2 diabetes mellitus\n- Obstruction of bile duct\n- Complication due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-04 08:05:00, ended at 2020-04-04 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Secondary malignant neoplasm of bone\n- Primary malignant neoplasm of descending colon\n- Secondary malignant neoplasm of left lung\n- Localized enlarged lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-08 00:00:00, ended at 2020-04-08 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-08 08:41:00, ended at 2020-04-08 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 116 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.12 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 235 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 534 (unit per liter)\n- Body height: 6' .835\" (inch (US))\n- MCV [Entitic volume] by Automated count: 86.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.48 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.75 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.80 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 16.3 (gram per deciliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2020-04-08, presumably until 2020-04-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-08 09:43:03, ended at 2020-04-08 11:10:25\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-12 13:15:16, ended at 2020-04-12 13:15:22\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- COVID-19\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-04-15 00:00:00, ended at 2020-04-15 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal and exchange of stent(s), biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent exchang\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-15 00:00:00, ended at 2020-04-15 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; endoscopic retrograde cholangiopancreatography (ERCP)\n\n### Condition\n- Disorder caused by alcohol\n- Obstruction of bile duct\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-04-15, presumably until 2020-04-15\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2020-04-15, presumably until 2020-04-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-15 07:54:00, ended at 2020-04-15 11:43:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.75\" (inch (US))\n\n### Procedure\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal and exchange of stent(s), biliary or pancreatic duct, including pre- and post-dilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent exchang\n- Endoscopic catheterization of the biliary ductal system, radiological supervision and interpretation\n\n### Condition\n- Gastritis\n- Hypoinsulinemia following procedure\n- Complication due to diabetes mellitus\n- Diabetes mellitus\n- Obstruction of bile duct\n- Secondary malignant neoplasm of bone\n- Acquired absence of organ\n- Disorder of digestive system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-16 00:00:00, ended at 2020-04-16 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-18 00:00:00, ended at 2020-04-18 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-04-18, presumably until 2020-04-25, with intended 1 refill(s). Instructions: take 2 Tabs (50 mg total) by mouth 2 times a day Take 1 tab am & pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-22 00:00:00, ended at 2020-04-22 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of descending colon\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of intestinal_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "41e27fe329c755b90caae223f03ac7d3eb5e99761547c8b59493057cd88004e5", "prompt_hash": "19cdcaf33b0f9d936592e5e22be01ea07a7b4f0caa7ba8a85c854dd6a924945b", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 6, "doc": {"person_id": 115970088, "visit_occurrence_id": 46889670, "death_date": "2014-11-07", "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2012-02-04 06:37:00", "visit_end_datetime": "2012-02-04 23:59:00", "visit_length_in_hours": 17.366666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-04 06:37:00, ended at 2012-02-04 23:59:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Benign carcinoid tumor\n- Imaging of abdomen abnormal\n- Malignant carcinoid tumor\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 126, "patient_first_visit_date": "2010-02-13 08:45:00", "patient_last_visit_date": "2014-11-07 18:40:00", "end_obs_date": "2013-02-03", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "recurrent", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "recurrent", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 26, "cumulated_visit_num": 26, "cumulated_approximate_token_count": 6639, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-13 08:45:00, ended at 2010-02-13 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.25\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of small intestine\n- Malignant carcinoid tumor of small intestine\n- Primary malignant neoplasm of ileum\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-14 00:00:00, ended at 2010-02-14 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-14 17:15:00, ended at 2010-02-14 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred material requiring preparation of slides\n- Morphometric analysis, tumor\n\n### Condition\n- Primary malignant neoplasm of cecum\n- Primary malignant neoplasm of ileum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-15 12:58:00, ended at 2010-02-15 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, pelvis; with contrast material(s)\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Secondary malignant neoplasm of liver\n- Benign carcinoid tumor\n- Primary malignant neoplasm of ileum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-16 00:00:00, ended at 2010-02-16 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-17 00:00:00, ended at 2010-02-17 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-17 14:00:00, ended at 2010-02-17 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-03-02 05:27:00, ended at 2010-03-19 15:45:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 938 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.3 (percent)\n- Prothrombin time (PT): 20.5 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 52 (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 455 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.6 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Computed tomography, abdomen; with contrast material(s)\n- Simple excision of other lymphatic structure\n- Tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure)\n- Other repair of diaphragm\n- Excision of lesion of other soft tissue\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Excision of lesion or tissue of diaphragm\n- Computed tomography, pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n- Insertion of pleural tube drain\n- Open and other right hemicolectomy\n- Radiologic examination, abdomen; single anteroposterior view\n- Radiologic examination, chest; single view, frontal\n- Fluoroscopy (separate procedure), up to 1 hour physician or other qualified health care professional time\n- Cholecystectomy\n- Insertion of other (naso-)gastric tube\n- Radiological guidance (ie, fluoroscopy, ultrasound, or computed tomography), for percutaneous drainage (eg, abscess, specimen collection), with placement of catheter, radiological supervision and interpretation\n- Hepatotomy; for percutaneous drainage of abscess or cyst, 1 or 2 stages\n- Total hepatectomy\n\n### Condition\n- Leukocytosis\n- Neoplasm of lymph node\n- Secondary malignant neoplasm of intra-abdominal organs\n- Ascites\n- Neoplasm of intrathoracic lymph nodes\n- Postprocedural state finding\n- Pleural effusion\n- Primary malignant neoplasm of ileum\n- Benign carcinoid tumor\n- Pneumothorax\n- Secondary malignant neoplasm of large intestine\n- Secondary malignant neoplastic disease\n- Malignant carcinoid tumor\n- Abscess of liver\n- Disorder of lung\n- Secondary malignant neoplasm of liver\n- Gastrointestinal complication of procedure\n- Intestinal obstruction\n- Lung field abnormal\n- Secondary malignant neoplasm of retroperitoneum and peritoneum\n- Atelectasis\n- Functional disorder of intestine\n\n### Drug\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2010-03-13, presumably until 2010-03-13\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-03-14, presumably until 2010-03-14\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2010-03-02, presumably until 2010-03-03\n- menthol, through Submucosal route, started on 2010-03-09, presumably until 2010-03-14\n- benzocaine, through Submucosal route, started on 2010-03-09, presumably until 2010-03-14\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2010-03-11, presumably until 2010-03-16\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-03-17, presumably until 2010-05-05, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-03-08, presumably until 2010-03-09\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-03-09, presumably until 2010-03-09\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2010-03-02, presumably until 2010-03-02\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2010-03-13, presumably until 2010-03-13\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-03\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-03-03, presumably until 2010-03-16\n- diatrizoate, through Oral route, started on 2010-03-15, presumably until 2010-03-15\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2010-03-11, presumably until 2010-03-11\n- cetylpyridinium, through Submucosal route, started on 2010-03-09, presumably until 2010-03-14\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-03-04, presumably until 2010-03-15\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.01 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-03-04, presumably until 2010-03-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2010-03-06, presumably until 2010-03-09\n- diatrizoic acid, through Oral route, started on 2010-03-15, presumably until 2010-03-15\n- soybean oil 200 MG/ML Injectable Suspension, through Intravenous route, started on 2010-03-13, presumably until 2010-03-15\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2010-03-15, presumably until 2010-03-16\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-02\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2010-03-09, presumably until 2010-03-17\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-03-10, presumably until 2010-03-10\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-03-05, presumably until 2010-03-13\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2010-03-06, presumably until 2010-03-07\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-03-07, presumably until 2010-04-18, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-03-06, presumably until 2010-03-14\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-03-07, presumably until 2010-03-10\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2010-03-13, presumably until 2010-03-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-03-24 00:00:00, ended at 2010-03-24 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-24 13:41:00, ended at 2010-03-24 14:13:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 310 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 477 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-24 14:14:00, ended at 2010-03-24 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-18 11:26:00, ended at 2010-04-18 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign carcinoid tumor\n- Primary malignant neoplasm of small intestine\n- Malignant carcinoid tumor of small intestine\n- Primary malignant neoplasm of ileum\n- Secondary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-19 14:52:00, ended at 2010-04-19 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 81.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- MCH [Entitic mass] by Automated count: 26.7 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.72 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 544 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.65 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 602 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-21 11:55:00, ended at 2010-04-21 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-05 10:38:00, ended at 2010-05-05 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Carcinoid syndrome\n- Benign carcinoid tumor\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-05-05, presumably until 2011-05-05, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-05-08 00:00:00, ended at 2010-05-08 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-02 08:15:00, ended at 2010-06-02 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.78\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-12 15:27:00, ended at 2010-06-12 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Abscess of peritoneum\n- Benign carcinoid tumor\n- Minor laceration of liver without open wound into abdominal cavity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-18 13:30:00, ended at 2010-07-18 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of islets of Langerhans\n- Benign carcinoid tumor\n- Secondary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 13:49:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-18 14:01:00, ended at 2010-12-18 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-02 00:00:00, ended at 2011-01-02 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-03 00:00:00, ended at 2011-01-03 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-16 13:26:00, ended at 2011-01-16 13:55:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.14 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.45 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-16 13:56:00, ended at 2011-01-16 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-04 06:37:00, ended at 2012-02-04 23:59:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Benign carcinoid tumor\n- Imaging of abdomen abnormal\n- Malignant carcinoid tumor\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-13 08:45:00, ended at 2010-02-13 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.25\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of small intestine\n- Malignant carcinoid tumor of small intestine\n- Primary malignant neoplasm of ileum\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-14 00:00:00, ended at 2010-02-14 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-14 17:15:00, ended at 2010-02-14 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred material requiring preparation of slides\n- Morphometric analysis, tumor\n\n### Condition\n- Primary malignant neoplasm of cecum\n- Primary malignant neoplasm of ileum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-15 12:58:00, ended at 2010-02-15 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, pelvis; with contrast material(s)\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Secondary malignant neoplasm of liver\n- Benign carcinoid tumor\n- Primary malignant neoplasm of ileum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-16 00:00:00, ended at 2010-02-16 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-17 00:00:00, ended at 2010-02-17 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-17 14:00:00, ended at 2010-02-17 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-03-02 05:27:00, ended at 2010-03-19 15:45:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 938 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.3 (percent)\n- Prothrombin time (PT): 20.5 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 52 (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 455 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.6 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Computed tomography, abdomen; with contrast material(s)\n- Simple excision of other lymphatic structure\n- Tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure)\n- Other repair of diaphragm\n- Excision of lesion of other soft tissue\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Excision of lesion or tissue of diaphragm\n- Computed tomography, pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n- Insertion of pleural tube drain\n- Open and other right hemicolectomy\n- Radiologic examination, abdomen; single anteroposterior view\n- Radiologic examination, chest; single view, frontal\n- Fluoroscopy (separate procedure), up to 1 hour physician or other qualified health care professional time\n- Cholecystectomy\n- Insertion of other (naso-)gastric tube\n- Radiological guidance (ie, fluoroscopy, ultrasound, or computed tomography), for percutaneous drainage (eg, abscess, specimen collection), with placement of catheter, radiological supervision and interpretation\n- Hepatotomy; for percutaneous drainage of abscess or cyst, 1 or 2 stages\n- Total hepatectomy\n\n### Condition\n- Leukocytosis\n- Neoplasm of lymph node\n- Secondary malignant neoplasm of intra-abdominal organs\n- Ascites\n- Neoplasm of intrathoracic lymph nodes\n- Postprocedural state finding\n- Pleural effusion\n- Primary malignant neoplasm of ileum\n- Benign carcinoid tumor\n- Pneumothorax\n- Secondary malignant neoplasm of large intestine\n- Secondary malignant neoplastic disease\n- Malignant carcinoid tumor\n- Abscess of liver\n- Disorder of lung\n- Secondary malignant neoplasm of liver\n- Gastrointestinal complication of procedure\n- Intestinal obstruction\n- Lung field abnormal\n- Secondary malignant neoplasm of retroperitoneum and peritoneum\n- Atelectasis\n- Functional disorder of intestine\n\n### Drug\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2010-03-13, presumably until 2010-03-13\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-03-14, presumably until 2010-03-14\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2010-03-02, presumably until 2010-03-03\n- menthol, through Submucosal route, started on 2010-03-09, presumably until 2010-03-14\n- benzocaine, through Submucosal route, started on 2010-03-09, presumably until 2010-03-14\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2010-03-11, presumably until 2010-03-16\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-03-17, presumably until 2010-05-05, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-03-08, presumably until 2010-03-09\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-03-09, presumably until 2010-03-09\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2010-03-02, presumably until 2010-03-02\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2010-03-13, presumably until 2010-03-13\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-03\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-03-03, presumably until 2010-03-16\n- diatrizoate, through Oral route, started on 2010-03-15, presumably until 2010-03-15\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2010-03-11, presumably until 2010-03-11\n- cetylpyridinium, through Submucosal route, started on 2010-03-09, presumably until 2010-03-14\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-03-04, presumably until 2010-03-15\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.01 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-03-04, presumably until 2010-03-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2010-03-06, presumably until 2010-03-09\n- diatrizoic acid, through Oral route, started on 2010-03-15, presumably until 2010-03-15\n- soybean oil 200 MG/ML Injectable Suspension, through Intravenous route, started on 2010-03-13, presumably until 2010-03-15\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2010-03-15, presumably until 2010-03-16\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-02\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2010-03-09, presumably until 2010-03-17\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-03-10, presumably until 2010-03-10\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-03-05, presumably until 2010-03-13\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2010-03-06, presumably until 2010-03-07\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-03-07, presumably until 2010-04-18, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-03-06, presumably until 2010-03-14\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-03-07, presumably until 2010-03-10\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2010-03-13, presumably until 2010-03-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-03-24 00:00:00, ended at 2010-03-24 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-24 13:41:00, ended at 2010-03-24 14:13:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 310 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 477 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-24 14:14:00, ended at 2010-03-24 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-18 11:26:00, ended at 2010-04-18 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign carcinoid tumor\n- Primary malignant neoplasm of small intestine\n- Malignant carcinoid tumor of small intestine\n- Primary malignant neoplasm of ileum\n- Secondary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-19 14:52:00, ended at 2010-04-19 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 81.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- MCH [Entitic mass] by Automated count: 26.7 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.72 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 544 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.65 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 602 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-21 11:55:00, ended at 2010-04-21 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-05 10:38:00, ended at 2010-05-05 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Carcinoid syndrome\n- Benign carcinoid tumor\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-05-05, presumably until 2011-05-05, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-05-08 00:00:00, ended at 2010-05-08 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-02 08:15:00, ended at 2010-06-02 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.78\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-12 15:27:00, ended at 2010-06-12 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Abscess of peritoneum\n- Benign carcinoid tumor\n- Minor laceration of liver without open wound into abdominal cavity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-18 13:30:00, ended at 2010-07-18 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of islets of Langerhans\n- Benign carcinoid tumor\n- Secondary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 13:49:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-18 14:01:00, ended at 2010-12-18 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-02 00:00:00, ended at 2011-01-02 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-03 00:00:00, ended at 2011-01-03 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-16 13:26:00, ended at 2011-01-16 13:55:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.14 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.45 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-16 13:56:00, ended at 2011-01-16 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign carcinoid tumor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-04 06:37:00, ended at 2012-02-04 23:59:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Benign carcinoid tumor\n- Imaging of abdomen abnormal\n- Malignant carcinoid tumor\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of intestinal_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "4e111607d796fa2c947e09be3420421e1d55bb7a5bb17c33554c75592758b10a", "prompt_hash": "3a4a2afddb87e3ae3104d3c497526e204d00e8b5096bad1d4e5d9965056dce98", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 7, "doc": {"person_id": 115971125, "visit_occurrence_id": 52447542, "death_date": "2014-02-02", "visit_concept_name": "Office Visit", "visit_start_datetime": "2013-02-24 13:21:16", "visit_end_datetime": "2013-02-24 15:25:16", "visit_length_in_hours": 2.066666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2013-02-24 13:21:16, ended at 2013-02-24 15:25:16\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Periapical abscess with sinus tract\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2008-03-31 00:00:00", "patient_last_visit_date": "2013-11-26 08:37:25", "end_obs_date": "2014-02-02", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 1, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 1, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 91, "cumulated_visit_num": 91, "cumulated_approximate_token_count": 22996, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-31 00:00:00, ended at 2008-03-31 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.03 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-27 00:00:00, ended at 2008-04-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.78 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-18 00:00:00, ended at 2009-03-18 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-11 00:00:00, ended at 2009-04-11 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary emphysema\n- Acute respiratory failure\n- Hypoxemia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-04-11, presumably until 2009-07-25, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day. \n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2009-04-11, presumably until 2010-03-31, with quantity of 30.0, with intended 6 refill(s). Instructions: 30 mcg by Inhalation route daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-13 00:00:00, ended at 2009-04-13 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-19 00:00:00, ended at 2009-04-19 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypoxemia\n- Acute respiratory failure\n- Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-04-19, presumably until 2009-04-19. Instructions: by Inhalation route. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-19 00:00:00, ended at 2009-04-19 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Hypoxemia\n- Pulmonary emphysema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-07-05 00:00:00, ended at 2009-07-05 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypoxemia\n- Acute respiratory failure\n- Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-07-05, presumably until 2010-09-04, with quantity of 14.7, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-08-09 00:00:00, ended at 2009-08-09 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-08-09, presumably until 2010-09-04, with quantity of 4.0, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-16 00:00:00, ended at 2009-09-16 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-04 09:36:00, ended at 2009-10-04 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 14:23:00, ended at 2009-10-10 15:28:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 15:29:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.65 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.8 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-28 12:16:37, ended at 2009-11-28 13:05:56\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Pulmonary emphysema\n- Disorder of lung\n- Hypoxemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-28 13:42:00, ended at 2009-11-28 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Chronic obstructive lung disease\n- Disorder of lung\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-05 14:20:00, ended at 2009-12-05 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-11 00:00:00, ended at 2010-01-11 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute exacerbation of chronic obstructive bronchitis\n- Acute respiratory failure\n- Pulmonary emphysema\n\n### Drug\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2010-01-11, presumably until 2010-03-09, with quantity of 5.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. Take 500 mg once a day by mouth with meals for 5 days. \n- prednisone 20 MG Oral Tablet, through Oral route, started on 2010-01-11, presumably until 2010-03-09, with quantity of 16.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. Each tab has 20 mg.  Take 40 mg [2 tabs] by mouth for 4 days followed by          30 mg [1and a 1/2 tabs] by mouth for 4 days followed by          20 mg [1 tab] by mouth for 2 days          \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-02-24 10:15:00, ended at 2010-03-10 16:02:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 38 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.1 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 70 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 92 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.6 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 65.8 (millimeter mercury column)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma: 41.0 (microgram per milliliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 13.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 38.2 (millimole per liter)\n- Body height: 5' 10\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.0 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 5.2 (microgram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.58 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.1 (milligram per deciliter)\n- Prothrombin time (PT): 14.2 (second)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Arterial puncture, withdrawal of blood for diagnosis\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; without contrast material\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n\n### Condition\n- Acute tubular necrosis\n- Drug abuse in remission\n- Loss of appetite\n- Malnutrition (calorie)\n- Insomnia\n- Psychostimulant dependence\n- Tobacco dependence syndrome\n- Acidosis\n- Pneumonia due to Pseudomonas\n- Chronic cor pulmonale\n- Chronic obstructive lung disease\n- Hyperkalemia\n- Chronic respiratory failure\n- Disorder of kidney and/or ureter\n- Dysthymia\n- Pleural effusion\n- Acquired coagulation factor deficiency\n- Increased frequency of urination\n- Acute renal failure syndrome\n- Colostomy present\n- Disorder of lung\n- Disorder of phosphorus metabolism\n- Infective pneumonia\n- Low blood pressure\n- Pulmonary emphysema\n- Tricuspid valve disorder\n- Anemia of chronic disease\n- Benign prostatic hyperplasia with outflow obstruction\n- Disorder of fluid AND/OR electrolyte\n- Dyspnea\n- Ostium secundum type atrial septal defect\n- Dependence on respiratory device\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2010-03-09, presumably until 2010-03-10\n- aluminum hydroxide 64 MG/ML Oral Suspension, through Oral route, started on 2010-03-05, presumably until 2010-03-08\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2010-02-25, presumably until 2010-02-25\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-06\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2010-02-25, presumably until 2010-03-07\n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, started on 2010-03-09, presumably until 2010-03-10\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2010-02-24, presumably until 2010-02-24\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-09\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2010-02-24, presumably until 2010-03-09\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-02-25, presumably until 2010-03-10\n- purified protein derivative of tuberculin 50 UNT/ML Injectable Solution, through Intradermal route, started on 2010-02-24, presumably until 2010-02-24\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2010-02-25, presumably until 2010-03-09\n- sevelamer hydrochloride 400 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-09\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2010-02-24, presumably until 2010-02-25\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2010-02-25, presumably until 2010-03-02\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2010-03-05, presumably until 2010-03-07\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2010-03-03, presumably until 2010-03-06\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2010-02-25, presumably until 2010-03-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-24, presumably until 2010-03-06\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2010-02-25, presumably until 2010-03-06\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2010-02-28, presumably until 2010-02-28\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2010-02-26, presumably until 2010-02-26\n- 14 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2010-02-26, presumably until 2010-03-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-02-28 07:36:27, ended at 2010-02-28 10:53:56\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-16 13:03:00, ended at 2010-03-16 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-03-22 00:00:00, ended at 2010-03-22 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-24 13:30:00, ended at 2010-03-24 16:55:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-03-24 16:56:00, ended at 2010-03-30 17:20:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 2 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.7 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.72 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 26.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.89 (micro-international unit per milliliter)\n- Body height: 5' 10\" (inch (US))\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 21.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 78 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 28.5 (thousand per microliter)\n- Prothrombin time (PT): 15.6 (second)\n- Base excess in Blood by calculation: 6.0 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, pelvis; without contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Computed tomography, abdomen; without contrast material\n- Collection of venous blood by venipuncture\n\n### Condition\n- Benign hypertensive renal disease with renal failure\n- Disorder of lung\n- Chronic obstructive lung disease\n- Clostridioides difficile infection\n- Inflammatory disorder of digestive tract\n- Abdominal pain\n- Ascites\n- Dependence on respiratory device\n- Leukocytosis\n- Hypokalemia\n- Disorder of magnesium metabolism\n- Atrial fibrillation\n- Chronic kidney disease\n- Colostomy present\n- Dyspnea\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2010-03-25, presumably until 2010-03-28\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-29, presumably until 2010-03-30\n- Lactobacillus acidophilus Oral Tablet, through Oral route, started on 2010-03-28, presumably until 2012-06-17, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2010-03-28, presumably until 2010-03-29\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-03-28, presumably until 2010-04-14, with quantity of 60.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-03-25\n- diatrizoate, through Oral route, started on 2010-03-24, presumably until 2010-03-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2010-03-28, presumably until 2010-03-29\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-03-26, presumably until 2010-03-29\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-03-28, presumably until 2010-03-28\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-03-25, presumably until 2010-03-29\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2010-03-25, presumably until 2010-03-30\n- diatrizoic acid, through Oral route, started on 2010-03-24, presumably until 2010-03-24\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2010-03-28, presumably until 2010-03-30\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-04-17, with quantity of 27.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-25, presumably until 2010-03-30\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2010-03-25, presumably until 2010-03-25\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2010-03-24, presumably until 2010-03-24\n- rifaximin 200 MG Oral Tablet, through Oral route, started on 2010-03-28, presumably until 2010-05-08, with quantity of 9.0, with intended 0 refill(s). Instructions: take 200 mg by mouth 3 times a day. \n- magnesium lactate 84 MG Extended Release Oral Tablet, through Oral route, started on 2010-03-30, presumably until 2010-05-08, with quantity of 120.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-09-26, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-03-24, presumably until 2010-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-31 13:58:25, ended at 2010-03-31 18:58:16\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Disorder of lung\n- Hypoxemia\n- Atrial fibrillation\n- Pulmonary emphysema\n\n### Drug\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2010-03-31, presumably until 2010-12-26, with quantity of 30.0, with intended 6 refill(s). Instructions: 30 mcg by Inhalation route daily. \n- amiodarone hydrochloride 400 MG Oral Tablet, through Oral route, started on 2010-03-31, presumably until 2010-04-14, with quantity of 90.0, with intended 0 refill(s). Instructions: take 200 mg by mouth every 12 hours. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 12:15:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 1.181\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n- Primary malignant neoplasm of colon\n- Chronic respiratory failure\n- Primary malignant neoplasm of rectum\n- Pulmonary emphysema\n- Hypoxemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-04-04 00:00:00, ended at 2010-04-04 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-04 13:23:00, ended at 2010-04-04 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing; simple (eg, 6-minute walk test, prolonged exercise test for bronchospasm with pre- and post-spirometry and oximetry)\n\n### Condition\n- Pulmonary emphysema\n- Hypoxemia\n- Chronic respiratory failure\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-06 08:59:00, ended at 2010-04-06 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 81 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.2 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 96 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 75 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Inflammatory disorder of digestive tract\n- Hypoxemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-04-14 00:00:00, ended at 2010-04-14 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-14 14:48:00, ended at 2010-04-14 16:19:40\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n- Atrial fibrillation\n- Generalized abdominal pain\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-04-14, presumably until 2010-05-03, with quantity of 60.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- amiodarone hydrochloride 400 MG Oral Tablet, through Oral route, started on 2010-04-14, presumably until 2010-05-08, with quantity of 90.0, with intended 0 refill(s). Instructions: take 200 mg by mouth daily. \n- vancomycin 125 MG Oral Capsule, through Oral route, started on 2010-04-14, presumably until 2010-05-08, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-14 16:34:00, ended at 2010-04-14 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Atrial fibrillation\n- Disorder of lung\n- Generalized abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-04-17 00:00:00, ended at 2010-04-17 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory disorder of digestive tract\n\n### Drug\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2010-04-17, presumably until 2010-04-21, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-21 15:00:16, ended at 2010-04-21 15:46:37\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic respiratory failure\n- Clostridioides difficile infection\n- Low back pain\n- Pulmonary emphysema\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-04-21, presumably until 2010-10-18, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed (flexeril was not covered by MediCAL) \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-04-21, presumably until 2010-05-08, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-05-03 00:00:00, ended at 2010-05-03 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2010-05-03, presumably until 2011-03-23, with intended 0 refill(s). Instructions: take 1 Packet by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-03 14:01:00, ended at 2010-05-03 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Bronchiectasis\n- Disorder of lung\n- Pulmonary emphysema\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-08 13:14:53, ended at 2010-05-08 14:30:01\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, presumably until 2010-12-26. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-08 14:47:00, ended at 2010-05-08 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypokalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-05-24 00:00:00, ended at 2010-05-24 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-24 09:57:00, ended at 2010-05-24 12:19:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-24 12:20:00, ended at 2010-05-24 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.61 (thousand per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.0 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypokalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-02 16:08:57, ended at 2010-06-02 17:06:54\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Insomnia\n- Clostridioides difficile infection\n\n### Drug\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-06-02, presumably until 2010-12-26, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime. \n- vancomycin 125 MG Oral Capsule, through Oral route, started on 2010-06-02, presumably until 2010-10-24, with quantity of 86.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. 1 cap 4 times daily for 14 days  1 cap bid for 7 days  1 cap daily for 7 days  1 cap every other day for 8 days  1cap every three days for 15 days \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-20 10:55:00, ended at 2010-06-20 11:19:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-20 11:20:00, ended at 2010-06-20 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Disorder of lung\n- Primary malignant neoplasm of rectum\n- Pulmonary emphysema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-06-21 00:00:00, ended at 2010-06-21 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Clostridioides difficile infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-21 12:18:00, ended at 2010-06-21 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Clostridioides difficile infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-08-30 00:00:00, ended at 2010-08-30 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tobacco dependence syndrome\n\n### Drug\n- nicotine 4 MG Chewing Gum, through Buccal route, started on 2010-08-31, presumably until 2011-03-23, with intended 4 refill(s). Instructions: 4 mg by Buccal route as directed. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-09-04 00:00:00, ended at 2010-09-04 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypoxemia\n- Pulmonary emphysema\n- Acute respiratory failure\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2010-09-04, presumably until 2010-12-26, with quantity of 14.7, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed \n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2010-09-04, presumably until 2010-12-26, with quantity of 4.0, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-10-13 00:00:00, ended at 2010-10-13 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anxiety state\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2010-10-13, presumably until 2010-12-20, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-24 13:50:37, ended at 2010-10-24 15:18:13\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Depressive disorder\n- Chronic respiratory failure\n\n### Drug\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2010-10-24, presumably until 2010-10-27, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-10-27 00:00:00, ended at 2010-10-27 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety state\n- Depressive disorder\n\n### Drug\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2010-10-27, presumably until 2010-11-13, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-13 13:21:16, ended at 2010-11-13 14:27:05\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n- Depressive disorder\n- Hearing loss\n- Low back pain\n\n### Drug\n- 12 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2010-11-13, presumably until 2010-12-12, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- escitalopram 20 MG Oral Tablet, through Oral route, started on 2010-11-13, presumably until 2010-11-13, with quantity of 30.0, with intended 6 refill(s). Instructions: take 20 mg by mouth Every Day. \n- carbamide peroxide 65 MG/ML Otic Solution, through Otic route, started on 2010-11-13, presumably until 2011-03-23, with intended 0 refill(s). Instructions: 1 Drop by Both Ears route 2 times a day. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-11-13, presumably until 2010-12-20, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-12 13:51:11, ended at 2010-12-12 15:29:57\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n- Abnormal breathing\n- Obsessive-compulsive disorder\n- Muscle atrophy\n- Constipation\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- sennosides, USP 1.76 MG/ML Oral Solution, through Oral route, started on 2010-12-12, presumably until 2011-05-08, with intended 0 refill(s). Instructions: take 5 mL by mouth every bedtime. \n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2010-12-12, presumably until 2011-05-08, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- sertraline 50 MG Oral Tablet, through Oral route, started on 2010-12-12, presumably until 2011-01-18, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-12-20 00:00:00, ended at 2010-12-20 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Anxiety state\n- Low back pain\n\n### Drug\n- vitamin E 100 UNT Oral Capsule, through Oral route, started on 2010-12-20, presumably until 2011-12-20, with quantity of 0.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily. \n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2010-12-20, presumably until 2010-12-26, with quantity of 7.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-20, presumably until 2010-12-26, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-01-18 00:00:00, ended at 2011-01-18 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obsessive-compulsive disorder\n- Generalized anxiety disorder\n\n### Drug\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2011-01-18, presumably until 2011-06-01, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-02-27 16:23:00, ended at 2011-03-07 20:45:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 36 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 80 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 16.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCV [Entitic volume] by Automated count: 97.7 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Body height: 5' 8\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Prothrombin time (PT): 13.7 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.9 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n\n### Procedure\n- Gastric intubation and aspiration(s) therapeutic, necessitating physician's skill (eg, for gastrointestinal hemorrhage), including lavage if performed\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Computed tomography, pelvis; with contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Computed tomography, abdomen; with contrast material(s)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Chronic cor pulmonale\n- Chronic obstructive lung disease\n- Chronic respiratory failure\n- Depressive disorder\n- Dependence on respiratory device\n- Infective pneumonia\n- Colostomy present\n- Intestinal obstruction\n- Pleural effusion\n- Left lower quadrant pain\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2011-02-28, presumably until 2011-03-07\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2011-03-06, presumably until 2011-03-23, with quantity of 1.0, with intended 1 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. \n- menthol, through Submucosal route, started on 2011-03-05, presumably until 2011-03-06\n- benzocaine, through Submucosal route, started on 2011-03-05, presumably until 2011-03-06\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2011-02-28, presumably until 2011-03-02\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-03-02, presumably until 2011-03-07\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-03-01, presumably until 2011-03-01\n- moxifloxacin 400 MG Oral Tablet, through Oral route, started on 2011-03-07, presumably until 2011-03-23, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-02-28, presumably until 2011-03-06\n- cetylpyridinium, through Submucosal route, started on 2011-03-05, presumably until 2011-03-06\n- 24 HR nicotine 0.292 MG/HR Transdermal System, through Transdermal route, started on 2011-03-03, presumably until 2011-03-07\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2011-02-28, presumably until 2011-03-07. Instructions: 30 mcg by Inhalation route daily. \n- 10 ML furosemide 10 MG/ML Injection, started on 2011-03-04, presumably until 2011-03-04\n- soybean oil 200 MG/ML Injectable Suspension, through Intravenous route, started on 2011-03-01, presumably until 2011-03-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-03-01, presumably until 2011-03-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-02-27, presumably until 2011-02-27\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-03-05, presumably until 2011-03-07\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-02-28, presumably until 2011-03-03\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2011-02-27, presumably until 2011-03-06\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2011-02-28, presumably until 2011-02-28\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2011-03-02, presumably until 2011-03-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-03-09 00:00:00, ended at 2011-03-09 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-03-09, presumably until 2011-04-05, with quantity of 90.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-04-20 13:30:47, ended at 2011-04-20 14:28:25\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute exacerbation of chronic obstructive bronchitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-04-25 00:00:00, ended at 2011-04-25 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-27 13:36:00, ended at 2011-04-27 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.15 (millimole per liter)\n\n### Procedure\n- Arterial puncture, withdrawal of blood for diagnosis\n- Plethysmography, total body; interpretation and report only\n- Determination of resistance to airflow, oscillatory or plethysmographic methods\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Carbon monoxide diffusing capacity (eg, single breath, steady state)\n- Thoracic gas volume\n\n### Condition\n- Chronic obstructive lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-05-02 00:00:00, ended at 2011-05-02 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety state\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-05-02, presumably until 2011-06-01, with quantity of 30.0, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-08 09:01:32, ended at 2011-05-08 11:28:29\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n- Primary diagnosis: Pulmonary emphysema\n- Hypoxemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-01 14:21:22, ended at 2011-06-01 16:39:54\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Insomnia\n- Generalized anxiety disorder\n- Primary diagnosis: Hypoxemia\n- Obsessive-compulsive disorder\n- Anxiety state\n\n### Drug\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2011-06-01, presumably until 2011-07-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2011-06-01, presumably until 2012-05-31, with intended 3 refill(s). Instructions: take 3 Tabs by mouth every bedtime.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-01, presumably until 2011-07-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2011-06-01, presumably until 2011-06-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-03 13:25:41, ended at 2011-07-03 16:10:38\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Anxiety state\n- Pulmonary emphysema\n- Hypoxemia\n- Primary diagnosis: Obsessive-compulsive disorder\n- Chronic respiratory failure\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2011-07-03, presumably until 2011-09-21, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. Give 90 day supply\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2011-07-03, presumably until 2012-07-02, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-07-03, presumably until 2011-12-30, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-07-03, presumably until 2011-07-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2011-07-03, presumably until 2011-07-04, with intended 3 refill(s). Instructions: 1.[000000] Caps by Inhalation route daily.\n- levalbuterol 0.103 MG/ML Inhalation Solution, through Inhalation, started on 2011-07-03, presumably until 2011-07-04, with intended 3 refill(s). Instructions: 0.63 mg by Nebulization route 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-07-04 00:00:00, ended at 2011-07-04 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Primary diagnosis: Pulmonary emphysema\n- Hypoxemia\n\n### Drug\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2011-07-04, presumably until 2011-09-21, with intended 3 refill(s). Instructions: 1 Cap by Inhalation route daily.\n- levalbuterol 0.103 MG/ML Inhalation Solution, through Inhalation, started on 2011-07-04, presumably until 2011-09-21, with intended 3 refill(s). Instructions: 0.63 mg by Nebulization route 4 times a day as needed for Bronchospasm/Wheezing.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-07-23 00:00:00, ended at 2011-07-23 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anxiety state\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-07-23, presumably until 2011-09-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-09-19 00:00:00, ended at 2011-09-19 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-09-19, presumably until 2012-03-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-21 15:28:04, ended at 2011-09-21 16:38:45\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Backache\n- Pulmonary emphysema\n- Chronic respiratory failure\n- Hypoxemia\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2011-09-21, presumably until 2012-06-13, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. Give 90 day supply\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2011-09-21, presumably until 2012-06-17, with intended 3 refill(s). Instructions: take 2 Caps by mouth 2 times a day.\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-09-21, presumably until 2012-03-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed. Must establish with new PCP as scheduled on 9/23 at 1:30 pm in order to get refill.\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2011-09-21, presumably until 2012-06-13, with intended 3 refill(s). Instructions: 1 Cap by Inhalation route daily.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2011-09-21, presumably until 2012-06-17, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime. If patient cannot get this med as prescription due to insurance issues, please direct patient to OTC med.\n- levalbuterol 0.103 MG/ML Inhalation Solution, through Inhalation, started on 2011-09-21, presumably until 2012-06-17, with intended 3 refill(s). Instructions: 0.63 mg by Nebulization route 4 times a day as needed for Bronchospasm/Wheezing.\n- lidocaine hydrochloride 0.05 MG/MG Topical Ointment, through Topical route, started on 2011-09-21, presumably until 2012-06-17, with intended 0 refill(s). Instructions: by Topical route as needed. Apply to affected area as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-19 13:24:59, ended at 2011-10-19 14:34:43\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n- Chronic respiratory failure\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-10-19, presumably until 2012-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-19 14:47:00, ended at 2011-10-19 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Chronic obstructive lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-30 00:00:00, ended at 2012-01-30 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2012-01-30, presumably until 2012-06-13, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-03-10 00:00:00, ended at 2012-03-10 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n- Generalized abdominal pain\n- Obsessive-compulsive disorder\n- Anxiety state\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2012-03-10, presumably until 2012-07-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed.\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-03-10, presumably until 2012-07-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-03-26 00:00:00, ended at 2012-03-26 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Pulmonary emphysema\n- Hypoxemia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, started on 2012-03-26, presumably until 2012-04-25, with intended 0 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-04-22 00:00:00, ended at 2012-04-22 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, started on 2012-04-22, presumably until 2012-06-13, with intended 0 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-13 00:00:00, ended at 2012-06-13 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic respiratory failure\n- Hypoxemia\n- Acute respiratory failure\n- Primary diagnosis: Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Oral route, started on 2012-06-13, presumably until 2012-06-17, with intended 12 refill(s). Instructions: take 2 Puffs by mouth as needed.\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2012-06-13, presumably until 2012-06-17, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. Give 90 day supply\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2012-06-13, presumably until 2012-10-16, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed.\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2012-06-13, presumably until 2012-06-17, with intended 6 refill(s). Instructions: 1 Cap by Inhalation route daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-17 11:14:41, ended at 2012-06-17 13:02:36\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic respiratory failure\n- Pulmonary emphysema\n- Hypoxemia\n- Acute respiratory failure\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Oral route, started on 2012-06-17, presumably until 2012-10-16, with intended 12 refill(s). Instructions: take 2 Puffs by mouth as needed.\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2012-06-17, presumably until 2012-10-16, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. Give 90 day supply\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2012-06-17, presumably until 2012-10-16, with intended 6 refill(s). Instructions: 1 Cap by Inhalation route daily.\n- levalbuterol 0.103 MG/ML Inhalation Solution, through Inhalation, started on 2012-06-17, presumably until 2012-10-16, with intended 3 refill(s). Instructions: 0.63 mg by Nebulization route 4 times a day as needed for Bronchospasm/Wheezing.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-23 00:00:00, ended at 2012-07-23 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic obstructive lung disease\n- Anxiety state\n- Generalized abdominal pain\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2012-07-23, presumably until 2012-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed.\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-07-23, presumably until 2012-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-29 14:16:24, ended at 2012-07-29 15:54:44\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Intestinal obstruction\n- Hypoxemia\n- Chronic respiratory failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-22 00:00:00, ended at 2012-08-22 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic obstructive lung disease\n- Anxiety state\n- Generalized abdominal pain\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2012-08-22, presumably until 2012-10-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed.\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-08-22, presumably until 2012-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-08-26 00:00:00, ended at 2012-08-26 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Convalescence after radiotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-27 10:00:00, ended at 2012-08-27 13:39:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Convalescence after radiotherapy\n- Primary malignant neoplasm of rectum\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-27 13:40:00, ended at 2012-08-27 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-09-30 00:00:00, ended at 2012-09-30 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-09-30, presumably until 2012-10-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-10-03 00:00:00, ended at 2012-10-03 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic obstructive lung disease\n- Generalized abdominal pain\n- Anxiety state\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2012-10-03, presumably until 2013-01-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-16 08:24:56, ended at 2012-10-16 09:41:06\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary emphysema\n- Hypoxemia\n- Chronic respiratory failure\n- Acute respiratory failure\n- Solitary nodule of lung\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2012-10-16, presumably until 2013-10-16, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. Give 90 day supply\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2012-10-16, presumably until 2013-04-27, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed.\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2012-10-16, presumably until 2013-04-27, with intended 3 refill(s). Instructions: 1 Cap by Inhalation route daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-31 13:28:05, ended at 2012-10-31 14:26:49\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Counseling\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Primary diagnosis: Chronic obstructive lung disease\n- Backache\n- Joint pain of pelvic region\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-10-31, presumably until 2013-01-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-31 14:49:00, ended at 2012-10-31 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; 1 view\n- Radiologic examination, spine, lumbosacral; 2 or 3 views\n\n### Condition\n- Low back pain\n- Joint pain of pelvic region\n- Scoliosis deformity of spine\n- Enthesopathy of hip region\n- Acquired spondylolisthesis\n- Degeneration of intervertebral disc\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-22 00:00:00, ended at 2013-01-22 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized abdominal pain\n- Anxiety state\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2013-01-22, presumably until 2013-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-28 00:00:00, ended at 2013-01-28 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-03-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-13 13:43:24, ended at 2013-02-13 14:35:18\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic respiratory failure\n- Osteoarthritis\n- Primary diagnosis: Dental caries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-19 11:46:51, ended at 2013-02-19 13:05:30\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute exacerbation of chronic obstructive bronchitis\n- Primary diagnosis: Pulmonary emphysema\n- Hypoxemia\n\n### Drug\n- methylprednisolone 4 MG Oral Tablet, started on 2013-02-19, presumably until 2013-05-29, with intended 0 refill(s). Instructions: Take by mouth.   Day 1: Take 2 tablet before breakfast, 1 after lunch, 1 after dinner and 2 at bedtime.  Day 2: Take 1 tablet before breakfast, 1 after lunch, 1 after dinner and 2 at bedtime.  Day 3: Take 1 tablet before breakfast, 1 after lunch, 1 after dinner and 1 at bedtime.  Day 4: Take 1 tablet before breakfast, 1 after lunch and 1 at bedtime.  Day 5: Take 1 tablet before breakfast and 1 at bedtime.  Day 6: Take 1 tablet before breakfast.\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2013-02-19, presumably until 2013-06-25, with intended 0 refill(s). Instructions: take 250 mg by mouth as directed. 2 tabs on day 1, then 1 tab daily thereafter\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-24 13:21:16, ended at 2013-02-24 15:25:16\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Periapical abscess with sinus tract\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-31 00:00:00, ended at 2008-03-31 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.03 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-27 00:00:00, ended at 2008-04-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.78 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-18 00:00:00, ended at 2009-03-18 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-11 00:00:00, ended at 2009-04-11 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary emphysema\n- Acute respiratory failure\n- Hypoxemia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-04-11, presumably until 2009-07-25, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day. \n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2009-04-11, presumably until 2010-03-31, with quantity of 30.0, with intended 6 refill(s). Instructions: 30 mcg by Inhalation route daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-13 00:00:00, ended at 2009-04-13 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-19 00:00:00, ended at 2009-04-19 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypoxemia\n- Acute respiratory failure\n- Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-04-19, presumably until 2009-04-19. Instructions: by Inhalation route. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-19 00:00:00, ended at 2009-04-19 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Hypoxemia\n- Pulmonary emphysema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-07-05 00:00:00, ended at 2009-07-05 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypoxemia\n- Acute respiratory failure\n- Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-07-05, presumably until 2010-09-04, with quantity of 14.7, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-08-09 00:00:00, ended at 2009-08-09 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-08-09, presumably until 2010-09-04, with quantity of 4.0, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-16 00:00:00, ended at 2009-09-16 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-04 09:36:00, ended at 2009-10-04 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 14:23:00, ended at 2009-10-10 15:28:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 15:29:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.65 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.8 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-28 12:16:37, ended at 2009-11-28 13:05:56\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Pulmonary emphysema\n- Disorder of lung\n- Hypoxemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-28 13:42:00, ended at 2009-11-28 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Chronic obstructive lung disease\n- Disorder of lung\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-05 14:20:00, ended at 2009-12-05 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-11 00:00:00, ended at 2010-01-11 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute exacerbation of chronic obstructive bronchitis\n- Acute respiratory failure\n- Pulmonary emphysema\n\n### Drug\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2010-01-11, presumably until 2010-03-09, with quantity of 5.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. Take 500 mg once a day by mouth with meals for 5 days. \n- prednisone 20 MG Oral Tablet, through Oral route, started on 2010-01-11, presumably until 2010-03-09, with quantity of 16.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. Each tab has 20 mg.  Take 40 mg [2 tabs] by mouth for 4 days followed by          30 mg [1and a 1/2 tabs] by mouth for 4 days followed by          20 mg [1 tab] by mouth for 2 days          \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-02-24 10:15:00, ended at 2010-03-10 16:02:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 38 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.1 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 70 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 92 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.6 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 65.8 (millimeter mercury column)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma: 41.0 (microgram per milliliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 13.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 38.2 (millimole per liter)\n- Body height: 5' 10\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.0 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 5.2 (microgram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.58 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.1 (milligram per deciliter)\n- Prothrombin time (PT): 14.2 (second)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Arterial puncture, withdrawal of blood for diagnosis\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; without contrast material\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n\n### Condition\n- Acute tubular necrosis\n- Drug abuse in remission\n- Loss of appetite\n- Malnutrition (calorie)\n- Insomnia\n- Psychostimulant dependence\n- Tobacco dependence syndrome\n- Acidosis\n- Pneumonia due to Pseudomonas\n- Chronic cor pulmonale\n- Chronic obstructive lung disease\n- Hyperkalemia\n- Chronic respiratory failure\n- Disorder of kidney and/or ureter\n- Dysthymia\n- Pleural effusion\n- Acquired coagulation factor deficiency\n- Increased frequency of urination\n- Acute renal failure syndrome\n- Colostomy present\n- Disorder of lung\n- Disorder of phosphorus metabolism\n- Infective pneumonia\n- Low blood pressure\n- Pulmonary emphysema\n- Tricuspid valve disorder\n- Anemia of chronic disease\n- Benign prostatic hyperplasia with outflow obstruction\n- Disorder of fluid AND/OR electrolyte\n- Dyspnea\n- Ostium secundum type atrial septal defect\n- Dependence on respiratory device\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2010-03-09, presumably until 2010-03-10\n- aluminum hydroxide 64 MG/ML Oral Suspension, through Oral route, started on 2010-03-05, presumably until 2010-03-08\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2010-02-25, presumably until 2010-02-25\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-06\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2010-02-25, presumably until 2010-03-07\n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, started on 2010-03-09, presumably until 2010-03-10\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2010-02-24, presumably until 2010-02-24\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-09\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2010-02-24, presumably until 2010-03-09\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-02-25, presumably until 2010-03-10\n- purified protein derivative of tuberculin 50 UNT/ML Injectable Solution, through Intradermal route, started on 2010-02-24, presumably until 2010-02-24\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2010-02-25, presumably until 2010-03-09\n- sevelamer hydrochloride 400 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-09\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2010-02-24, presumably until 2010-02-25\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2010-02-25, presumably until 2010-03-02\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2010-03-05, presumably until 2010-03-07\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2010-03-03, presumably until 2010-03-06\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2010-02-25, presumably until 2010-03-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-24, presumably until 2010-03-06\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2010-02-25, presumably until 2010-03-06\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2010-02-28, presumably until 2010-02-28\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2010-02-26, presumably until 2010-02-26\n- 14 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2010-02-26, presumably until 2010-03-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-02-28 07:36:27, ended at 2010-02-28 10:53:56\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-16 13:03:00, ended at 2010-03-16 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-03-22 00:00:00, ended at 2010-03-22 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-24 13:30:00, ended at 2010-03-24 16:55:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-03-24 16:56:00, ended at 2010-03-30 17:20:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 2 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.7 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.72 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 26.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.89 (micro-international unit per milliliter)\n- Body height: 5' 10\" (inch (US))\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 21.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 78 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 28.5 (thousand per microliter)\n- Prothrombin time (PT): 15.6 (second)\n- Base excess in Blood by calculation: 6.0 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, pelvis; without contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Computed tomography, abdomen; without contrast material\n- Collection of venous blood by venipuncture\n\n### Condition\n- Benign hypertensive renal disease with renal failure\n- Disorder of lung\n- Chronic obstructive lung disease\n- Clostridioides difficile infection\n- Inflammatory disorder of digestive tract\n- Abdominal pain\n- Ascites\n- Dependence on respiratory device\n- Leukocytosis\n- Hypokalemia\n- Disorder of magnesium metabolism\n- Atrial fibrillation\n- Chronic kidney disease\n- Colostomy present\n- Dyspnea\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2010-03-25, presumably until 2010-03-28\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-29, presumably until 2010-03-30\n- Lactobacillus acidophilus Oral Tablet, through Oral route, started on 2010-03-28, presumably until 2012-06-17, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2010-03-28, presumably until 2010-03-29\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-03-28, presumably until 2010-04-14, with quantity of 60.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-03-25\n- diatrizoate, through Oral route, started on 2010-03-24, presumably until 2010-03-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2010-03-28, presumably until 2010-03-29\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-03-26, presumably until 2010-03-29\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-03-28, presumably until 2010-03-28\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-03-25, presumably until 2010-03-29\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2010-03-25, presumably until 2010-03-30\n- diatrizoic acid, through Oral route, started on 2010-03-24, presumably until 2010-03-24\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2010-03-28, presumably until 2010-03-30\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-04-17, with quantity of 27.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-25, presumably until 2010-03-30\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2010-03-25, presumably until 2010-03-25\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2010-03-24, presumably until 2010-03-24\n- rifaximin 200 MG Oral Tablet, through Oral route, started on 2010-03-28, presumably until 2010-05-08, with quantity of 9.0, with intended 0 refill(s). Instructions: take 200 mg by mouth 3 times a day. \n- magnesium lactate 84 MG Extended Release Oral Tablet, through Oral route, started on 2010-03-30, presumably until 2010-05-08, with quantity of 120.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-09-26, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-03-24, presumably until 2010-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-31 13:58:25, ended at 2010-03-31 18:58:16\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Disorder of lung\n- Hypoxemia\n- Atrial fibrillation\n- Pulmonary emphysema\n\n### Drug\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2010-03-31, presumably until 2010-12-26, with quantity of 30.0, with intended 6 refill(s). Instructions: 30 mcg by Inhalation route daily. \n- amiodarone hydrochloride 400 MG Oral Tablet, through Oral route, started on 2010-03-31, presumably until 2010-04-14, with quantity of 90.0, with intended 0 refill(s). Instructions: take 200 mg by mouth every 12 hours. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 12:15:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 1.181\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n- Primary malignant neoplasm of colon\n- Chronic respiratory failure\n- Primary malignant neoplasm of rectum\n- Pulmonary emphysema\n- Hypoxemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-04-04 00:00:00, ended at 2010-04-04 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-04 13:23:00, ended at 2010-04-04 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing; simple (eg, 6-minute walk test, prolonged exercise test for bronchospasm with pre- and post-spirometry and oximetry)\n\n### Condition\n- Pulmonary emphysema\n- Hypoxemia\n- Chronic respiratory failure\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-06 08:59:00, ended at 2010-04-06 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 81 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.2 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 96 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 75 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Inflammatory disorder of digestive tract\n- Hypoxemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-04-14 00:00:00, ended at 2010-04-14 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-14 14:48:00, ended at 2010-04-14 16:19:40\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n- Atrial fibrillation\n- Generalized abdominal pain\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-04-14, presumably until 2010-05-03, with quantity of 60.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- amiodarone hydrochloride 400 MG Oral Tablet, through Oral route, started on 2010-04-14, presumably until 2010-05-08, with quantity of 90.0, with intended 0 refill(s). Instructions: take 200 mg by mouth daily. \n- vancomycin 125 MG Oral Capsule, through Oral route, started on 2010-04-14, presumably until 2010-05-08, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-14 16:34:00, ended at 2010-04-14 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Atrial fibrillation\n- Disorder of lung\n- Generalized abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-04-17 00:00:00, ended at 2010-04-17 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory disorder of digestive tract\n\n### Drug\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2010-04-17, presumably until 2010-04-21, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-21 15:00:16, ended at 2010-04-21 15:46:37\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic respiratory failure\n- Clostridioides difficile infection\n- Low back pain\n- Pulmonary emphysema\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-04-21, presumably until 2010-10-18, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed (flexeril was not covered by MediCAL) \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-04-21, presumably until 2010-05-08, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-05-03 00:00:00, ended at 2010-05-03 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2010-05-03, presumably until 2011-03-23, with intended 0 refill(s). Instructions: take 1 Packet by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-03 14:01:00, ended at 2010-05-03 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Bronchiectasis\n- Disorder of lung\n- Pulmonary emphysema\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-08 13:14:53, ended at 2010-05-08 14:30:01\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, presumably until 2010-12-26. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-08 14:47:00, ended at 2010-05-08 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypokalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-05-24 00:00:00, ended at 2010-05-24 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of colon\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-24 09:57:00, ended at 2010-05-24 12:19:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-24 12:20:00, ended at 2010-05-24 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.61 (thousand per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.0 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypokalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-02 16:08:57, ended at 2010-06-02 17:06:54\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Insomnia\n- Clostridioides difficile infection\n\n### Drug\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-06-02, presumably until 2010-12-26, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime. \n- vancomycin 125 MG Oral Capsule, through Oral route, started on 2010-06-02, presumably until 2010-10-24, with quantity of 86.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. 1 cap 4 times daily for 14 days  1 cap bid for 7 days  1 cap daily for 7 days  1 cap every other day for 8 days  1cap every three days for 15 days \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-20 10:55:00, ended at 2010-06-20 11:19:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of colon\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-20 11:20:00, ended at 2010-06-20 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Disorder of lung\n- Primary malignant neoplasm of rectum\n- Pulmonary emphysema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-06-21 00:00:00, ended at 2010-06-21 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Clostridioides difficile infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-21 12:18:00, ended at 2010-06-21 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Clostridioides difficile infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-08-30 00:00:00, ended at 2010-08-30 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tobacco dependence syndrome\n\n### Drug\n- nicotine 4 MG Chewing Gum, through Buccal route, started on 2010-08-31, presumably until 2011-03-23, with intended 4 refill(s). Instructions: 4 mg by Buccal route as directed. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-09-04 00:00:00, ended at 2010-09-04 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypoxemia\n- Pulmonary emphysema\n- Acute respiratory failure\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2010-09-04, presumably until 2010-12-26, with quantity of 14.7, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed \n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2010-09-04, presumably until 2010-12-26, with quantity of 4.0, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-10-13 00:00:00, ended at 2010-10-13 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anxiety state\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2010-10-13, presumably until 2010-12-20, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-24 13:50:37, ended at 2010-10-24 15:18:13\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Depressive disorder\n- Chronic respiratory failure\n\n### Drug\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2010-10-24, presumably until 2010-10-27, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-10-27 00:00:00, ended at 2010-10-27 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety state\n- Depressive disorder\n\n### Drug\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2010-10-27, presumably until 2010-11-13, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-13 13:21:16, ended at 2010-11-13 14:27:05\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n- Depressive disorder\n- Hearing loss\n- Low back pain\n\n### Drug\n- 12 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2010-11-13, presumably until 2010-12-12, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- escitalopram 20 MG Oral Tablet, through Oral route, started on 2010-11-13, presumably until 2010-11-13, with quantity of 30.0, with intended 6 refill(s). Instructions: take 20 mg by mouth Every Day. \n- carbamide peroxide 65 MG/ML Otic Solution, through Otic route, started on 2010-11-13, presumably until 2011-03-23, with intended 0 refill(s). Instructions: 1 Drop by Both Ears route 2 times a day. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-11-13, presumably until 2010-12-20, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-12 13:51:11, ended at 2010-12-12 15:29:57\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n- Abnormal breathing\n- Obsessive-compulsive disorder\n- Muscle atrophy\n- Constipation\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- sennosides, USP 1.76 MG/ML Oral Solution, through Oral route, started on 2010-12-12, presumably until 2011-05-08, with intended 0 refill(s). Instructions: take 5 mL by mouth every bedtime. \n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2010-12-12, presumably until 2011-05-08, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- sertraline 50 MG Oral Tablet, through Oral route, started on 2010-12-12, presumably until 2011-01-18, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-12-20 00:00:00, ended at 2010-12-20 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Anxiety state\n- Low back pain\n\n### Drug\n- vitamin E 100 UNT Oral Capsule, through Oral route, started on 2010-12-20, presumably until 2011-12-20, with quantity of 0.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily. \n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2010-12-20, presumably until 2010-12-26, with quantity of 7.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-20, presumably until 2010-12-26, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-01-18 00:00:00, ended at 2011-01-18 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obsessive-compulsive disorder\n- Generalized anxiety disorder\n\n### Drug\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2011-01-18, presumably until 2011-06-01, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-02-27 16:23:00, ended at 2011-03-07 20:45:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 36 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 80 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 16.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCV [Entitic volume] by Automated count: 97.7 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Body height: 5' 8\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Prothrombin time (PT): 13.7 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.9 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n\n### Procedure\n- Gastric intubation and aspiration(s) therapeutic, necessitating physician's skill (eg, for gastrointestinal hemorrhage), including lavage if performed\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Computed tomography, pelvis; with contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Computed tomography, abdomen; with contrast material(s)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Chronic cor pulmonale\n- Chronic obstructive lung disease\n- Chronic respiratory failure\n- Depressive disorder\n- Dependence on respiratory device\n- Infective pneumonia\n- Colostomy present\n- Intestinal obstruction\n- Pleural effusion\n- Left lower quadrant pain\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2011-02-28, presumably until 2011-03-07\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2011-03-06, presumably until 2011-03-23, with quantity of 1.0, with intended 1 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. \n- menthol, through Submucosal route, started on 2011-03-05, presumably until 2011-03-06\n- benzocaine, through Submucosal route, started on 2011-03-05, presumably until 2011-03-06\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2011-02-28, presumably until 2011-03-02\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-03-02, presumably until 2011-03-07\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-03-01, presumably until 2011-03-01\n- moxifloxacin 400 MG Oral Tablet, through Oral route, started on 2011-03-07, presumably until 2011-03-23, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-02-28, presumably until 2011-03-06\n- cetylpyridinium, through Submucosal route, started on 2011-03-05, presumably until 2011-03-06\n- 24 HR nicotine 0.292 MG/HR Transdermal System, through Transdermal route, started on 2011-03-03, presumably until 2011-03-07\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2011-02-28, presumably until 2011-03-07. Instructions: 30 mcg by Inhalation route daily. \n- 10 ML furosemide 10 MG/ML Injection, started on 2011-03-04, presumably until 2011-03-04\n- soybean oil 200 MG/ML Injectable Suspension, through Intravenous route, started on 2011-03-01, presumably until 2011-03-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-03-01, presumably until 2011-03-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-02-27, presumably until 2011-02-27\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-03-05, presumably until 2011-03-07\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-02-28, presumably until 2011-03-03\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2011-02-27, presumably until 2011-03-06\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2011-02-28, presumably until 2011-02-28\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2011-03-02, presumably until 2011-03-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-03-09 00:00:00, ended at 2011-03-09 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-03-09, presumably until 2011-04-05, with quantity of 90.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-04-20 13:30:47, ended at 2011-04-20 14:28:25\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute exacerbation of chronic obstructive bronchitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-04-25 00:00:00, ended at 2011-04-25 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-27 13:36:00, ended at 2011-04-27 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.15 (millimole per liter)\n\n### Procedure\n- Arterial puncture, withdrawal of blood for diagnosis\n- Plethysmography, total body; interpretation and report only\n- Determination of resistance to airflow, oscillatory or plethysmographic methods\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Carbon monoxide diffusing capacity (eg, single breath, steady state)\n- Thoracic gas volume\n\n### Condition\n- Chronic obstructive lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-05-02 00:00:00, ended at 2011-05-02 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety state\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-05-02, presumably until 2011-06-01, with quantity of 30.0, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-08 09:01:32, ended at 2011-05-08 11:28:29\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n- Primary diagnosis: Pulmonary emphysema\n- Hypoxemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-01 14:21:22, ended at 2011-06-01 16:39:54\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Insomnia\n- Generalized anxiety disorder\n- Primary diagnosis: Hypoxemia\n- Obsessive-compulsive disorder\n- Anxiety state\n\n### Drug\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2011-06-01, presumably until 2011-07-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2011-06-01, presumably until 2012-05-31, with intended 3 refill(s). Instructions: take 3 Tabs by mouth every bedtime.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-01, presumably until 2011-07-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2011-06-01, presumably until 2011-06-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-03 13:25:41, ended at 2011-07-03 16:10:38\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Anxiety state\n- Pulmonary emphysema\n- Hypoxemia\n- Primary diagnosis: Obsessive-compulsive disorder\n- Chronic respiratory failure\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2011-07-03, presumably until 2011-09-21, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. Give 90 day supply\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2011-07-03, presumably until 2012-07-02, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-07-03, presumably until 2011-12-30, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-07-03, presumably until 2011-07-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2011-07-03, presumably until 2011-07-04, with intended 3 refill(s). Instructions: 1.[000000] Caps by Inhalation route daily.\n- levalbuterol 0.103 MG/ML Inhalation Solution, through Inhalation, started on 2011-07-03, presumably until 2011-07-04, with intended 3 refill(s). Instructions: 0.63 mg by Nebulization route 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-07-04 00:00:00, ended at 2011-07-04 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Primary diagnosis: Pulmonary emphysema\n- Hypoxemia\n\n### Drug\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2011-07-04, presumably until 2011-09-21, with intended 3 refill(s). Instructions: 1 Cap by Inhalation route daily.\n- levalbuterol 0.103 MG/ML Inhalation Solution, through Inhalation, started on 2011-07-04, presumably until 2011-09-21, with intended 3 refill(s). Instructions: 0.63 mg by Nebulization route 4 times a day as needed for Bronchospasm/Wheezing.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-07-23 00:00:00, ended at 2011-07-23 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anxiety state\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-07-23, presumably until 2011-09-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-09-19 00:00:00, ended at 2011-09-19 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-09-19, presumably until 2012-03-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-21 15:28:04, ended at 2011-09-21 16:38:45\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Backache\n- Pulmonary emphysema\n- Chronic respiratory failure\n- Hypoxemia\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2011-09-21, presumably until 2012-06-13, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. Give 90 day supply\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2011-09-21, presumably until 2012-06-17, with intended 3 refill(s). Instructions: take 2 Caps by mouth 2 times a day.\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-09-21, presumably until 2012-03-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed. Must establish with new PCP as scheduled on 9/23 at 1:30 pm in order to get refill.\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2011-09-21, presumably until 2012-06-13, with intended 3 refill(s). Instructions: 1 Cap by Inhalation route daily.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2011-09-21, presumably until 2012-06-17, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime. If patient cannot get this med as prescription due to insurance issues, please direct patient to OTC med.\n- levalbuterol 0.103 MG/ML Inhalation Solution, through Inhalation, started on 2011-09-21, presumably until 2012-06-17, with intended 3 refill(s). Instructions: 0.63 mg by Nebulization route 4 times a day as needed for Bronchospasm/Wheezing.\n- lidocaine hydrochloride 0.05 MG/MG Topical Ointment, through Topical route, started on 2011-09-21, presumably until 2012-06-17, with intended 0 refill(s). Instructions: by Topical route as needed. Apply to affected area as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-19 13:24:59, ended at 2011-10-19 14:34:43\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n- Chronic respiratory failure\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-10-19, presumably until 2012-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-19 14:47:00, ended at 2011-10-19 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Chronic obstructive lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-30 00:00:00, ended at 2012-01-30 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2012-01-30, presumably until 2012-06-13, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-03-10 00:00:00, ended at 2012-03-10 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n- Generalized abdominal pain\n- Obsessive-compulsive disorder\n- Anxiety state\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2012-03-10, presumably until 2012-07-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed.\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-03-10, presumably until 2012-07-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-03-26 00:00:00, ended at 2012-03-26 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute respiratory failure\n- Pulmonary emphysema\n- Hypoxemia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, started on 2012-03-26, presumably until 2012-04-25, with intended 0 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-04-22 00:00:00, ended at 2012-04-22 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, started on 2012-04-22, presumably until 2012-06-13, with intended 0 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-13 00:00:00, ended at 2012-06-13 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic respiratory failure\n- Hypoxemia\n- Acute respiratory failure\n- Primary diagnosis: Pulmonary emphysema\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Oral route, started on 2012-06-13, presumably until 2012-06-17, with intended 12 refill(s). Instructions: take 2 Puffs by mouth as needed.\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2012-06-13, presumably until 2012-06-17, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. Give 90 day supply\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2012-06-13, presumably until 2012-10-16, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed.\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2012-06-13, presumably until 2012-06-17, with intended 6 refill(s). Instructions: 1 Cap by Inhalation route daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-17 11:14:41, ended at 2012-06-17 13:02:36\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic respiratory failure\n- Pulmonary emphysema\n- Hypoxemia\n- Acute respiratory failure\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Oral route, started on 2012-06-17, presumably until 2012-10-16, with intended 12 refill(s). Instructions: take 2 Puffs by mouth as needed.\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2012-06-17, presumably until 2012-10-16, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. Give 90 day supply\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2012-06-17, presumably until 2012-10-16, with intended 6 refill(s). Instructions: 1 Cap by Inhalation route daily.\n- levalbuterol 0.103 MG/ML Inhalation Solution, through Inhalation, started on 2012-06-17, presumably until 2012-10-16, with intended 3 refill(s). Instructions: 0.63 mg by Nebulization route 4 times a day as needed for Bronchospasm/Wheezing.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-23 00:00:00, ended at 2012-07-23 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic obstructive lung disease\n- Anxiety state\n- Generalized abdominal pain\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2012-07-23, presumably until 2012-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed.\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-07-23, presumably until 2012-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-29 14:16:24, ended at 2012-07-29 15:54:44\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Intestinal obstruction\n- Hypoxemia\n- Chronic respiratory failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-22 00:00:00, ended at 2012-08-22 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic obstructive lung disease\n- Anxiety state\n- Generalized abdominal pain\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2012-08-22, presumably until 2012-10-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed.\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-08-22, presumably until 2012-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-08-26 00:00:00, ended at 2012-08-26 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Convalescence after radiotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-27 10:00:00, ended at 2012-08-27 13:39:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Convalescence after radiotherapy\n- Primary malignant neoplasm of rectum\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-27 13:40:00, ended at 2012-08-27 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-09-30 00:00:00, ended at 2012-09-30 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-09-30, presumably until 2012-10-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-10-03 00:00:00, ended at 2012-10-03 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic obstructive lung disease\n- Generalized abdominal pain\n- Anxiety state\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2012-10-03, presumably until 2013-01-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-16 08:24:56, ended at 2012-10-16 09:41:06\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary emphysema\n- Hypoxemia\n- Chronic respiratory failure\n- Acute respiratory failure\n- Solitary nodule of lung\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2012-10-16, presumably until 2013-10-16, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. Give 90 day supply\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2012-10-16, presumably until 2013-04-27, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 4 times a day as needed.\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2012-10-16, presumably until 2013-04-27, with intended 3 refill(s). Instructions: 1 Cap by Inhalation route daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-31 13:28:05, ended at 2012-10-31 14:26:49\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Counseling\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Primary diagnosis: Chronic obstructive lung disease\n- Backache\n- Joint pain of pelvic region\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-10-31, presumably until 2013-01-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-31 14:49:00, ended at 2012-10-31 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; 1 view\n- Radiologic examination, spine, lumbosacral; 2 or 3 views\n\n### Condition\n- Low back pain\n- Joint pain of pelvic region\n- Scoliosis deformity of spine\n- Enthesopathy of hip region\n- Acquired spondylolisthesis\n- Degeneration of intervertebral disc\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-22 00:00:00, ended at 2013-01-22 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized abdominal pain\n- Anxiety state\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2013-01-22, presumably until 2013-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-28 00:00:00, ended at 2013-01-28 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-03-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-13 13:43:24, ended at 2013-02-13 14:35:18\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic respiratory failure\n- Osteoarthritis\n- Primary diagnosis: Dental caries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-19 11:46:51, ended at 2013-02-19 13:05:30\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute exacerbation of chronic obstructive bronchitis\n- Primary diagnosis: Pulmonary emphysema\n- Hypoxemia\n\n### Drug\n- methylprednisolone 4 MG Oral Tablet, started on 2013-02-19, presumably until 2013-05-29, with intended 0 refill(s). Instructions: Take by mouth.   Day 1: Take 2 tablet before breakfast, 1 after lunch, 1 after dinner and 2 at bedtime.  Day 2: Take 1 tablet before breakfast, 1 after lunch, 1 after dinner and 2 at bedtime.  Day 3: Take 1 tablet before breakfast, 1 after lunch, 1 after dinner and 1 at bedtime.  Day 4: Take 1 tablet before breakfast, 1 after lunch and 1 at bedtime.  Day 5: Take 1 tablet before breakfast and 1 at bedtime.  Day 6: Take 1 tablet before breakfast.\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2013-02-19, presumably until 2013-06-25, with intended 0 refill(s). Instructions: take 250 mg by mouth as directed. 2 tabs on day 1, then 1 tab daily thereafter\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-24 13:21:16, ended at 2013-02-24 15:25:16\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Periapical abscess with sinus tract\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of intestinal_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "8af5cb0d3f3d1e9a558f5c10e9776265c80805f3bb562edd0b8463ffb7462cc4", "prompt_hash": "77f81af252bc56e87938a459224ad71f25d42f3f90fae66ec6645e2d70e697f4", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 8, "doc": {"person_id": 115967555, "visit_occurrence_id": 127249141, "death_date": "2020-07-28", "visit_concept_name": "Office Visit", "visit_start_datetime": "2018-11-24 09:52:33", "visit_end_datetime": "2018-11-24 17:25:05", "visit_length_in_hours": 7.542222222222223, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2018-11-24 09:52:33, ended at 2018-11-24 17:25:05\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 95, "patient_first_visit_date": "2015-12-07 00:00:00", "patient_last_visit_date": "2020-07-11 16:47:00", "end_obs_date": "2019-11-24", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "recurrent", "lung_cancer_one_year_diagnosis": 1, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 181, "cumulated_visit_num": 181, "cumulated_approximate_token_count": 48441, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-07 00:00:00, ended at 2015-12-07 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-07 13:03:42, ended at 2015-12-07 15:13:14\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.386\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2018-12-22, with intended 0 refill(s). Instructions: take 500 mg by mouth every 6 hours as needed\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2015-12-05, presumably until 2016-04-30, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-23 14:16:00, ended at 2016-01-23 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Hydronephrosis\n- Lipoma of skin and subcutaneous tissue of trunk\n- Abnormal findings on diagnostic imaging of lung\n- Anorectal disorder\n- Idiopathic aseptic necrosis of bone\n- Disorder of bone\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-25 12:24:10, ended at 2016-01-25 15:13:07\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.976\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Neoplastic disease\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-12-22, presumably until 2016-02-15, with intended 0 refill(s). Instructions: take by mouth\n- hydrocortisone 25 MG/ML Topical Cream, started on 2015-05-18, presumably until 2016-08-17, with intended 0 refill(s). Instructions: Apply 2 times a day to affected area(s)\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-12-22, presumably until 2016-02-15, with intended 0 refill(s). Instructions: take by mouth\n- lorazepam 1 MG Oral Tablet, through Sublingual route, started on 2015-12-22, presumably until 2016-02-15, with intended 0 refill(s). Instructions: place under the tongue and let dissolve\n- triamcinolone acetonide 1 MG/ML Topical Cream, through Topical route, started on 2015-10-21, presumably until 2016-02-15, with intended 0 refill(s). Instructions: by Topical route\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-31 09:40:32, ended at 2016-01-31 11:05:33\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-09 00:00:00, ended at 2016-02-09 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-02-17 00:00:00, ended at 2016-02-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bacitracin 5000 UNT/ML Injectable Solution, through Intramuscular route, started on 2016-02-17, presumably until 2016-02-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-02-17 00:00:00, ended at 2016-02-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in lower abdomen including laparoscopy; not otherwise specified\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2016-02-17, presumably until 2016-02-17\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-02-17, presumably until 2016-02-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2016-02-17, presumably until 2016-02-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-02-17 05:25:00, ended at 2016-02-25 11:16:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.0 (millimeter mercury column)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.07 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 231.0 (millimeter mercury column)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.66 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 95 (percent)\n- Base excess in Blood by calculation: -1 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lidocaine [Mass/volume] in Serum or Plasma: 2.4 (microgram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Blood: 130 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.7 (percent)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.2 (millimole per liter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide [Partial pressure] in Arterial blood: 36.7 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- Lactate [Moles/volume] in Blood: 1.0 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 395 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 76 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Base excess in Arterial blood by calculation: -3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n\n### Procedure\n- Excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor greater than 10.0 cm diameter\n- Excision of Abdominal Aorta, Open Approach\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Extirpation of Matter from Left Ureter, Open Approach\n- Radiologic examination, chest; single view, frontal\n- Excision of Retroperitoneum, Open Approach\n- Resection of Spleen, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Repair blood vessel, direct; intra-abdominal\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Collection of venous blood by venipuncture\n- Resection of Left Kidney, Open Approach\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Resection of Left Large Intestine, Open Approach\n- Excision of Duodenum, Open Approach\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Physical therapy evaluation\n- Excision of Pancreas, Open Approach\n- Resection of Left Adrenal Gland, Open Approach\n- Daily hospital management of epidural or subarachnoid continuous drug administration\n- Occupational therapy evaluation\n\n### Condition\n- Electrocardiogram abnormal\n- Pleural effusion\n- Pneumothorax\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Primary malignant neoplasm of trunk\n- Malignant neoplasm of connective and soft tissue of thorax\n- Primary malignant neoplasm of retroperitoneum\n- Secondary malignant neoplastic disease\n- Anemia due to and following chemotherapy\n- Nephrosclerosis\n- Overlapping malignant neoplasm of retroperitoneum and peritoneum\n- Secondary malignant neoplasm of lung\n- Secondary malignant neoplasm of small intestine\n- Essential hypertension\n- Benign prostatic hyperplasia\n- Orthostatic hypotension\n- Persistent pain following procedure\n- Malignant neoplasm of connective and soft tissue of abdomen\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-22\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-02-19, presumably until 2016-02-19\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-02-25, presumably until 2016-04-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day before meals\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2016-02-18, presumably until 2016-02-24\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2016-02-23, presumably until 2016-02-23\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-02-18, presumably until 2016-02-18\n- 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection, through Intramuscular route, started on 2016-02-23, presumably until 2016-02-23\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2016-02-18, presumably until 2016-02-19\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2016-02-17, presumably until 2016-02-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-19\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2016-02-25, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1 Packet by mouth One Time\n- 0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogr..., through Intramuscular route, started on 2016-02-23, presumably until 2016-02-23\n- 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria m..., through Intramuscular route, started on 2016-02-23, presumably until 2016-02-23\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-02-21, presumably until 2017-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2016-02-21, presumably until 2016-02-24\n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2016-02-18, presumably until 2016-02-19\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-02-21, presumably until 2016-03-29, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2016-03-02 12:33:00, ended at 2016-03-29 12:39:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bicarbonate [Moles/volume] in Specimen: 31.6 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 30.9 (millimeter mercury column)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 6583 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- Left ventricular Ejection fraction: 40.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 43.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Base excess in Arterial blood by calculation: 6.4 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 1.4 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 445 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 5' 7.992\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.43 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 72.4 (millimeter mercury column)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Oxygen [Partial pressure] in Arterial blood: 81.1 (millimeter mercury column)\n- Thrombin time: 15.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.50 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 595 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.2 (gram per deciliter)\n- Lactate [Moles/volume] in Blood: 3.7 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.51 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 33.95 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 96.3 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Platelets [#/volume] in Blood by Automated count: 901 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 8.5 (microgram per milliliter)\n- Base excess in Blood by calculation: 8 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.34 (millimole per liter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: >3000 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Prothrombin time (PT): 21.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.5 (second)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 35 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.42 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 63 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n\n### Procedure\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Physical therapy evaluation\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Insertion of intravascular vena cava filter, endovascular approach including vascular access, vessel selection, and radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance (ultrasound and fluoroscopy), when performed\n- Intubation, endotracheal, emergency procedure\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Respiratory Ventilation, Greater than 96 Consecutive Hours\n- Arterial puncture, withdrawal of blood for diagnosis\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Fluoroscopy of Inferior Vena Cava using Low Osmolar Contrast\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Drainage of Left Trunk Muscle, Percutaneous Approach\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Controlled ventilation procedure and therapy, initiation and management\n- Computed tomography, abdomen and pelvis; without contrast material\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Flexible endoscopic evaluation of swallowing by cine or video recording\n- Monitoring of Central Nervous Electrical Activity, External Approach\n- Radiologic examination, abdomen; single anteroposterior view\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Insertion of Intraluminal Device into Inferior Vena Cava, Percutaneous Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Evaluation of oral and pharyngeal swallowing function\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Image-guided fluid collection drainage by catheter (eg, abscess, hematoma, seroma, lymphocele, cyst); peritoneal or retroperitoneal, percutaneous\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, gastrointestinal tract, upper; with or without delayed images, with KUB\n- Inspection of Larynx, Via Natural or Artificial Opening Endoscopic\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Insertion of Endotracheal Airway into Trachea, Via Natural or Artificial Opening\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Esophagogastroduodenoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n- Occupational therapy evaluation\n- Respiratory Ventilation, 24-96 Consecutive Hours\n- Radiologic examination, chest; single view, frontal\n- Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours\n- Computed tomography, thorax, diagnostic; without contrast material\n- Insertion of Feeding Device into Stomach, Via Natural or Artificial Opening Endoscopic\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Altered mental status\n- Gastrointestinal hemorrhage\n- Intestinal obstruction co-occurrent and due to decreased peristalsis\n- Postoperative intestinal obstruction\n- Postoperative state\n- Tachycardia\n- Ventilator associated pneumonia\n- Abnormal findings on diagnostic imaging of lung\n- Acute deep venous thrombosis of femoral vein\n- Primary diagnosis: Acute hypoxemic respiratory failure\n- Benign prostatic hyperplasia\n- Disorder of digestive system\n- Dysphonia\n- Dyspnea\n- Edema, generalized\n- Mild protein-calorie malnutrition (weight for age 75-89 percent of standard)\n- Pneumonia\n- Primary malignant neoplasm of retroperitoneum\n- Tachypnea\n- Abdominal distension, gaseous\n- Complication of surgical procedure\n- Electroencephalogram abnormal\n- Localized edema\n- Low blood pressure\n- Pulmonary embolism\n- Septic shock\n- Chronic pulmonary edema\n- Embolism from thrombosis of vein of lower extremity\n- Hematemesis\n- Hereditary thrombophilia\n- Impaction of intestine\n- Acute respiratory distress syndrome\n- Electrocardiogram abnormal\n- Essential hypertension\n- Acute hemorrhagic gastritis\n- Acute posthemorrhagic anemia\n- Adrenocortical hypofunction following procedure\n- Alkalosis\n- Diarrhea\n- Erythema of skin\n- Neoplastic disease\n- Vomiting\n- Abscess of peritoneum\n- Absent kidney\n- Acute vascular insufficiency of intestine\n- Ascites\n- Chest pain\n- Conduction disorder of the heart\n- Disorder of intestine\n- Pleural effusion\n- Secondary hypertension\n- Sepsis due to anaerobic bacteria\n- Acquired absence of organ\n- Disorder of bilirubin metabolism\n- Gastric hemorrhage\n- Hypoxemia\n- Infection due to enterococcus\n- Intestinal obstruction\n- Intra-abdominal and pelvic swelling, mass and lump\n- Long QT syndrome\n- Nausea and vomiting\n- Pneumonitis due to inhaled substance\n- Right bundle branch block\n- Ventricular premature complex\n- Acquired absence of spleen\n- Cardiomegaly\n- Iliopsoas abscess\n- Pneumonia due to Klebsiella pneumoniae\n- Somatoform disorder\n\n### Drug\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-03-02, presumably until 2016-03-02\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2016-03-03, presumably until 2016-03-18\n- haloperidol 5 MG/ML Injectable Solution, started on 2016-03-09, presumably until 2016-03-09\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-05, presumably until 2016-03-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-03-27, presumably until 2017-03-29, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day before meals\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2016-03-04, presumably until 2016-03-04\n- 100 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2016-03-15, presumably until 2016-03-17\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2016-03-03, presumably until 2016-03-27\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2016-03-08, presumably until 2016-03-08\n- 500 ML tromethamine 36 MG/ML Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-03\n- diatrizoate, through Oral route, started on 2016-03-02, presumably until 2016-03-02\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-03-04, presumably until 2016-03-04\n- vecuronium bromide 1 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-02, presumably until 2016-03-02\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2016-03-10, presumably until 2016-03-17\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-17\n- quetiapine 25 MG Oral Tablet, through Oral route, started on 2016-03-08, presumably until 2016-03-16\n- calcium chloride 0.001 MEQ/ML / glucose 50 MG/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-03-03, presumably until 2016-03-04\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2017-03-29, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-03-02, presumably until 2016-03-03\n- acetazolamide 500 MG Injection, started on 2016-03-08, presumably until 2016-03-08\n- 10 ML furosemide 10 MG/ML Injection, started on 2016-03-06, presumably until 2016-03-14\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2016-03-15, presumably until 2016-07-04, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day Hold for heart rate under 60, systolic blood pressure under 90.\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-07, presumably until 2016-03-09\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-02, presumably until 2016-03-02\n- diatrizoic acid, through Oral route, started on 2016-03-02, presumably until 2016-03-02\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2016-03-03, presumably until 2016-03-26\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2016-03-02, presumably until 2016-03-29\n- soybean oil 200 MG/ML Injectable Suspension, through Intravenous route, started on 2016-03-04, presumably until 2016-03-25\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2016-03-07, presumably until 2016-03-12\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-03-28, presumably until 2016-10-23, with intended 6 refill(s). Instructions: inject 0.8 mL subcutaneous (under the skin) Every Day\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-16, presumably until 2016-03-16\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-09\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-03-02, presumably until 2016-03-02\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2016-03-06, presumably until 2016-03-06\n- acetylcysteine 200 MG/ML Inhalation Solution, started on 2016-03-15, presumably until 2016-03-18\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-03-02, presumably until 2016-03-02\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2016-03-15, presumably until 2016-12-21, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2016-03-02, presumably until 2016-03-16\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2016-03-08, presumably until 2016-03-15\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-16\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-02\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-03-26, presumably until 2016-03-28, with intended 12 refill(s). Instructions: inject 0.8 mL subcutaneous (under the skin) Every Day\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2016-03-29, presumably until 2016-05-02, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2016-03-02, presumably until 2016-03-02\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2016-03-14, presumably until 2016-03-29\n- midazolam 1 MG/ML Injectable Solution, started on 2016-03-02, presumably until 2016-03-03\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2016-03-04, presumably until 2016-03-17\n- psyllium 6000 MG Powder for Oral Suspension, through Oral route, started on 2016-03-28, presumably until 2018-05-16, with intended 3 refill(s). Instructions: take 1 Packet by mouth daily as needed (for loose stools)\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2016-03-03, presumably until 2016-03-03\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-03-06, presumably until 2016-03-15\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2016-03-07, presumably until 2016-03-09\n- hydrocortisone 100 MG Injection, started on 2016-03-03, presumably until 2016-03-04\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2016-03-03, presumably until 2016-03-03\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2016-03-06, presumably until 2016-03-13\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-03-03, presumably until 2016-03-03\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-16\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-16\n- 100 ML levetiracetam 10 MG/ML Injection, through Intravenous route, started on 2016-03-05, presumably until 2016-03-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-05 09:00:00, ended at 2016-03-05 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 90 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 46.0 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 43.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Blood: 171 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-11, presumably until 2016-03-11\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2016-03-11, presumably until 2016-03-11\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2016-03-11, presumably until 2016-03-11\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2016-03-11, presumably until 2016-03-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-19 00:00:00, ended at 2016-03-19 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Embolism from thrombosis of vein of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-04 10:37:19, ended at 2016-04-04 12:46:55\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.882\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-19 12:37:00, ended at 2016-04-19 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Embolism from thrombosis of vein of lower extremity\n- Phlebitis of tibial vein\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-19 12:38:26, ended at 2016-04-19 14:32:22\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Embolism from thrombosis of vein of lower extremity\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- rivaroxaban, started on 2016-04-19, presumably until 2016-10-23, with intended 0 refill(s). Instructions: Take 1 round (15 mg) tab twice daily with food for 21 days then 1 triangle tab (20 mg) daily with food\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2016-04-19, presumably until 2016-09-18, with intended 2 refill(s). Instructions: take 20 mg by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-25 10:09:10, ended at 2016-04-25 11:03:11\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-30 12:56:28, ended at 2016-04-30 15:12:34\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 7 (milligram per liter)\n- Body height: 5' 8.701\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 83.10 (milligram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Type 2 diabetes mellitus without complication\n- Pulmonary embolism\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-02 08:03:00, ended at 2016-05-02 11:56:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 45 (percent)\n- Potassium [Moles/volume] in Blood: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.3 (gram per deciliter)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Retrieval (removal) of intravascular vena cava filter, endovascular approach including vascular access, vessel selection, and radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance (ultrasound and fluoroscopy), when\n- Fluoroscopy of Inferior Vena Cava using Low Osmolar Contrast\n- Removal of Intraluminal Device from Lower Vein, Percutaneous Approach\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Essential hypertension\n- Pulmonary embolism\n- Blood glucose abnormal\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-02, presumably until 2016-05-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-14 00:00:00, ended at 2016-05-14 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-14 09:39:02, ended at 2016-05-14 10:47:05\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-29 08:46:22, ended at 2016-05-29 09:40:24\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.27 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 87 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-01 13:02:00, ended at 2016-06-01 13:02:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Computed tomography, thorax, diagnostic; without contrast material\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Solitary nodule of lung\n- Primary malignant neoplasm of retroperitoneum\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-01 13:03:00, ended at 2016-06-01 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pneumonia\n- Postoperative state\n- Primary malignant neoplasm of retroperitoneum\n- Abnormal findings on diagnostic imaging of lung\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-08 00:00:00, ended at 2016-06-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary embolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-04 00:00:00, ended at 2016-07-04 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2016-07-04, presumably until 2016-10-23, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day Hold for heart rate under 60, systolic blood pressure under 90.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-04 00:00:00, ended at 2016-09-04 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute deep venous thrombosis of femoral vein\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-06 13:53:27, ended at 2016-09-06 15:42:55\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.307\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Retroperitoneum\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-11 13:45:00, ended at 2016-09-11 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Pulmonary embolism\n- Phlebitis of the femoral vein\n- Acute deep venous thrombosis of femoral vein\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-11 13:49:40, ended at 2016-09-11 15:02:45\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary embolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-18 00:00:00, ended at 2016-09-18 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Exudative age-related macular degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-25 14:05:05, ended at 2016-09-25 15:36:37\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n- Intraocular pressure of left eye: 17 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Primary diagnosis: Degenerative disorder of macula\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-26 10:51:00, ended at 2016-09-26 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Postoperative state\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-05 13:59:00, ended at 2016-10-05 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Pneumonia\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-10 00:00:00, ended at 2016-10-10 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-15 00:00:00, ended at 2016-10-15 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-23 15:01:49, ended at 2016-10-23 15:46:07\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 1\n- Essential hypertension\n- Hearing loss\n- Primary diagnosis: Inguinal hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-26 15:26:01, ended at 2016-10-26 16:46:15\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2016-12-06, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-07 14:42:49, ended at 2016-11-07 15:36:11\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.46 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 09:20:49, ended at 2016-12-03 11:17:22\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n- Tympanometry and reflex threshold measurements\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 09:23:11, ended at 2016-12-03 11:19:54\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-04 14:24:20, ended at 2016-12-04 16:11:19\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 277 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.06 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.58 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.4 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.1 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Inguinal hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-06 00:00:00, ended at 2016-12-06 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Chronic kidney disease stage 1\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-21 09:02:20, ended at 2016-12-21 15:52:21\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.33 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 131.00 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.8 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 17 (milligram per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Blood chemistry abnormal\n- Kidney stone\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-24 13:57:00, ended at 2016-12-24 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Postoperative state\n- Abnormal findings on diagnostic imaging of lung\n- Fibrosis of lung\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-26 14:29:10, ended at 2016-12-26 15:55:45\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Primary diagnosis: Degenerative disorder of macula\n- Nonexudative age-related macular degeneration\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-27 00:00:00, ended at 2016-12-27 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-31 00:00:00, ended at 2016-12-31 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in lower abdomen; not otherwise specified\n\n### Condition\n- Inguinal hernia\n\n### Drug\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2016-12-31, presumably until 2016-12-31\n- cefazolin 1000 MG Injection, started on 2016-12-31, presumably until 2016-12-31\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2016-12-31, presumably until 2016-12-31\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-31, presumably until 2016-12-31\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-12-31, presumably until 2016-12-31\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-12-31, presumably until 2016-12-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-31 13:34:00, ended at 2017-01-01 11:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Supplement Left Inguinal Region with Synthetic Substitute, Open Approach\n\n### Condition\n- Retention of urine\n- Absent kidney\n- Inguinal hernia\n- Abnormal findings on diagnostic imaging of lung\n- Acquired absence of organ\n- Anemia due to and following chemotherapy\n- Primary malignant neoplasm of retroperitoneum\n- Acquired absence of spleen\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-12-31, presumably until 2016-12-31\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-01-01, presumably until 2017-01-01\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-12-31, presumably until 2017-01-01\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2016-12-31, presumably until 2016-12-31\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2016-12-31, presumably until 2016-12-31\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-01-01, presumably until 2017-01-01\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2017-01-01, presumably until 2017-01-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-03 12:05:45, ended at 2017-01-03 13:06:18\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-07 00:00:00, ended at 2017-01-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-10 11:42:00, ended at 2017-01-10 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; complete study\n\n### Condition\n- Kidney stone\n- Blood chemistry abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-17 00:00:00, ended at 2017-01-17 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-21 00:00:00, ended at 2017-01-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone 25 MG/ML Topical Cream, started on 2017-01-21, presumably until 2019-11-23, with intended 5 refill(s). Instructions: Apply as needed to affected areas.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-08 11:58:00, ended at 2017-02-08 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of peritoneum\n- Postoperative state\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-26 11:31:00, ended at 2017-03-26 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-03 00:00:00, ended at 2017-04-03 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-04 00:00:00, ended at 2017-04-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-04 00:00:00, ended at 2017-04-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-04 14:12:34, ended at 2017-04-04 15:34:18\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, presumably until 2017-04-05, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-05 00:00:00, ended at 2017-04-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-04-08, presumably until 2018-04-08, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-10 14:49:11, ended at 2017-04-10 16:49:04\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.898\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2017-09-19, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-16 10:13:00, ended at 2017-04-16 10:47:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Respiratory flow volume loop\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-16 10:48:00, ended at 2017-04-16 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 56.2 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Rheumatic tricuspid valve regurgitation\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-01 10:50:35, ended at 2017-05-01 13:33:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Electrocardiogram abnormal\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Right bundle branch block\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-01 13:32:46, ended at 2017-05-01 14:09:48\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.51 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Body height: 5' 9\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.86 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.8 (percent)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Prothrombin time (PT): 12.9 (second)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-01 14:14:00, ended at 2017-05-01 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-02 00:00:00, ended at 2017-05-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-05-02 00:00:00, ended at 2017-05-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for thoracotomy procedures involving lungs, pleura, diaphragm, and mediastinum (including surgical thoracoscopy); not otherwise specified\n\n### Condition\n- Primary malignant neoplasm\n- Secondary malignant neoplasm of right lung\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-05-02, presumably until 2017-05-02\n- cefazolin 1000 MG Injection, started on 2017-05-02, presumably until 2017-05-02\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-05-02, presumably until 2017-05-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- midazolam 1 MG/ML Injectable Solution, started on 2017-05-02, presumably until 2017-05-02\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2017-05-02, presumably until 2017-05-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-05-02 00:00:00, ended at 2017-05-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 30 ML ropivacaine hydrochloride 5 MG/ML Injection, started on 2017-05-02, presumably until 2017-05-02\n- midazolam 1 MG/ML Injectable Solution, started on 2017-05-02, presumably until 2017-05-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-05-02 05:26:00, ended at 2017-05-05 15:35:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 13.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Body height: 5' 9\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Prothrombin time (PT): 13.2 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 244 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n\n### Procedure\n- Excision of Right Upper Lobe Bronchus, Percutaneous Endoscopic Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Excision of Right Middle Lobe Bronchus, Percutaneous Endoscopic Approach\n- Inspection of Tracheobronchial Tree, Via Natural or Artificial Opening Endoscopic\n- Thoracoscopy, surgical; with lobectomy (single lobe)\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Extirpation of Matter from Right Diaphragm, Percutaneous Endoscopic Approach (Deprecated)\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Excision of Thorax Lymphatic, Percutaneous Endoscopic Approach, Diagnostic\n- Radiologic examination, chest; single view, frontal\n- Collection of venous blood by venipuncture\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Resection of Right Lower Lung Lobe, Percutaneous Endoscopic Approach\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; diagnostic, with cell washing, when performed (separate procedure)\n- Thoracoscopy, surgical; with therapeutic wedge resection (eg, mass, nodule), initial unilateral\n\n### Condition\n- Postoperative state\n- Chronic kidney disease due to hypertension\n- Pneumothorax\n- Primary malignant neoplasm\n- Pneumothorax due to and following procedure\n- Prediabetes\n- Primary malignant neoplasm of retroperitoneum\n- Abnormal findings on diagnostic imaging of lung\n- Exudative age-related macular degeneration\n- Secondary malignant neoplasm of right lung\n- Persistent pain following procedure\n- Chronic kidney disease stage 1\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-05-02, presumably until 2017-05-04\n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2017-05-02, presumably until 2017-05-05\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-05-05, presumably until 2017-05-05\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-05-02, presumably until 2017-05-05\n- melatonin 1 MG Oral Tablet, through Oral route, started on 2017-05-02, presumably until 2017-05-04\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-05-02, presumably until 2017-05-15, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2017-05-02, presumably until 2017-05-03\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-05-04, presumably until 2017-05-04\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-05-04, presumably until 2017-05-05\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-05-02, presumably until 2017-05-05\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-05-02, presumably until 2017-05-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-05-05, presumably until 2017-05-05\n- magnesium chloride 598 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-04, presumably until 2017-05-05\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-05-05, presumably until 2017-05-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-03, presumably until 2017-05-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-15 13:55:00, ended at 2017-05-15 17:05:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pneumothorax\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-05-15 17:06:00, ended at 2017-05-18 17:50:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Body height: 5' 9\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.16 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.31 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.35 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.5 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 452 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Drainage of Right Pleural Cavity with Drainage Device, Percutaneous Approach\n- Collection of venous blood by venipuncture\n- Collection of capillary blood specimen (eg, finger, heel, ear stick)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Pleural effusion\n- Acquired absence of organ\n- Leukocytosis\n- Pleurisy\n- Atherosclerosis of aorta\n- Benign prostatic hyperplasia\n- Insomnia\n- Prediabetes\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Complication of surgical procedure\n- Pneumothorax\n- Disorder of digestive system\n- Essential hypertension\n- Pneumothorax due to and following procedure\n- Absence of lung\n\n### Drug\n- melatonin 1 MG Oral Tablet, through Oral route, started on 2017-05-15, presumably until 2017-05-17\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-05-15, presumably until 2017-05-17\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-05-17, presumably until 2018-05-17, with intended 0 refill(s). Instructions: take 2 Caps by mouth daily Over the counter medication.\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2017-05-17, presumably until 2017-05-18\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-05-15, presumably until 2017-05-17\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-05-15, presumably until 2017-05-18\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-05-16, presumably until 2017-05-18\n- magnesium chloride 598 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-18, presumably until 2017-05-18\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-16, presumably until 2017-05-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-22 00:00:00, ended at 2017-05-22 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pneumothorax\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-29 10:34:12, ended at 2017-05-29 11:10:44\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-29 13:54:00, ended at 2017-05-29 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Essential hypertension\n- Pleural effusion\n- Primary malignant neoplasm of retroperitoneum\n- Pneumothorax\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-29 14:15:01, ended at 2017-05-29 15:51:41\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-20 00:00:00, ended at 2017-06-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-26 11:59:00, ended at 2017-06-26 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Solitary nodule of lung\n- Pleural effusion\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-26 11:59:00, ended at 2017-06-26 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Pneumothorax\n- Primary malignant neoplasm of soft tissues\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-28 10:24:32, ended at 2017-06-28 11:32:04\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 21 (millimeter mercury column)\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Cataract\n- Primary diagnosis: Degenerative disorder of macula\n- Nonexudative age-related macular degeneration\n- Exudative age-related macular degeneration\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-11 00:00:00, ended at 2017-07-11 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-07-11, presumably until 2017-08-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed for Nausea\n- temozolomide 140 MG Oral Capsule, through Oral route, started on 2017-07-11, presumably until 2018-04-25, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-11 11:12:25, ended at 2017-07-11 13:28:22\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-11 14:30:38, ended at 2017-07-11 15:36:44\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Hip pain\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-31 13:56:09, ended at 2017-07-31 15:24:09\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion)\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n\n### Condition\n- Squamous cell carcinoma of skin\n- Actinic keratosis\n- Primary diagnosis: Neoplasm of uncertain behavior of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-06 00:00:00, ended at 2017-08-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-08-06, presumably until 2017-08-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-09 00:00:00, ended at 2017-08-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-08-09, presumably until 2018-06-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-12 00:00:00, ended at 2017-08-12 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Squamous cell carcinoma of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-09 00:00:00, ended at 2017-09-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-13 09:53:00, ended at 2017-09-13 10:30:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Solitary nodule of lung\n- Primary malignant neoplasm of soft tissues\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-13 10:31:00, ended at 2017-09-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of retroperitoneum\n- Primary malignant neoplasm of soft tissues\n- Secondary malignant neoplasm of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-25 00:00:00, ended at 2017-09-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-25 10:32:23, ended at 2017-09-25 15:37:31\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-25 11:26:00, ended at 2017-11-25 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-25 11:26:00, ended at 2017-11-25 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-05 00:00:00, ended at 2017-12-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-05 11:16:27, ended at 2017-12-05 12:27:07\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-12-05, presumably until 2018-05-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-11 00:00:00, ended at 2017-12-11 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-11 09:23:04, ended at 2017-12-11 11:32:11\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Hearing loss\n- Primary malignant neoplasm of retroperitoneum\n- Chronic kidney disease stage 1\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, presumably until 2017-12-17, with intended 0 refill(s). Instructions: take 5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-13 12:10:00, ended at 2017-12-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-12-13, presumably until 2017-12-13\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-12-13, presumably until 2017-12-13\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2017-12-13, presumably until 2017-12-13\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-12-13, presumably until 2017-12-13\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2017-12-13, presumably until 2017-12-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-15 00:00:00, ended at 2017-12-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-16 00:00:00, ended at 2017-12-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2017-12-16, presumably until 2018-12-16, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-16 00:00:00, ended at 2017-12-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-12-17, presumably until 2018-12-24, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-03 09:30:00, ended at 2018-01-03 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.819\" (inch (US))\n\n### Procedure\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-01-03, presumably until 2018-01-03\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-01-03, presumably until 2018-01-03\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-01-03, presumably until 2018-01-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-03, presumably until 2018-01-03\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2018-01-03, presumably until 2018-01-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-16 09:19:17, ended at 2018-01-16 10:49:40\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tympanometry (impedance testing)\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-16 09:21:40, ended at 2018-01-16 10:53:06\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-21 09:55:00, ended at 2018-01-21 09:55:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-21 09:56:00, ended at 2018-01-21 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-23 09:31:18, ended at 2018-01-23 10:27:08\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-31 15:02:00, ended at 2018-01-31 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.74\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-01-31, presumably until 2018-01-31\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-01-31, presumably until 2018-01-31\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-01-31, presumably until 2018-01-31\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-31, presumably until 2018-01-31\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2018-01-31, presumably until 2018-01-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-28 08:56:00, ended at 2018-02-28 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.858\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-02-28, presumably until 2018-02-28\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-02-28, presumably until 2018-02-28\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-02-28, presumably until 2018-02-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-02-28, presumably until 2018-02-28\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2018-02-28, presumably until 2018-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-19 13:54:16, ended at 2018-03-19 14:52:36\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-21 10:43:11, ended at 2018-03-21 14:20:15\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Glaucoma suspect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-21 11:28:07, ended at 2018-03-21 13:45:56\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30, or quantitative, automated threshold perim\n\n### Condition\n- Glaucoma suspect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-24 13:10:00, ended at 2018-03-24 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-24 13:10:00, ended at 2018-03-24 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Pleural effusion\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-27 00:00:00, ended at 2018-03-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-27 00:00:00, ended at 2018-03-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-27 09:40:00, ended at 2018-03-27 11:27:08\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.858\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-27 11:13:00, ended at 2018-03-27 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-28 09:06:00, ended at 2018-03-28 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.661\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-03-28, presumably until 2018-03-28\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-03-28, presumably until 2018-03-28\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-03-28, presumably until 2018-03-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-03-28, presumably until 2018-03-28\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2018-03-28, presumably until 2018-03-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-04 11:34:17, ended at 2018-04-04 13:16:54\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-08 00:00:00, ended at 2018-04-08 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2018-04-08, presumably until 2019-05-02, with intended 12 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-24 00:00:00, ended at 2018-04-24 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 07:37:00, ended at 2018-04-25 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.661\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-04-25, presumably until 2018-04-25\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-04-25, presumably until 2018-04-25\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-04-25, presumably until 2018-04-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-04-25, presumably until 2018-04-25\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2018-04-25, presumably until 2018-04-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 14:34:37, ended at 2018-04-25 14:47:04\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-07 08:53:19, ended at 2018-05-07 09:28:58\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-14 13:50:02, ended at 2018-05-14 15:52:32\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.504\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 1\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-15 14:51:00, ended at 2018-05-15 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-15 14:51:00, ended at 2018-05-15 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-05-16 00:00:00, ended at 2018-05-16 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-05-16, presumably until 2018-05-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-16 00:00:00, ended at 2018-05-16 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for therapeutic interventional radiological procedures involving the arterial system; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Abnormal findings on diagnostic imaging of lung\n- Essential hypertension\n- Anemia\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2018-05-16, presumably until 2018-05-16\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2018-05-16, presumably until 2018-05-16\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2018-05-16, presumably until 2018-05-16\n- cefazolin 1000 MG Injection, started on 2018-05-16, presumably until 2018-05-16\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-05-16, presumably until 2018-05-16\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2018-05-16, presumably until 2018-05-16\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-05-16, presumably until 2018-05-16\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-05-16, presumably until 2018-05-16\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-05-16, presumably until 2018-05-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-16 06:08:00, ended at 2018-05-17 14:20:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n- INR in Blood by Coagulation assay: <0.9 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Collection of venous blood by venipuncture\n- Pleural drainage, percutaneous, with insertion of indwelling catheter; with imaging guidance\n- Ablation therapy for reduction or eradication of 1 or more pulmonary tumor(s) including pleura or chest wall when involved by tumor extension, percutaneous, including imaging guidance when performed, unilateral; radiofrequency\n- Radiologic examination, chest; single view\n- Computed tomography guidance for, and monitoring of, parenchymal tissue ablation\n- Drainage of Left Pleural Cavity with Drainage Device, Percutaneous Approach\n- Destruction of Left Lower Lobe Bronchus, Percutaneous Approach\n\n### Condition\n- Primary malignant neoplasm\n- Essential hypertension\n- Pneumothorax due to and following procedure\n- Secondary malignant neoplasm of right lung\n- Primary diagnosis: Solitary nodule of lung\n- Complication of procedure\n- Pneumothorax\n- Prediabetes\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-05-16, presumably until 2018-05-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-22 13:26:00, ended at 2018-05-22 15:02:36\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Body height: 5' 9.016\" (inch (US))\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 343 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n\n### Condition\n- Right bundle branch block\n- Electrocardiogram abnormal\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-27 00:00:00, ended at 2018-05-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-28 00:00:00, ended at 2018-05-28 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-28 09:04:00, ended at 2018-05-28 09:04:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-28 09:05:00, ended at 2018-05-28 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Presbyopia\n- Nuclear senile cataract\n- Degenerative disorder of macula\n- Glaucoma suspect\n- Myopia\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-03 00:00:00, ended at 2018-06-03 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-06-03, presumably until 2019-06-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed for Nausea\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2018-06-03, presumably until 2019-06-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, started on 2018-06-03, presumably until 2019-04-09, with intended 3 refill(s). Instructions: take 20 mL by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-09 09:01:00, ended at 2018-06-09 10:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.1 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.04 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 146 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.60 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.3 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-09 11:00:00, ended at 2018-06-09 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.504\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Conduction disorder of the heart\n- Electrocardiogram abnormal\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-10 00:00:00, ended at 2018-06-10 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-12 00:00:00, ended at 2018-06-12 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-12 10:40:26, ended at 2018-06-12 11:28:20\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-17 09:00:00, ended at 2018-06-17 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.39 (thousand per microliter)\n- Prothrombin time (PT): 13.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.36 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- MCV [Entitic volume] by Automated count: 104.6 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.2 (percent)\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.0 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 147 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-20 00:00:00, ended at 2018-06-20 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-23 00:00:00, ended at 2018-06-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-23 09:02:00, ended at 2018-06-23 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- MCH [Entitic mass] by Automated count: 34.4 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.39 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 138 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.7 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.67 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.3 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-30 09:06:00, ended at 2018-06-30 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.40 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 124 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.67 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Prothrombin time (PT): 12.8 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.14 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.9 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 249 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Non-toxic uninodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-07 08:00:00, ended at 2018-07-07 08:39:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation\n\n### Condition\n- Non-toxic uninodular goiter\n- Primary malignant neoplasm of soft tissues\n- Lipoma of head and neck\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-07 08:40:00, ended at 2018-07-07 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.1 (second)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.50 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.53 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 124 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Prothrombin time (PT): 13.4 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-14 00:00:00, ended at 2018-07-14 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-14 09:02:00, ended at 2018-07-14 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.43 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.4 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.17 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 127 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.5 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-18 09:32:00, ended at 2018-07-18 09:32:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-18 09:33:00, ended at 2018-07-18 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-21 00:00:00, ended at 2018-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Right bundle branch block\n- Cardiomegaly\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-21 00:00:00, ended at 2018-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-21 09:02:00, ended at 2018-07-21 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.29 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 142 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- Prothrombin time (PT): 13.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.47 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.3 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-21 09:46:47, ended at 2018-07-21 10:24:13\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-04 09:04:00, ended at 2018-08-04 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.60 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Prothrombin time (PT): 13.0 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.40 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 136 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.4 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-04 09:50:55, ended at 2018-08-04 10:11:23\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-18 08:59:00, ended at 2018-08-18 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 98.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.2 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 151 (unit per liter)\n- Prothrombin time (PT): 13.3 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.35 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.23 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.4 (percent)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-18 09:49:30, ended at 2018-08-18 10:34:53\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-01 08:50:00, ended at 2018-09-01 19:33:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.1 (second)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 234 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.47 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 146 (unit per liter)\n- Prothrombin time (PT): 13.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- MCV [Entitic volume] by Automated count: 97.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.94 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-01 19:34:00, ended at 2018-09-01 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-02 10:20:00, ended at 2018-09-02 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-08 14:17:23, ended at 2018-09-08 15:09:17\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion)\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n\n### Condition\n- Primary diagnosis: Actinic keratosis\n\n### Drug\n- fluorouracil 50 MG/ML Topical Cream, started on 2018-09-08, presumably until 2019-07-27, with intended 0 refill(s). Instructions: Apply twice daily for 2 weeks to the face\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-23 08:56:00, ended at 2018-09-23 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 245 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 121 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.1 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.67 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prothrombin time (PT): 13.2 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.68 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-10 09:49:00, ended at 2018-10-10 09:53:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-10 09:54:00, ended at 2018-10-10 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Secondary malignant neoplasm of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-13 09:05:00, ended at 2018-10-13 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 75 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 145 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.00 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.58 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.28 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Prothrombin time (PT): 12.8 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.25 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-03 09:05:00, ended at 2018-11-03 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Prothrombin time (PT): 12.3 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.5 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.78 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 139 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-03 09:52:09, ended at 2018-11-03 10:37:56\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-11 00:00:00, ended at 2018-11-11 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-21 13:57:00, ended at 2018-11-21 14:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-21 14:01:00, ended at 2018-11-21 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-24 08:55:00, ended at 2018-11-24 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.21 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 110 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.52 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.4 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.8 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Prothrombin time (PT): 12.5 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-24 09:52:33, ended at 2018-11-24 17:25:05\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-07 00:00:00, ended at 2015-12-07 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-07 13:03:42, ended at 2015-12-07 15:13:14\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.386\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2018-12-22, with intended 0 refill(s). Instructions: take 500 mg by mouth every 6 hours as needed\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2015-12-05, presumably until 2016-04-30, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-23 14:16:00, ended at 2016-01-23 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Hydronephrosis\n- Lipoma of skin and subcutaneous tissue of trunk\n- Abnormal findings on diagnostic imaging of lung\n- Anorectal disorder\n- Idiopathic aseptic necrosis of bone\n- Disorder of bone\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-25 12:24:10, ended at 2016-01-25 15:13:07\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.976\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Neoplastic disease\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-12-22, presumably until 2016-02-15, with intended 0 refill(s). Instructions: take by mouth\n- hydrocortisone 25 MG/ML Topical Cream, started on 2015-05-18, presumably until 2016-08-17, with intended 0 refill(s). Instructions: Apply 2 times a day to affected area(s)\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-12-22, presumably until 2016-02-15, with intended 0 refill(s). Instructions: take by mouth\n- lorazepam 1 MG Oral Tablet, through Sublingual route, started on 2015-12-22, presumably until 2016-02-15, with intended 0 refill(s). Instructions: place under the tongue and let dissolve\n- triamcinolone acetonide 1 MG/ML Topical Cream, through Topical route, started on 2015-10-21, presumably until 2016-02-15, with intended 0 refill(s). Instructions: by Topical route\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-31 09:40:32, ended at 2016-01-31 11:05:33\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-09 00:00:00, ended at 2016-02-09 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-02-17 00:00:00, ended at 2016-02-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bacitracin 5000 UNT/ML Injectable Solution, through Intramuscular route, started on 2016-02-17, presumably until 2016-02-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-02-17 00:00:00, ended at 2016-02-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in lower abdomen including laparoscopy; not otherwise specified\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2016-02-17, presumably until 2016-02-17\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-02-17, presumably until 2016-02-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-17\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2016-02-17, presumably until 2016-02-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-02-17 05:25:00, ended at 2016-02-25 11:16:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.0 (millimeter mercury column)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.07 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 231.0 (millimeter mercury column)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.66 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 95 (percent)\n- Base excess in Blood by calculation: -1 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lidocaine [Mass/volume] in Serum or Plasma: 2.4 (microgram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Blood: 130 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.7 (percent)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.2 (millimole per liter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide [Partial pressure] in Arterial blood: 36.7 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- Lactate [Moles/volume] in Blood: 1.0 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 395 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 76 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Base excess in Arterial blood by calculation: -3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n\n### Procedure\n- Excision or destruction, open, intra-abdominal tumors, cysts or endometriomas, 1 or more peritoneal, mesenteric, or retroperitoneal primary or secondary tumors; largest tumor greater than 10.0 cm diameter\n- Excision of Abdominal Aorta, Open Approach\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Extirpation of Matter from Left Ureter, Open Approach\n- Radiologic examination, chest; single view, frontal\n- Excision of Retroperitoneum, Open Approach\n- Resection of Spleen, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Repair blood vessel, direct; intra-abdominal\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Collection of venous blood by venipuncture\n- Resection of Left Kidney, Open Approach\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Resection of Left Large Intestine, Open Approach\n- Excision of Duodenum, Open Approach\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Physical therapy evaluation\n- Excision of Pancreas, Open Approach\n- Resection of Left Adrenal Gland, Open Approach\n- Daily hospital management of epidural or subarachnoid continuous drug administration\n- Occupational therapy evaluation\n\n### Condition\n- Electrocardiogram abnormal\n- Pleural effusion\n- Pneumothorax\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Primary malignant neoplasm of trunk\n- Malignant neoplasm of connective and soft tissue of thorax\n- Primary malignant neoplasm of retroperitoneum\n- Secondary malignant neoplastic disease\n- Anemia due to and following chemotherapy\n- Nephrosclerosis\n- Overlapping malignant neoplasm of retroperitoneum and peritoneum\n- Secondary malignant neoplasm of lung\n- Secondary malignant neoplasm of small intestine\n- Essential hypertension\n- Benign prostatic hyperplasia\n- Orthostatic hypotension\n- Persistent pain following procedure\n- Malignant neoplasm of connective and soft tissue of abdomen\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-02-17, presumably until 2016-02-22\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-02-19, presumably until 2016-02-19\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-02-25, presumably until 2016-04-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day before meals\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2016-02-18, presumably until 2016-02-24\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2016-02-23, presumably until 2016-02-23\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-02-18, presumably until 2016-02-18\n- 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection, through Intramuscular route, started on 2016-02-23, presumably until 2016-02-23\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2016-02-18, presumably until 2016-02-19\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2016-02-17, presumably until 2016-02-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-19\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2016-02-25, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1 Packet by mouth One Time\n- 0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogr..., through Intramuscular route, started on 2016-02-23, presumably until 2016-02-23\n- 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria m..., through Intramuscular route, started on 2016-02-23, presumably until 2016-02-23\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-02-21, presumably until 2017-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2016-02-21, presumably until 2016-02-24\n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2016-02-18, presumably until 2016-02-19\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-02-21, presumably until 2016-03-29, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-02-17, presumably until 2016-02-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2016-03-02 12:33:00, ended at 2016-03-29 12:39:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bicarbonate [Moles/volume] in Specimen: 31.6 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 30.9 (millimeter mercury column)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 6583 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- Left ventricular Ejection fraction: 40.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 43.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Base excess in Arterial blood by calculation: 6.4 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 1.4 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 445 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 5' 7.992\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.43 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 72.4 (millimeter mercury column)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Oxygen [Partial pressure] in Arterial blood: 81.1 (millimeter mercury column)\n- Thrombin time: 15.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.50 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 595 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.2 (gram per deciliter)\n- Lactate [Moles/volume] in Blood: 3.7 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.51 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 33.95 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 96.3 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Platelets [#/volume] in Blood by Automated count: 901 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 8.5 (microgram per milliliter)\n- Base excess in Blood by calculation: 8 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.34 (millimole per liter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: >3000 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Prothrombin time (PT): 21.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.5 (second)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 35 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.42 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 63 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n\n### Procedure\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Physical therapy evaluation\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Insertion of intravascular vena cava filter, endovascular approach including vascular access, vessel selection, and radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance (ultrasound and fluoroscopy), when performed\n- Intubation, endotracheal, emergency procedure\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Respiratory Ventilation, Greater than 96 Consecutive Hours\n- Arterial puncture, withdrawal of blood for diagnosis\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Fluoroscopy of Inferior Vena Cava using Low Osmolar Contrast\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Drainage of Left Trunk Muscle, Percutaneous Approach\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Controlled ventilation procedure and therapy, initiation and management\n- Computed tomography, abdomen and pelvis; without contrast material\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Flexible endoscopic evaluation of swallowing by cine or video recording\n- Monitoring of Central Nervous Electrical Activity, External Approach\n- Radiologic examination, abdomen; single anteroposterior view\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Insertion of Intraluminal Device into Inferior Vena Cava, Percutaneous Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Evaluation of oral and pharyngeal swallowing function\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Image-guided fluid collection drainage by catheter (eg, abscess, hematoma, seroma, lymphocele, cyst); peritoneal or retroperitoneal, percutaneous\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, gastrointestinal tract, upper; with or without delayed images, with KUB\n- Inspection of Larynx, Via Natural or Artificial Opening Endoscopic\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Insertion of Endotracheal Airway into Trachea, Via Natural or Artificial Opening\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Esophagogastroduodenoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n- Occupational therapy evaluation\n- Respiratory Ventilation, 24-96 Consecutive Hours\n- Radiologic examination, chest; single view, frontal\n- Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours\n- Computed tomography, thorax, diagnostic; without contrast material\n- Insertion of Feeding Device into Stomach, Via Natural or Artificial Opening Endoscopic\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Altered mental status\n- Gastrointestinal hemorrhage\n- Intestinal obstruction co-occurrent and due to decreased peristalsis\n- Postoperative intestinal obstruction\n- Postoperative state\n- Tachycardia\n- Ventilator associated pneumonia\n- Abnormal findings on diagnostic imaging of lung\n- Acute deep venous thrombosis of femoral vein\n- Primary diagnosis: Acute hypoxemic respiratory failure\n- Benign prostatic hyperplasia\n- Disorder of digestive system\n- Dysphonia\n- Dyspnea\n- Edema, generalized\n- Mild protein-calorie malnutrition (weight for age 75-89 percent of standard)\n- Pneumonia\n- Primary malignant neoplasm of retroperitoneum\n- Tachypnea\n- Abdominal distension, gaseous\n- Complication of surgical procedure\n- Electroencephalogram abnormal\n- Localized edema\n- Low blood pressure\n- Pulmonary embolism\n- Septic shock\n- Chronic pulmonary edema\n- Embolism from thrombosis of vein of lower extremity\n- Hematemesis\n- Hereditary thrombophilia\n- Impaction of intestine\n- Acute respiratory distress syndrome\n- Electrocardiogram abnormal\n- Essential hypertension\n- Acute hemorrhagic gastritis\n- Acute posthemorrhagic anemia\n- Adrenocortical hypofunction following procedure\n- Alkalosis\n- Diarrhea\n- Erythema of skin\n- Neoplastic disease\n- Vomiting\n- Abscess of peritoneum\n- Absent kidney\n- Acute vascular insufficiency of intestine\n- Ascites\n- Chest pain\n- Conduction disorder of the heart\n- Disorder of intestine\n- Pleural effusion\n- Secondary hypertension\n- Sepsis due to anaerobic bacteria\n- Acquired absence of organ\n- Disorder of bilirubin metabolism\n- Gastric hemorrhage\n- Hypoxemia\n- Infection due to enterococcus\n- Intestinal obstruction\n- Intra-abdominal and pelvic swelling, mass and lump\n- Long QT syndrome\n- Nausea and vomiting\n- Pneumonitis due to inhaled substance\n- Right bundle branch block\n- Ventricular premature complex\n- Acquired absence of spleen\n- Cardiomegaly\n- Iliopsoas abscess\n- Pneumonia due to Klebsiella pneumoniae\n- Somatoform disorder\n\n### Drug\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-03-02, presumably until 2016-03-02\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2016-03-03, presumably until 2016-03-18\n- haloperidol 5 MG/ML Injectable Solution, started on 2016-03-09, presumably until 2016-03-09\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-05, presumably until 2016-03-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-03-27, presumably until 2017-03-29, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day before meals\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2016-03-04, presumably until 2016-03-04\n- 100 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2016-03-15, presumably until 2016-03-17\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2016-03-03, presumably until 2016-03-27\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2016-03-08, presumably until 2016-03-08\n- 500 ML tromethamine 36 MG/ML Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-03\n- diatrizoate, through Oral route, started on 2016-03-02, presumably until 2016-03-02\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-03-04, presumably until 2016-03-04\n- vecuronium bromide 1 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-02, presumably until 2016-03-02\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2016-03-10, presumably until 2016-03-17\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-17\n- quetiapine 25 MG Oral Tablet, through Oral route, started on 2016-03-08, presumably until 2016-03-16\n- calcium chloride 0.001 MEQ/ML / glucose 50 MG/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-03-03, presumably until 2016-03-04\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2017-03-29, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-03-02, presumably until 2016-03-03\n- acetazolamide 500 MG Injection, started on 2016-03-08, presumably until 2016-03-08\n- 10 ML furosemide 10 MG/ML Injection, started on 2016-03-06, presumably until 2016-03-14\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2016-03-15, presumably until 2016-07-04, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day Hold for heart rate under 60, systolic blood pressure under 90.\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-07, presumably until 2016-03-09\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-02, presumably until 2016-03-02\n- diatrizoic acid, through Oral route, started on 2016-03-02, presumably until 2016-03-02\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2016-03-03, presumably until 2016-03-26\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2016-03-02, presumably until 2016-03-29\n- soybean oil 200 MG/ML Injectable Suspension, through Intravenous route, started on 2016-03-04, presumably until 2016-03-25\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2016-03-07, presumably until 2016-03-12\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-03-28, presumably until 2016-10-23, with intended 6 refill(s). Instructions: inject 0.8 mL subcutaneous (under the skin) Every Day\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-16, presumably until 2016-03-16\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-09\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-03-02, presumably until 2016-03-02\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2016-03-06, presumably until 2016-03-06\n- acetylcysteine 200 MG/ML Inhalation Solution, started on 2016-03-15, presumably until 2016-03-18\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-03-02, presumably until 2016-03-02\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2016-03-15, presumably until 2016-12-21, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2016-03-02, presumably until 2016-03-16\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2016-03-08, presumably until 2016-03-15\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-16\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-02\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-03-26, presumably until 2016-03-28, with intended 12 refill(s). Instructions: inject 0.8 mL subcutaneous (under the skin) Every Day\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2016-03-29, presumably until 2016-05-02, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2016-03-02, presumably until 2016-03-02\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2016-03-14, presumably until 2016-03-29\n- midazolam 1 MG/ML Injectable Solution, started on 2016-03-02, presumably until 2016-03-03\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2016-03-04, presumably until 2016-03-17\n- psyllium 6000 MG Powder for Oral Suspension, through Oral route, started on 2016-03-28, presumably until 2018-05-16, with intended 3 refill(s). Instructions: take 1 Packet by mouth daily as needed (for loose stools)\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2016-03-03, presumably until 2016-03-03\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-03-06, presumably until 2016-03-15\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2016-03-07, presumably until 2016-03-09\n- hydrocortisone 100 MG Injection, started on 2016-03-03, presumably until 2016-03-04\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2016-03-03, presumably until 2016-03-03\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2016-03-06, presumably until 2016-03-13\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-03-03, presumably until 2016-03-03\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-16\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2016-03-02, presumably until 2016-03-16\n- 100 ML levetiracetam 10 MG/ML Injection, through Intravenous route, started on 2016-03-05, presumably until 2016-03-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-05 09:00:00, ended at 2016-03-05 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 90 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 46.0 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 43.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Blood: 171 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-03-11, presumably until 2016-03-11\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2016-03-11, presumably until 2016-03-11\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2016-03-11, presumably until 2016-03-11\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2016-03-11, presumably until 2016-03-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-19 00:00:00, ended at 2016-03-19 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Embolism from thrombosis of vein of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-04 10:37:19, ended at 2016-04-04 12:46:55\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.882\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-19 12:37:00, ended at 2016-04-19 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Embolism from thrombosis of vein of lower extremity\n- Phlebitis of tibial vein\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-19 12:38:26, ended at 2016-04-19 14:32:22\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Embolism from thrombosis of vein of lower extremity\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- rivaroxaban, started on 2016-04-19, presumably until 2016-10-23, with intended 0 refill(s). Instructions: Take 1 round (15 mg) tab twice daily with food for 21 days then 1 triangle tab (20 mg) daily with food\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2016-04-19, presumably until 2016-09-18, with intended 2 refill(s). Instructions: take 20 mg by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-25 10:09:10, ended at 2016-04-25 11:03:11\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-30 12:56:28, ended at 2016-04-30 15:12:34\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 7 (milligram per liter)\n- Body height: 5' 8.701\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 83.10 (milligram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Type 2 diabetes mellitus without complication\n- Pulmonary embolism\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-02 08:03:00, ended at 2016-05-02 11:56:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 45 (percent)\n- Potassium [Moles/volume] in Blood: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.3 (gram per deciliter)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Retrieval (removal) of intravascular vena cava filter, endovascular approach including vascular access, vessel selection, and radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance (ultrasound and fluoroscopy), when\n- Fluoroscopy of Inferior Vena Cava using Low Osmolar Contrast\n- Removal of Intraluminal Device from Lower Vein, Percutaneous Approach\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Essential hypertension\n- Pulmonary embolism\n- Blood glucose abnormal\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-02, presumably until 2016-05-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-14 00:00:00, ended at 2016-05-14 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-14 09:39:02, ended at 2016-05-14 10:47:05\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-29 08:46:22, ended at 2016-05-29 09:40:24\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.27 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 87 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-01 13:02:00, ended at 2016-06-01 13:02:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Computed tomography, thorax, diagnostic; without contrast material\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Solitary nodule of lung\n- Primary malignant neoplasm of retroperitoneum\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-01 13:03:00, ended at 2016-06-01 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pneumonia\n- Postoperative state\n- Primary malignant neoplasm of retroperitoneum\n- Abnormal findings on diagnostic imaging of lung\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-08 00:00:00, ended at 2016-06-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary embolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-04 00:00:00, ended at 2016-07-04 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2016-07-04, presumably until 2016-10-23, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day Hold for heart rate under 60, systolic blood pressure under 90.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-04 00:00:00, ended at 2016-09-04 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute deep venous thrombosis of femoral vein\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-06 13:53:27, ended at 2016-09-06 15:42:55\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.307\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Retroperitoneum\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-11 13:45:00, ended at 2016-09-11 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Pulmonary embolism\n- Phlebitis of the femoral vein\n- Acute deep venous thrombosis of femoral vein\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-11 13:49:40, ended at 2016-09-11 15:02:45\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary embolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-18 00:00:00, ended at 2016-09-18 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Exudative age-related macular degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-25 14:05:05, ended at 2016-09-25 15:36:37\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n- Intraocular pressure of left eye: 17 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Primary diagnosis: Degenerative disorder of macula\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-26 10:51:00, ended at 2016-09-26 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Postoperative state\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-05 13:59:00, ended at 2016-10-05 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Pneumonia\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-10 00:00:00, ended at 2016-10-10 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-15 00:00:00, ended at 2016-10-15 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-23 15:01:49, ended at 2016-10-23 15:46:07\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 1\n- Essential hypertension\n- Hearing loss\n- Primary diagnosis: Inguinal hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-26 15:26:01, ended at 2016-10-26 16:46:15\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2016-12-06, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-07 14:42:49, ended at 2016-11-07 15:36:11\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.46 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 09:20:49, ended at 2016-12-03 11:17:22\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n- Tympanometry and reflex threshold measurements\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 09:23:11, ended at 2016-12-03 11:19:54\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-04 14:24:20, ended at 2016-12-04 16:11:19\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 277 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.06 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.58 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.4 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.1 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Inguinal hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-06 00:00:00, ended at 2016-12-06 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Chronic kidney disease stage 1\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-21 09:02:20, ended at 2016-12-21 15:52:21\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.33 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 131.00 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.8 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 17 (milligram per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Blood chemistry abnormal\n- Kidney stone\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-24 13:57:00, ended at 2016-12-24 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Postoperative state\n- Abnormal findings on diagnostic imaging of lung\n- Fibrosis of lung\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-26 14:29:10, ended at 2016-12-26 15:55:45\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Primary diagnosis: Degenerative disorder of macula\n- Nonexudative age-related macular degeneration\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-27 00:00:00, ended at 2016-12-27 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-31 00:00:00, ended at 2016-12-31 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in lower abdomen; not otherwise specified\n\n### Condition\n- Inguinal hernia\n\n### Drug\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2016-12-31, presumably until 2016-12-31\n- cefazolin 1000 MG Injection, started on 2016-12-31, presumably until 2016-12-31\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2016-12-31, presumably until 2016-12-31\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-31, presumably until 2016-12-31\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-12-31, presumably until 2016-12-31\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-12-31, presumably until 2016-12-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-31 13:34:00, ended at 2017-01-01 11:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Supplement Left Inguinal Region with Synthetic Substitute, Open Approach\n\n### Condition\n- Retention of urine\n- Absent kidney\n- Inguinal hernia\n- Abnormal findings on diagnostic imaging of lung\n- Acquired absence of organ\n- Anemia due to and following chemotherapy\n- Primary malignant neoplasm of retroperitoneum\n- Acquired absence of spleen\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-12-31, presumably until 2016-12-31\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-01-01, presumably until 2017-01-01\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-12-31, presumably until 2017-01-01\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2016-12-31, presumably until 2016-12-31\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2016-12-31, presumably until 2016-12-31\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-01-01, presumably until 2017-01-01\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2017-01-01, presumably until 2017-01-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-03 12:05:45, ended at 2017-01-03 13:06:18\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-07 00:00:00, ended at 2017-01-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-10 11:42:00, ended at 2017-01-10 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; complete study\n\n### Condition\n- Kidney stone\n- Blood chemistry abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-17 00:00:00, ended at 2017-01-17 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-21 00:00:00, ended at 2017-01-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone 25 MG/ML Topical Cream, started on 2017-01-21, presumably until 2019-11-23, with intended 5 refill(s). Instructions: Apply as needed to affected areas.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-08 11:58:00, ended at 2017-02-08 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of peritoneum\n- Postoperative state\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-26 11:31:00, ended at 2017-03-26 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-03 00:00:00, ended at 2017-04-03 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-04 00:00:00, ended at 2017-04-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-04 00:00:00, ended at 2017-04-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-04 14:12:34, ended at 2017-04-04 15:34:18\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, presumably until 2017-04-05, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-05 00:00:00, ended at 2017-04-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-04-08, presumably until 2018-04-08, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-10 14:49:11, ended at 2017-04-10 16:49:04\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.898\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2017-09-19, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-16 10:13:00, ended at 2017-04-16 10:47:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Respiratory flow volume loop\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-16 10:48:00, ended at 2017-04-16 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 56.2 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Rheumatic tricuspid valve regurgitation\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-01 10:50:35, ended at 2017-05-01 13:33:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Electrocardiogram abnormal\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Right bundle branch block\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-01 13:32:46, ended at 2017-05-01 14:09:48\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.51 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Body height: 5' 9\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.86 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.8 (percent)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Prothrombin time (PT): 12.9 (second)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-01 14:14:00, ended at 2017-05-01 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-02 00:00:00, ended at 2017-05-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-05-02 00:00:00, ended at 2017-05-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for thoracotomy procedures involving lungs, pleura, diaphragm, and mediastinum (including surgical thoracoscopy); not otherwise specified\n\n### Condition\n- Primary malignant neoplasm\n- Secondary malignant neoplasm of right lung\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-05-02, presumably until 2017-05-02\n- cefazolin 1000 MG Injection, started on 2017-05-02, presumably until 2017-05-02\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-05-02, presumably until 2017-05-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- midazolam 1 MG/ML Injectable Solution, started on 2017-05-02, presumably until 2017-05-02\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2017-05-02, presumably until 2017-05-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-05-02 00:00:00, ended at 2017-05-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 30 ML ropivacaine hydrochloride 5 MG/ML Injection, started on 2017-05-02, presumably until 2017-05-02\n- midazolam 1 MG/ML Injectable Solution, started on 2017-05-02, presumably until 2017-05-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-05-02 05:26:00, ended at 2017-05-05 15:35:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 13.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Body height: 5' 9\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Prothrombin time (PT): 13.2 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 244 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n\n### Procedure\n- Excision of Right Upper Lobe Bronchus, Percutaneous Endoscopic Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Excision of Right Middle Lobe Bronchus, Percutaneous Endoscopic Approach\n- Inspection of Tracheobronchial Tree, Via Natural or Artificial Opening Endoscopic\n- Thoracoscopy, surgical; with lobectomy (single lobe)\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Extirpation of Matter from Right Diaphragm, Percutaneous Endoscopic Approach (Deprecated)\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Excision of Thorax Lymphatic, Percutaneous Endoscopic Approach, Diagnostic\n- Radiologic examination, chest; single view, frontal\n- Collection of venous blood by venipuncture\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Resection of Right Lower Lung Lobe, Percutaneous Endoscopic Approach\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; diagnostic, with cell washing, when performed (separate procedure)\n- Thoracoscopy, surgical; with therapeutic wedge resection (eg, mass, nodule), initial unilateral\n\n### Condition\n- Postoperative state\n- Chronic kidney disease due to hypertension\n- Pneumothorax\n- Primary malignant neoplasm\n- Pneumothorax due to and following procedure\n- Prediabetes\n- Primary malignant neoplasm of retroperitoneum\n- Abnormal findings on diagnostic imaging of lung\n- Exudative age-related macular degeneration\n- Secondary malignant neoplasm of right lung\n- Persistent pain following procedure\n- Chronic kidney disease stage 1\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-05-02, presumably until 2017-05-04\n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2017-05-02, presumably until 2017-05-05\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-05-05, presumably until 2017-05-05\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-05-02, presumably until 2017-05-05\n- melatonin 1 MG Oral Tablet, through Oral route, started on 2017-05-02, presumably until 2017-05-04\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-05-02, presumably until 2017-05-15, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2017-05-02, presumably until 2017-05-03\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-05-04, presumably until 2017-05-04\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-05-04, presumably until 2017-05-05\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-05-02, presumably until 2017-05-05\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-05-02, presumably until 2017-05-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-05-02, presumably until 2017-05-02\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-05-05, presumably until 2017-05-05\n- magnesium chloride 598 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-04, presumably until 2017-05-05\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-05-05, presumably until 2017-05-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-03, presumably until 2017-05-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-15 13:55:00, ended at 2017-05-15 17:05:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pneumothorax\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-05-15 17:06:00, ended at 2017-05-18 17:50:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Body height: 5' 9\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.16 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.31 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.35 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.5 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 452 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Drainage of Right Pleural Cavity with Drainage Device, Percutaneous Approach\n- Collection of venous blood by venipuncture\n- Collection of capillary blood specimen (eg, finger, heel, ear stick)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Pleural effusion\n- Acquired absence of organ\n- Leukocytosis\n- Pleurisy\n- Atherosclerosis of aorta\n- Benign prostatic hyperplasia\n- Insomnia\n- Prediabetes\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Complication of surgical procedure\n- Pneumothorax\n- Disorder of digestive system\n- Essential hypertension\n- Pneumothorax due to and following procedure\n- Absence of lung\n\n### Drug\n- melatonin 1 MG Oral Tablet, through Oral route, started on 2017-05-15, presumably until 2017-05-17\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-05-15, presumably until 2017-05-17\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-05-17, presumably until 2018-05-17, with intended 0 refill(s). Instructions: take 2 Caps by mouth daily Over the counter medication.\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2017-05-17, presumably until 2017-05-18\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-05-15, presumably until 2017-05-17\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-05-15, presumably until 2017-05-18\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-05-16, presumably until 2017-05-18\n- magnesium chloride 598 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-18, presumably until 2017-05-18\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-16, presumably until 2017-05-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-22 00:00:00, ended at 2017-05-22 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pneumothorax\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-29 10:34:12, ended at 2017-05-29 11:10:44\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-29 13:54:00, ended at 2017-05-29 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Essential hypertension\n- Pleural effusion\n- Primary malignant neoplasm of retroperitoneum\n- Pneumothorax\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-29 14:15:01, ended at 2017-05-29 15:51:41\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-20 00:00:00, ended at 2017-06-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-26 11:59:00, ended at 2017-06-26 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Solitary nodule of lung\n- Pleural effusion\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-26 11:59:00, ended at 2017-06-26 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Pneumothorax\n- Primary malignant neoplasm of soft tissues\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-28 10:24:32, ended at 2017-06-28 11:32:04\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 21 (millimeter mercury column)\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Cataract\n- Primary diagnosis: Degenerative disorder of macula\n- Nonexudative age-related macular degeneration\n- Exudative age-related macular degeneration\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-11 00:00:00, ended at 2017-07-11 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-07-11, presumably until 2017-08-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed for Nausea\n- temozolomide 140 MG Oral Capsule, through Oral route, started on 2017-07-11, presumably until 2018-04-25, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-11 11:12:25, ended at 2017-07-11 13:28:22\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-11 14:30:38, ended at 2017-07-11 15:36:44\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Hip pain\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-31 13:56:09, ended at 2017-07-31 15:24:09\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion)\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n\n### Condition\n- Squamous cell carcinoma of skin\n- Actinic keratosis\n- Primary diagnosis: Neoplasm of uncertain behavior of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-06 00:00:00, ended at 2017-08-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-08-06, presumably until 2017-08-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-09 00:00:00, ended at 2017-08-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-08-09, presumably until 2018-06-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-12 00:00:00, ended at 2017-08-12 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Squamous cell carcinoma of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-09 00:00:00, ended at 2017-09-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-13 09:53:00, ended at 2017-09-13 10:30:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Solitary nodule of lung\n- Primary malignant neoplasm of soft tissues\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-13 10:31:00, ended at 2017-09-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of retroperitoneum\n- Primary malignant neoplasm of soft tissues\n- Secondary malignant neoplasm of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-25 00:00:00, ended at 2017-09-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-25 10:32:23, ended at 2017-09-25 15:37:31\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-25 11:26:00, ended at 2017-11-25 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-25 11:26:00, ended at 2017-11-25 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-05 00:00:00, ended at 2017-12-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-05 11:16:27, ended at 2017-12-05 12:27:07\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-12-05, presumably until 2018-05-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-11 00:00:00, ended at 2017-12-11 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-11 09:23:04, ended at 2017-12-11 11:32:11\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Hearing loss\n- Primary malignant neoplasm of retroperitoneum\n- Chronic kidney disease stage 1\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, presumably until 2017-12-17, with intended 0 refill(s). Instructions: take 5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-13 12:10:00, ended at 2017-12-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-12-13, presumably until 2017-12-13\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2017-12-13, presumably until 2017-12-13\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2017-12-13, presumably until 2017-12-13\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-12-13, presumably until 2017-12-13\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2017-12-13, presumably until 2017-12-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-15 00:00:00, ended at 2017-12-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-16 00:00:00, ended at 2017-12-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2017-12-16, presumably until 2018-12-16, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-16 00:00:00, ended at 2017-12-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-12-17, presumably until 2018-12-24, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-03 09:30:00, ended at 2018-01-03 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.819\" (inch (US))\n\n### Procedure\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-01-03, presumably until 2018-01-03\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-01-03, presumably until 2018-01-03\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-01-03, presumably until 2018-01-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-03, presumably until 2018-01-03\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2018-01-03, presumably until 2018-01-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-16 09:19:17, ended at 2018-01-16 10:49:40\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tympanometry (impedance testing)\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-16 09:21:40, ended at 2018-01-16 10:53:06\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-21 09:55:00, ended at 2018-01-21 09:55:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-21 09:56:00, ended at 2018-01-21 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-23 09:31:18, ended at 2018-01-23 10:27:08\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.819\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-31 15:02:00, ended at 2018-01-31 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.74\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-01-31, presumably until 2018-01-31\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-01-31, presumably until 2018-01-31\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-01-31, presumably until 2018-01-31\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-31, presumably until 2018-01-31\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2018-01-31, presumably until 2018-01-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-28 08:56:00, ended at 2018-02-28 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.858\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-02-28, presumably until 2018-02-28\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-02-28, presumably until 2018-02-28\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-02-28, presumably until 2018-02-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-02-28, presumably until 2018-02-28\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2018-02-28, presumably until 2018-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-19 13:54:16, ended at 2018-03-19 14:52:36\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-21 10:43:11, ended at 2018-03-21 14:20:15\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Glaucoma suspect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-21 11:28:07, ended at 2018-03-21 13:45:56\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30, or quantitative, automated threshold perim\n\n### Condition\n- Glaucoma suspect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-24 13:10:00, ended at 2018-03-24 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-24 13:10:00, ended at 2018-03-24 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Pleural effusion\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-27 00:00:00, ended at 2018-03-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-27 00:00:00, ended at 2018-03-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-27 09:40:00, ended at 2018-03-27 11:27:08\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.858\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-27 11:13:00, ended at 2018-03-27 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-28 09:06:00, ended at 2018-03-28 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.661\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-03-28, presumably until 2018-03-28\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-03-28, presumably until 2018-03-28\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-03-28, presumably until 2018-03-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-03-28, presumably until 2018-03-28\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2018-03-28, presumably until 2018-03-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-04 11:34:17, ended at 2018-04-04 13:16:54\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-08 00:00:00, ended at 2018-04-08 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2018-04-08, presumably until 2019-05-02, with intended 12 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-24 00:00:00, ended at 2018-04-24 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 07:37:00, ended at 2018-04-25 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.661\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Application of on-body injector (includes cannula insertion) for timed subcutaneous injection\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-04-25, presumably until 2018-04-25\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-04-25, presumably until 2018-04-25\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2018-04-25, presumably until 2018-04-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-04-25, presumably until 2018-04-25\n- 0.6 ML pegfilgrastim 10 MG/ML Injection, through Subcutaneous route, started on 2018-04-25, presumably until 2018-04-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 14:34:37, ended at 2018-04-25 14:47:04\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-07 08:53:19, ended at 2018-05-07 09:28:58\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-14 13:50:02, ended at 2018-05-14 15:52:32\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.504\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 1\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-15 14:51:00, ended at 2018-05-15 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-15 14:51:00, ended at 2018-05-15 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-05-16 00:00:00, ended at 2018-05-16 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-05-16, presumably until 2018-05-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-16 00:00:00, ended at 2018-05-16 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for therapeutic interventional radiological procedures involving the arterial system; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Abnormal findings on diagnostic imaging of lung\n- Essential hypertension\n- Anemia\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2018-05-16, presumably until 2018-05-16\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2018-05-16, presumably until 2018-05-16\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2018-05-16, presumably until 2018-05-16\n- cefazolin 1000 MG Injection, started on 2018-05-16, presumably until 2018-05-16\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-05-16, presumably until 2018-05-16\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2018-05-16, presumably until 2018-05-16\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-05-16, presumably until 2018-05-16\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-05-16, presumably until 2018-05-16\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-05-16, presumably until 2018-05-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-16 06:08:00, ended at 2018-05-17 14:20:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n- INR in Blood by Coagulation assay: <0.9 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Collection of venous blood by venipuncture\n- Pleural drainage, percutaneous, with insertion of indwelling catheter; with imaging guidance\n- Ablation therapy for reduction or eradication of 1 or more pulmonary tumor(s) including pleura or chest wall when involved by tumor extension, percutaneous, including imaging guidance when performed, unilateral; radiofrequency\n- Radiologic examination, chest; single view\n- Computed tomography guidance for, and monitoring of, parenchymal tissue ablation\n- Drainage of Left Pleural Cavity with Drainage Device, Percutaneous Approach\n- Destruction of Left Lower Lobe Bronchus, Percutaneous Approach\n\n### Condition\n- Primary malignant neoplasm\n- Essential hypertension\n- Pneumothorax due to and following procedure\n- Secondary malignant neoplasm of right lung\n- Primary diagnosis: Solitary nodule of lung\n- Complication of procedure\n- Pneumothorax\n- Prediabetes\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-05-16, presumably until 2018-05-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-22 13:26:00, ended at 2018-05-22 15:02:36\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Body height: 5' 9.016\" (inch (US))\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 343 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n\n### Condition\n- Right bundle branch block\n- Electrocardiogram abnormal\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-27 00:00:00, ended at 2018-05-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-28 00:00:00, ended at 2018-05-28 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-28 09:04:00, ended at 2018-05-28 09:04:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-28 09:05:00, ended at 2018-05-28 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Presbyopia\n- Nuclear senile cataract\n- Degenerative disorder of macula\n- Glaucoma suspect\n- Myopia\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-03 00:00:00, ended at 2018-06-03 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-06-03, presumably until 2019-06-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed for Nausea\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2018-06-03, presumably until 2019-06-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, started on 2018-06-03, presumably until 2019-04-09, with intended 3 refill(s). Instructions: take 20 mL by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-09 09:01:00, ended at 2018-06-09 10:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.1 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.04 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 146 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.60 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.3 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-09 11:00:00, ended at 2018-06-09 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.504\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Conduction disorder of the heart\n- Electrocardiogram abnormal\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-10 00:00:00, ended at 2018-06-10 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-12 00:00:00, ended at 2018-06-12 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-12 10:40:26, ended at 2018-06-12 11:28:20\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-17 09:00:00, ended at 2018-06-17 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.39 (thousand per microliter)\n- Prothrombin time (PT): 13.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.36 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- MCV [Entitic volume] by Automated count: 104.6 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.2 (percent)\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.0 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 147 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-20 00:00:00, ended at 2018-06-20 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-23 00:00:00, ended at 2018-06-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-23 09:02:00, ended at 2018-06-23 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- MCH [Entitic mass] by Automated count: 34.4 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.39 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 138 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.7 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.67 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.3 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-30 09:06:00, ended at 2018-06-30 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.40 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 124 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.67 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Prothrombin time (PT): 12.8 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.14 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.9 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 249 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Non-toxic uninodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-07 08:00:00, ended at 2018-07-07 08:39:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation\n\n### Condition\n- Non-toxic uninodular goiter\n- Primary malignant neoplasm of soft tissues\n- Lipoma of head and neck\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-07 08:40:00, ended at 2018-07-07 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.1 (second)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.50 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.53 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 124 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Prothrombin time (PT): 13.4 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-14 00:00:00, ended at 2018-07-14 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-14 09:02:00, ended at 2018-07-14 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.43 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.4 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.17 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 127 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.5 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-18 09:32:00, ended at 2018-07-18 09:32:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-18 09:33:00, ended at 2018-07-18 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-21 00:00:00, ended at 2018-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Right bundle branch block\n- Cardiomegaly\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-21 00:00:00, ended at 2018-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-21 09:02:00, ended at 2018-07-21 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.29 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 142 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- Prothrombin time (PT): 13.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.47 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.3 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-21 09:46:47, ended at 2018-07-21 10:24:13\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-04 09:04:00, ended at 2018-08-04 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.60 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Prothrombin time (PT): 13.0 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.40 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 136 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.4 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-04 09:50:55, ended at 2018-08-04 10:11:23\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-18 08:59:00, ended at 2018-08-18 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 98.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.2 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 151 (unit per liter)\n- Prothrombin time (PT): 13.3 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.35 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.23 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.4 (percent)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-18 09:49:30, ended at 2018-08-18 10:34:53\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-01 08:50:00, ended at 2018-09-01 19:33:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.1 (second)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 234 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.47 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 146 (unit per liter)\n- Prothrombin time (PT): 13.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- MCV [Entitic volume] by Automated count: 97.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.94 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-01 19:34:00, ended at 2018-09-01 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-02 10:20:00, ended at 2018-09-02 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-08 14:17:23, ended at 2018-09-08 15:09:17\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion)\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n\n### Condition\n- Primary diagnosis: Actinic keratosis\n\n### Drug\n- fluorouracil 50 MG/ML Topical Cream, started on 2018-09-08, presumably until 2019-07-27, with intended 0 refill(s). Instructions: Apply twice daily for 2 weeks to the face\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-23 08:56:00, ended at 2018-09-23 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 245 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 121 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.1 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.67 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prothrombin time (PT): 13.2 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.68 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-10 09:49:00, ended at 2018-10-10 09:53:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-10 09:54:00, ended at 2018-10-10 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n- Secondary malignant neoplasm of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-13 09:05:00, ended at 2018-10-13 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 75 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 145 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.00 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.58 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.28 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Prothrombin time (PT): 12.8 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.25 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-03 09:05:00, ended at 2018-11-03 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Prothrombin time (PT): 12.3 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.5 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.78 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 139 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-03 09:52:09, ended at 2018-11-03 10:37:56\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-11 00:00:00, ended at 2018-11-11 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-21 13:57:00, ended at 2018-11-21 14:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-21 14:01:00, ended at 2018-11-21 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-24 08:55:00, ended at 2018-11-24 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.21 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 110 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.52 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.4 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.8 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Prothrombin time (PT): 12.5 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-24 09:52:33, ended at 2018-11-24 17:25:05\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of intestinal_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "6ac982c4906a8dc3bdbbc49004856a2b5a17e1fa23ff8f0854a3b8d5301d0b5f", "prompt_hash": "8bedf3b444c89e167c8cc66c867f2926ab6de4a0d7bdc127784bc4a840aaa3af", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 9, "doc": {"person_id": 115969365, "visit_occurrence_id": 49302577, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2012-07-24 09:52:00", "visit_end_datetime": "2012-07-24 23:59:00", "visit_length_in_hours": 14.116666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-24 09:52:00, ended at 2012-07-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 181 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 936, "patient_first_visit_date": "2008-03-10 21:46:00", "patient_last_visit_date": "2022-05-23 00:00:00", "end_obs_date": "2013-07-24", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 1, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 56, "cumulated_visit_num": 56, "cumulated_approximate_token_count": 26614, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2008-03-10 21:46:00, ended at 2008-03-11 14:25:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.50 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma: 34.2 (microgram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 135 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-20 01:45:00, ended at 2008-07-22 12:47:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 38 (percent)\n- Sodium [Moles/volume] in Blood: 130 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.2 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 54.6 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.9 (percent)\n- Prothrombin time (PT): 14.2 (second)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.44 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.5 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 5.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 22 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 7.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Chronic kidney disease stage 5 due to hypertension\n- Diaphragmatic hernia\n- Anemia in chronic kidney disease\n- Systemic lupus erythematosus\n- Nausea\n- Stricture of esophagus\n- Acute posthemorrhagic anemia\n- Mitral valve disorder\n- Hematochezia\n- Hepatic necrosis\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2008-07-22. Instructions: take 30 mg by mouth daily. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-07-21, presumably until 2008-07-22\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2008-07-20, presumably until 2008-07-21\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-19, presumably until 2008-07-20\n- prochlorperazine 5 MG/ML Injectable Solution, started on 2008-07-20, presumably until 2008-07-20\n- lamotrigine 200 MG Oral Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 200 mg by mouth 2 times a day. \n- atorvastatin 10 MG Oral Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 10 mg by mouth every bedtime. \n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-07-21, presumably until 2008-07-21\n- rabeprazole sodium 20 MG Delayed Release Oral Tablet, through Oral route, started on 2008-07-22, presumably until 2009-04-03, with quantity of 90.0, with intended 5 refill(s). Instructions: take 20 mg by mouth 2 times a day. Take Aciphex 1 pill two times a day for 2 weeks and then switch to once daily indefinitely. \n- prednisone 1 MG Oral Tablet, through Oral route, started on 2008-07-20, presumably until 2009-04-03. Instructions: take 2 mg by mouth daily. \n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, started on 2008-07-20, presumably until 2008-07-22\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2008-07-20, presumably until 2009-04-03. Instructions: take 200 mg by mouth 2 times a day. \n- lanthanum carbonate 750 MG Chewable Tablet, through Oral route, presumably until 2009-04-03. Instructions: take by mouth. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-07-19, presumably until 2008-07-20\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-20, presumably until 2008-07-20\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-07-21, presumably until 2008-07-21\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2008-07-19, presumably until 2008-07-19\n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2008-07-21, presumably until 2008-07-21\n- albuterol 5 MG/ML Inhalation Solution, through Intravenous route, started on 2008-07-20, presumably until 2008-07-20\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-20, presumably until 2008-07-21\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2008-07-20, presumably until 2008-07-20\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-07-20, presumably until 2008-07-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-10-01 07:25:00, ended at 2008-10-01 17:15:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body wall\n- Inguinal hernia\n\n### Drug\n- epoetin alfa 10000 UNT/ML Injectable Solution, presumably until 2009-04-03. Instructions: 1 mL by Injection route as needed Every other week\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-10-01, presumably until 2008-10-01\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2008-10-01, presumably until 2008-10-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2009-02-24 15:00:00, ended at 2009-02-26 15:40:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 17.7 (gram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 39 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 16.3 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 42.5 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Prothrombin time (PT): 14.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 52 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 373 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 99 (thousand per microliter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 21.5 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 65.6 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.24 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.1 (percent)\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 132 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure\n- Sepsis\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Disorder of phosphorus metabolism\n- Nausea and vomiting\n- Epilepsy\n- Hyperparathyroidism due to renal insufficiency\n- Kidney disease\n- Primary bacterial peritonitis\n- Systemic lupus erythematosus\n- Essential hypertension\n- Peritonitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2009-02-24, presumably until 2009-02-26\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-24\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 100 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- 0.4 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe, started on 2009-02-25, presumably until 2009-02-25\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- diatrizoate, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- prochlorperazine 5 MG/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-24\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-26\n- diatrizoic acid, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2009-02-24, presumably until 2009-02-26\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-02-25, presumably until 2009-02-25\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-02-24, presumably until 2009-02-24\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2009-02-24, presumably until 2009-02-24\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2009-02-24, presumably until 2009-02-24\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2009-02-26, presumably until 2009-02-26\n- ceftazidime 1000 MG Injection, through Intravenous route, started on 2009-02-26, presumably until 2009-04-03, with quantity of 0.0, with intended 0 refill(s). Instructions: 1 g by Intravenous route daily. \n- ciprofloxacin 750 MG Oral Tablet, through Oral route, started on 2009-02-26, presumably until 2009-04-03, with quantity of 13.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- methylprednisolone 125 MG Injection, started on 2009-02-24, presumably until 2009-02-24\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2009-02-24, presumably until 2009-02-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2009-04-03 16:31:00, ended at 2009-04-04 10:50:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 4.961\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 13.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 128 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Prothrombin time (PT): 13.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 135 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 57.5 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5 due to hypertension\n- Congenital anomaly of esophagus\n- Kidney disease\n- Disorder of peritoneal dialysis catheter\n- Gastroesophageal reflux disease\n- Systemic lupus erythematosus\n- Hyperparathyroidism\n- Hypo-osmolality and or hyponatremia\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Primary bacterial peritonitis\n- Anemia of chronic disease\n- Epilepsy\n\n### Drug\n- gentamicin 0.003 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2009-04-04, presumably until 2010-04-04, with intended 1 refill(s). Instructions: 0.5 Inches by Both Eyes route 3 times a day. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-04\n- lanthanum carbonate 1000 MG Chewable Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 1 Tab by mouth 3 times a day. \n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2009-09-21. Instructions: take 1 Tab by mouth 3 times a day with meals. \n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, presumably until 2011-06-04. Instructions: take 50000 Units by mouth every month. \n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2011-06-04. Instructions: take 10 mg by mouth daily. \n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2009-04-04\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2009-04-04\n- rabeprazole sodium 20 MG Delayed Release Oral Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 20 mg by mouth daily. \n- prednisone 1 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-09-21. Instructions: take 4 mg by mouth daily. \n- sevelamer hydrochloride 400 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-03\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-04\n- promethazine hydrochloride 25 MG Rectal Suppository, through Rectal route, presumably until 2011-06-04. Instructions: 25 mg by Rectal route daily as needed \n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2010-04-04, with quantity of 11.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every other day. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-04-04, presumably until 2009-04-04\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-04-03, presumably until 2009-04-03\n- metoclopramide 10 MG Oral Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 10 mg by mouth daily as needed \n- ceftazidime 1000 MG Injection, through Intravenous route, started on 2009-04-03, presumably until 2009-04-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-21 16:19:39, ended at 2009-09-21 18:10:30\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.842\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Systemic lupus erythematosus\n- End-stage renal disease\n\n### Drug\n- lanthanum carbonate 1000 MG Chewable Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 1000 mg by mouth daily. \n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2012-05-12. Instructions: take 2-3 Tabs by mouth 3 times a day with meals. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-03 09:36:00, ended at 2010-03-03 14:10:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Radiologic examination, abscess, fistula or sinus tract study, radiological supervision and interpretation\n- Exchange of previously placed abscess or cyst drainage catheter under radiological guidance (separate procedure)\n- Change of percutaneous tube or drainage catheter with contrast monitoring (eg, genitourinary system, abscess), radiological supervision and interpretation\n- X-ray, other and unspecified\n- Contrast injection for assessment of abscess or cyst via previously placed drainage catheter or tube (separate procedure)\n\n### Condition\n- Abdominal pain\n- End-stage renal disease\n- Mechanical complication of device\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 10:20:00, ended at 2010-04-09 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Chronic glomerulonephritis associated with another disorder\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-14 10:20:00, ended at 2010-04-14 15:07:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Chronic glomerulonephritis associated with another disorder\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-14 15:08:00, ended at 2010-04-14 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-20 00:10:00, ended at 2010-12-20 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-12-22 22:24:00, ended at 2010-12-23 00:05:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Peritoneal dialysis catheter maintenance\n\n### Condition\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Complication associated with device\n- Disorder of peritoneal dialysis catheter\n- Epilepsy\n- Complication of renal dialysis\n- Complication of internal prosthetic device\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-26 15:23:00, ended at 2010-12-26 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-01 00:10:00, ended at 2011-01-01 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-08 14:30:00, ended at 2011-01-08 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-09 00:00:00, ended at 2011-01-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-25 14:30:00, ended at 2011-01-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-30 14:30:00, ended at 2011-01-30 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-02 14:30:00, ended at 2011-02-02 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-04 09:20:00, ended at 2011-06-04 18:35:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 90 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Insertion of tunneled intraperitoneal catheter for dialysis, open\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Creation of cutaneoperitoneal fistula\n\n### Condition\n- Systemic lupus erythematosus\n- End-stage renal disease\n\n### Drug\n- estrogens, conjugated (USP) 0.625 MG/ML Vaginal Cream, through Topical route, presumably until 2012-05-12. Instructions: 0.5 g by Topical route daily. Pt reports not using  \n- simvastatin 10 MG Oral Tablet, through Oral route, presumably until 2012-05-12. Instructions: take  by mouth every bedtime.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-04, presumably until 2012-05-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- epoetin alfa 10000 UNT/ML Injectable Solution, presumably until 2012-05-12. Instructions: by Injection route. Every other week \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-06-04, presumably until 2011-12-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-18 11:05:00, ended at 2011-06-18 17:08:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n\n### Procedure\n- Removal of peritoneal drainage device\n- Incision of peritoneum\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Collection of venous blood by venipuncture\n- Removal of tunneled intraperitoneal catheter\n\n### Condition\n- Disorder of peritoneal dialysis catheter\n- End-stage renal disease\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Kidney disease\n- Systemic lupus erythematosus\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-18, presumably until 2012-05-11, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-06-18, presumably until 2011-12-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-01-25 12:29:00, ended at 2012-01-25 19:12:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 4.25 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.10 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 20.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 401 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 6.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Reticulocytes [#/volume] in Blood by Automated count: 88.8 (thousand per microliter)\n\n### Procedure\n- Splitting of blood or blood products, each unit\n- Transfusion, blood or blood components\n\n### Condition\n- Gastroesophageal reflux disease\n- Systemic lupus erythematosus\n- Anemia\n- End-stage renal disease\n- Hyperparathyroidism due to renal insufficiency\n- Dieulafoy's vascular malformation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-02-18 00:00:00, ended at 2012-02-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-19 16:13:00, ended at 2012-02-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 12.6 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 57.4 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-11 16:23:00, ended at 2012-04-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-29 00:00:00, ended at 2012-04-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 15:33:00, ended at 2012-04-30 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- MCV [Entitic volume] by Automated count: 88.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.6 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 67.7 (second)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.77 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-01 00:00:00, ended at 2012-05-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-01 20:25:00, ended at 2012-05-01 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-05-06 13:25:00, ended at 2012-05-11 13:30:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.62 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.32 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.8 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Prothrombin time (PT): 12.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 3.386\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 59.1 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 213 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Incision of peritoneum\n- Removal of peritoneal drainage device\n- Other kidney transplantation\n- Peritoneal dialysis\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view, frontal\n- Transplant from live related donor\n\n### Condition\n- Gastroesophageal reflux disease\n- Hypercoagulability state\n- Mitral valve disorder\n- Disorder of peritoneal dialysis catheter\n- End-stage renal disease\n- Hyperparathyroidism due to renal insufficiency\n- Disorder of phosphorus metabolism\n- Disorder of nasal cavity\n- Atelectasis\n- Dieulafoy's vascular malformation\n- Cardiomegaly\n- Degeneration of intervertebral disc\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Epilepsy\n- Chronic glomerulonephritis associated with another disorder\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Systemic lupus erythematosus\n- Anemia\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous gluconate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous fumarate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous ascorbate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron,peptonized, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous succinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous bisglycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous cysteine glycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous aspartate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ammonium ferrous sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- soy protein-iron complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-09\n- ferrous carbonate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2012-05-07, presumably until 2012-05-11\n- ferrous glycine sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- folic acid, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-05-07, presumably until 2012-05-10\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-08\n- iron succinyl milk protein complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron-dextran complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- teferrol, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-07\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2012-05-07, presumably until 2012-05-07\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- tacrolimus 5 MG Oral Capsule, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous asparto glycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-07\n- ferrous cacodylate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-05-09, presumably until 2012-05-09\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-05-09\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-05-11\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2012-05-09, presumably until 2012-05-10\n- iron, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous oxalate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-05-07, presumably until 2012-05-09\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-08\n- iron sucrose, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron carbonyl, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-09\n- ferrous lactate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous chloride, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2012-05-11, presumably until 2012-05-11\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-09\n- iron sorbitex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous phosphate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- methylprednisolone 125 MG Injection, started on 2012-05-08, presumably until 2012-05-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-09 00:00:00, ended at 2012-05-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-09 00:00:00, ended at 2012-05-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-12 08:52:00, ended at 2012-05-12 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.7 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 196 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.58 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 11.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 222 (unit per liter)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Chronic glomerulonephritis associated with another disorder\n- Dizziness and giddiness\n- Chronic postoperative pain\n- End-stage renal disease\n- Epigastric pain\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-12 09:26:05, ended at 2012-05-12 10:46:20\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, through Oral route, presumably until 2012-05-15. Instructions: take 6.25 mg by mouth 2 times a day with meals.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-15 09:31:00, ended at 2012-05-15 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 205 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 195 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 198 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-15 09:52:43, ended at 2012-05-15 10:43:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-19 10:41:00, ended at 2012-05-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: >30.0 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 211 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.93 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-19 11:09:34, ended at 2012-05-19 12:30:09\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Immune defect\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-22 10:24:00, ended at 2012-05-22 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 160 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 186 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.89 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 227 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperparathyroidism due to renal insufficiency\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-22 11:00:36, ended at 2012-05-22 12:04:54\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Systemic lupus erythematosus\n- Hyperparathyroidism due to renal insufficiency\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-26 00:00:00, ended at 2012-05-26 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-26 09:21:52, ended at 2012-05-26 10:13:43\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted kidney present\n- Immune defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-26 10:17:00, ended at 2012-05-26 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.17 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.1 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 217 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 194 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 12.1 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Immune defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 12:00:00, ended at 2012-05-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); simple\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-29 09:38:00, ended at 2012-05-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 187 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 168 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 10.1 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.37 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-05 09:13:00, ended at 2012-06-05 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 181 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 46.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 234 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 231 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 168 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.56 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 14.5 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Leukopenia\n- Immune defect\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-05 09:52:37, ended at 2012-06-05 10:52:38\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Transplanted kidney present\n- Immune defect\n- Leukopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-12 09:23:00, ended at 2012-06-12 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 177 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 193 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 49.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.2 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.91 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.64 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-19 10:36:00, ended at 2012-06-19 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 178 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 11.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 190 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 212 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-19 11:19:17, ended at 2012-06-19 11:44:05\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2012-06-20, presumably until 2013-06-20, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-26 09:55:00, ended at 2012-06-26 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 210 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.7 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 233 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-26 10:26:03, ended at 2012-06-26 13:37:29\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.764\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Chronic kidney disease\n- Immune defect\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-10 09:09:00, ended at 2012-07-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 212 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 232 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 47.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.43 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.9 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Leukopenia\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-10 09:28:21, ended at 2012-07-10 10:23:22\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Transplanted kidney present\n- Primary diagnosis: Leukopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-17 09:08:00, ended at 2012-07-17 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 201 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.56 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 13.5 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 47.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- MCV [Entitic volume] by Automated count: 93.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 37.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 132 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-24 09:52:00, ended at 2012-07-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 181 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-03-10 21:46:00, ended at 2008-03-11 14:25:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.50 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma: 34.2 (microgram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 135 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-20 01:45:00, ended at 2008-07-22 12:47:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 38 (percent)\n- Sodium [Moles/volume] in Blood: 130 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.2 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 54.6 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.9 (percent)\n- Prothrombin time (PT): 14.2 (second)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.44 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.5 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 5.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 22 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 7.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Chronic kidney disease stage 5 due to hypertension\n- Diaphragmatic hernia\n- Anemia in chronic kidney disease\n- Systemic lupus erythematosus\n- Nausea\n- Stricture of esophagus\n- Acute posthemorrhagic anemia\n- Mitral valve disorder\n- Hematochezia\n- Hepatic necrosis\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2008-07-22. Instructions: take 30 mg by mouth daily. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-07-21, presumably until 2008-07-22\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2008-07-20, presumably until 2008-07-21\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-19, presumably until 2008-07-20\n- prochlorperazine 5 MG/ML Injectable Solution, started on 2008-07-20, presumably until 2008-07-20\n- lamotrigine 200 MG Oral Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 200 mg by mouth 2 times a day. \n- atorvastatin 10 MG Oral Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 10 mg by mouth every bedtime. \n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-07-21, presumably until 2008-07-21\n- rabeprazole sodium 20 MG Delayed Release Oral Tablet, through Oral route, started on 2008-07-22, presumably until 2009-04-03, with quantity of 90.0, with intended 5 refill(s). Instructions: take 20 mg by mouth 2 times a day. Take Aciphex 1 pill two times a day for 2 weeks and then switch to once daily indefinitely. \n- prednisone 1 MG Oral Tablet, through Oral route, started on 2008-07-20, presumably until 2009-04-03. Instructions: take 2 mg by mouth daily. \n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, started on 2008-07-20, presumably until 2008-07-22\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2008-07-20, presumably until 2009-04-03. Instructions: take 200 mg by mouth 2 times a day. \n- lanthanum carbonate 750 MG Chewable Tablet, through Oral route, presumably until 2009-04-03. Instructions: take by mouth. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-07-19, presumably until 2008-07-20\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-20, presumably until 2008-07-20\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-07-21, presumably until 2008-07-21\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2008-07-19, presumably until 2008-07-19\n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2008-07-21, presumably until 2008-07-21\n- albuterol 5 MG/ML Inhalation Solution, through Intravenous route, started on 2008-07-20, presumably until 2008-07-20\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-20, presumably until 2008-07-21\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2008-07-20, presumably until 2008-07-20\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-07-20, presumably until 2008-07-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-10-01 07:25:00, ended at 2008-10-01 17:15:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body wall\n- Inguinal hernia\n\n### Drug\n- epoetin alfa 10000 UNT/ML Injectable Solution, presumably until 2009-04-03. Instructions: 1 mL by Injection route as needed Every other week\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-10-01, presumably until 2008-10-01\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2008-10-01, presumably until 2008-10-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2009-02-24 15:00:00, ended at 2009-02-26 15:40:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 17.7 (gram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 39 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 16.3 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 42.5 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Prothrombin time (PT): 14.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 52 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 373 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 99 (thousand per microliter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 21.5 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 65.6 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.24 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.1 (percent)\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 132 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure\n- Sepsis\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Disorder of phosphorus metabolism\n- Nausea and vomiting\n- Epilepsy\n- Hyperparathyroidism due to renal insufficiency\n- Kidney disease\n- Primary bacterial peritonitis\n- Systemic lupus erythematosus\n- Essential hypertension\n- Peritonitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2009-02-24, presumably until 2009-02-26\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-24\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 100 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- 0.4 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe, started on 2009-02-25, presumably until 2009-02-25\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- diatrizoate, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- prochlorperazine 5 MG/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-24\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-26\n- diatrizoic acid, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2009-02-24, presumably until 2009-02-26\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-02-25, presumably until 2009-02-25\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-02-24, presumably until 2009-02-24\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2009-02-24, presumably until 2009-02-24\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2009-02-24, presumably until 2009-02-24\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2009-02-26, presumably until 2009-02-26\n- ceftazidime 1000 MG Injection, through Intravenous route, started on 2009-02-26, presumably until 2009-04-03, with quantity of 0.0, with intended 0 refill(s). Instructions: 1 g by Intravenous route daily. \n- ciprofloxacin 750 MG Oral Tablet, through Oral route, started on 2009-02-26, presumably until 2009-04-03, with quantity of 13.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- methylprednisolone 125 MG Injection, started on 2009-02-24, presumably until 2009-02-24\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2009-02-24, presumably until 2009-02-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2009-04-03 16:31:00, ended at 2009-04-04 10:50:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 4.961\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 13.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 128 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Prothrombin time (PT): 13.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 135 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 57.5 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5 due to hypertension\n- Congenital anomaly of esophagus\n- Kidney disease\n- Disorder of peritoneal dialysis catheter\n- Gastroesophageal reflux disease\n- Systemic lupus erythematosus\n- Hyperparathyroidism\n- Hypo-osmolality and or hyponatremia\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Primary bacterial peritonitis\n- Anemia of chronic disease\n- Epilepsy\n\n### Drug\n- gentamicin 0.003 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2009-04-04, presumably until 2010-04-04, with intended 1 refill(s). Instructions: 0.5 Inches by Both Eyes route 3 times a day. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-04\n- lanthanum carbonate 1000 MG Chewable Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 1 Tab by mouth 3 times a day. \n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2009-09-21. Instructions: take 1 Tab by mouth 3 times a day with meals. \n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, presumably until 2011-06-04. Instructions: take 50000 Units by mouth every month. \n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2011-06-04. Instructions: take 10 mg by mouth daily. \n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2009-04-04\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2009-04-04\n- rabeprazole sodium 20 MG Delayed Release Oral Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 20 mg by mouth daily. \n- prednisone 1 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-09-21. Instructions: take 4 mg by mouth daily. \n- sevelamer hydrochloride 400 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-03\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-04\n- promethazine hydrochloride 25 MG Rectal Suppository, through Rectal route, presumably until 2011-06-04. Instructions: 25 mg by Rectal route daily as needed \n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2010-04-04, with quantity of 11.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every other day. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-04-04, presumably until 2009-04-04\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-04-03, presumably until 2009-04-03\n- metoclopramide 10 MG Oral Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 10 mg by mouth daily as needed \n- ceftazidime 1000 MG Injection, through Intravenous route, started on 2009-04-03, presumably until 2009-04-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-21 16:19:39, ended at 2009-09-21 18:10:30\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.842\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Systemic lupus erythematosus\n- End-stage renal disease\n\n### Drug\n- lanthanum carbonate 1000 MG Chewable Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 1000 mg by mouth daily. \n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2012-05-12. Instructions: take 2-3 Tabs by mouth 3 times a day with meals. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-03 09:36:00, ended at 2010-03-03 14:10:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Radiologic examination, abscess, fistula or sinus tract study, radiological supervision and interpretation\n- Exchange of previously placed abscess or cyst drainage catheter under radiological guidance (separate procedure)\n- Change of percutaneous tube or drainage catheter with contrast monitoring (eg, genitourinary system, abscess), radiological supervision and interpretation\n- X-ray, other and unspecified\n- Contrast injection for assessment of abscess or cyst via previously placed drainage catheter or tube (separate procedure)\n\n### Condition\n- Abdominal pain\n- End-stage renal disease\n- Mechanical complication of device\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 10:20:00, ended at 2010-04-09 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Chronic glomerulonephritis associated with another disorder\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-14 10:20:00, ended at 2010-04-14 15:07:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Chronic glomerulonephritis associated with another disorder\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-14 15:08:00, ended at 2010-04-14 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-20 00:10:00, ended at 2010-12-20 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-12-22 22:24:00, ended at 2010-12-23 00:05:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Peritoneal dialysis catheter maintenance\n\n### Condition\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Complication associated with device\n- Disorder of peritoneal dialysis catheter\n- Epilepsy\n- Complication of renal dialysis\n- Complication of internal prosthetic device\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-26 15:23:00, ended at 2010-12-26 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-01 00:10:00, ended at 2011-01-01 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-08 14:30:00, ended at 2011-01-08 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-09 00:00:00, ended at 2011-01-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-25 14:30:00, ended at 2011-01-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-30 14:30:00, ended at 2011-01-30 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-02 14:30:00, ended at 2011-02-02 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-04 09:20:00, ended at 2011-06-04 18:35:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 90 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Insertion of tunneled intraperitoneal catheter for dialysis, open\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Creation of cutaneoperitoneal fistula\n\n### Condition\n- Systemic lupus erythematosus\n- End-stage renal disease\n\n### Drug\n- estrogens, conjugated (USP) 0.625 MG/ML Vaginal Cream, through Topical route, presumably until 2012-05-12. Instructions: 0.5 g by Topical route daily. Pt reports not using  \n- simvastatin 10 MG Oral Tablet, through Oral route, presumably until 2012-05-12. Instructions: take  by mouth every bedtime.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-04, presumably until 2012-05-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- epoetin alfa 10000 UNT/ML Injectable Solution, presumably until 2012-05-12. Instructions: by Injection route. Every other week \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-06-04, presumably until 2011-12-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-18 11:05:00, ended at 2011-06-18 17:08:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n\n### Procedure\n- Removal of peritoneal drainage device\n- Incision of peritoneum\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Collection of venous blood by venipuncture\n- Removal of tunneled intraperitoneal catheter\n\n### Condition\n- Disorder of peritoneal dialysis catheter\n- End-stage renal disease\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Kidney disease\n- Systemic lupus erythematosus\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-18, presumably until 2012-05-11, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-06-18, presumably until 2011-12-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-01-25 12:29:00, ended at 2012-01-25 19:12:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 4.25 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.10 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 20.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 401 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 6.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Reticulocytes [#/volume] in Blood by Automated count: 88.8 (thousand per microliter)\n\n### Procedure\n- Splitting of blood or blood products, each unit\n- Transfusion, blood or blood components\n\n### Condition\n- Gastroesophageal reflux disease\n- Systemic lupus erythematosus\n- Anemia\n- End-stage renal disease\n- Hyperparathyroidism due to renal insufficiency\n- Dieulafoy's vascular malformation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-02-18 00:00:00, ended at 2012-02-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-19 16:13:00, ended at 2012-02-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 12.6 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 57.4 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-11 16:23:00, ended at 2012-04-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-29 00:00:00, ended at 2012-04-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 15:33:00, ended at 2012-04-30 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- MCV [Entitic volume] by Automated count: 88.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.6 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 67.7 (second)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.77 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-01 00:00:00, ended at 2012-05-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-01 20:25:00, ended at 2012-05-01 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-05-06 13:25:00, ended at 2012-05-11 13:30:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.62 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.32 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.8 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Prothrombin time (PT): 12.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 3.386\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 59.1 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 213 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Incision of peritoneum\n- Removal of peritoneal drainage device\n- Other kidney transplantation\n- Peritoneal dialysis\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view, frontal\n- Transplant from live related donor\n\n### Condition\n- Gastroesophageal reflux disease\n- Hypercoagulability state\n- Mitral valve disorder\n- Disorder of peritoneal dialysis catheter\n- End-stage renal disease\n- Hyperparathyroidism due to renal insufficiency\n- Disorder of phosphorus metabolism\n- Disorder of nasal cavity\n- Atelectasis\n- Dieulafoy's vascular malformation\n- Cardiomegaly\n- Degeneration of intervertebral disc\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Epilepsy\n- Chronic glomerulonephritis associated with another disorder\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Systemic lupus erythematosus\n- Anemia\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous gluconate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous fumarate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous ascorbate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron,peptonized, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous succinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous bisglycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous cysteine glycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous aspartate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ammonium ferrous sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- soy protein-iron complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-09\n- ferrous carbonate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2012-05-07, presumably until 2012-05-11\n- ferrous glycine sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- folic acid, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-05-07, presumably until 2012-05-10\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-08\n- iron succinyl milk protein complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron-dextran complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- teferrol, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-07\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2012-05-07, presumably until 2012-05-07\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- tacrolimus 5 MG Oral Capsule, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous asparto glycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-07\n- ferrous cacodylate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-05-09, presumably until 2012-05-09\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-05-09\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-05-11\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2012-05-09, presumably until 2012-05-10\n- iron, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous oxalate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-05-07, presumably until 2012-05-09\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-08\n- iron sucrose, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron carbonyl, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-09\n- ferrous lactate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous chloride, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2012-05-11, presumably until 2012-05-11\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-09\n- iron sorbitex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous phosphate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- methylprednisolone 125 MG Injection, started on 2012-05-08, presumably until 2012-05-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-09 00:00:00, ended at 2012-05-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-09 00:00:00, ended at 2012-05-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-12 08:52:00, ended at 2012-05-12 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.7 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 196 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.58 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 11.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 222 (unit per liter)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Chronic glomerulonephritis associated with another disorder\n- Dizziness and giddiness\n- Chronic postoperative pain\n- End-stage renal disease\n- Epigastric pain\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-12 09:26:05, ended at 2012-05-12 10:46:20\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, through Oral route, presumably until 2012-05-15. Instructions: take 6.25 mg by mouth 2 times a day with meals.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-15 09:31:00, ended at 2012-05-15 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 205 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 195 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 198 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-15 09:52:43, ended at 2012-05-15 10:43:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-19 10:41:00, ended at 2012-05-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: >30.0 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 211 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.93 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-19 11:09:34, ended at 2012-05-19 12:30:09\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Immune defect\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-22 10:24:00, ended at 2012-05-22 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 160 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 186 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.89 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 227 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperparathyroidism due to renal insufficiency\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-22 11:00:36, ended at 2012-05-22 12:04:54\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Systemic lupus erythematosus\n- Hyperparathyroidism due to renal insufficiency\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-26 00:00:00, ended at 2012-05-26 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-26 09:21:52, ended at 2012-05-26 10:13:43\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted kidney present\n- Immune defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-26 10:17:00, ended at 2012-05-26 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.17 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.1 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 217 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 194 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 12.1 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Immune defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 12:00:00, ended at 2012-05-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); simple\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-29 09:38:00, ended at 2012-05-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 187 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 168 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 10.1 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.37 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-05 09:13:00, ended at 2012-06-05 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 181 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 46.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 234 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 231 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 168 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.56 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 14.5 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Leukopenia\n- Immune defect\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-05 09:52:37, ended at 2012-06-05 10:52:38\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Transplanted kidney present\n- Immune defect\n- Leukopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-12 09:23:00, ended at 2012-06-12 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 177 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 193 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 49.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.2 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.91 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.64 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-19 10:36:00, ended at 2012-06-19 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 178 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 11.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 190 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 212 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-19 11:19:17, ended at 2012-06-19 11:44:05\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2012-06-20, presumably until 2013-06-20, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-26 09:55:00, ended at 2012-06-26 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 210 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.7 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 233 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-26 10:26:03, ended at 2012-06-26 13:37:29\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.764\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Chronic kidney disease\n- Immune defect\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-10 09:09:00, ended at 2012-07-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 212 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 232 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 47.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.43 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.9 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Leukopenia\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-10 09:28:21, ended at 2012-07-10 10:23:22\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Transplanted kidney present\n- Primary diagnosis: Leukopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-17 09:08:00, ended at 2012-07-17 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 201 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.56 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 13.5 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 47.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- MCV [Entitic volume] by Automated count: 93.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 37.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 132 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-24 09:52:00, ended at 2012-07-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 181 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of intestine within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of intestinal_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "f33c524e957f0bc5539b59258cb6215da761de280c5b4a44e8d1f3c79ab3e737", "prompt_hash": "457c6176d6bc419c7db13cd6c37c23a8b875c3973d49bf5054b1a256bf6700b0", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
